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The pharmaceutical analysis of illicit drugs and the associated impurity profiling 
can contribute to a harm reduction approach.  Impurities in illicit drugs represent a complex 
problem that requires detailed and reproducible analysis, in part because cutting agents are 
not often reported by the forensic science community.  This research project is focussed on 
characterising Novel Psychoactive Substances (NPS) and determining their purity/impurity 
(adulteration) employing a wide range of spectroscopic and chromatographic methods, 
mainly NMR spectroscopy and Mass Spectrometry.  Another aim is to develop a routine, 
rapid, and quantitative analytical protocol to identify illicit drugs and their impurities 
(cutting agents) in seized street samples.  These two major aims were achieved. 
A comprehensive, but critical review of the current literature is provided with 
respect to the analytical chemistry aspects of illicit drugs and especially their cutting agents.  
This literature review has a focus on the global concern arising from the current and 
continuing emergence of NPS and their diverse public health effects.  Evidence is provided 
of illegal drugs, mainly so-called “legal highs” (NPS), from detailed analysis of the 
contents of amnesty bins and their adulterants provided by the Police from a Bristol night 
club and from the 2013 Glastonbury music festival, besides other samples they had seized.  
An accurate chemical assignment of flephedrone regioisomers is made and compared with 
mephedrone.  Impurity profiling of street mephedrone and ketamine samples and their 
adulterants is presented.  A possible link between mephedrone samples is investigated by 
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Introduction to impurity profiling of illicit drugs 
 
1.1. New Psychoactive Substances 
 
According to the 2014/15 Crime Survey for England and Wales (CSEW) data, 
2.8 million (8.6%) people aged between 16 and 59 had taken illicit drugs in the previous 
year [1].!!Of 3,346 drug-poisoning deaths in England, 2,248 (67%) were linked to drug 
misuse [2].  Drug legislation in the UK classifies illicit drugs under the Misuse of Drugs 
Act 1971 into three classes:  A, B, and C.  These are related to their potential harms and 
define the maximum penalties for supply, possession, or cultivating drugs.  The 
classification assigned is about probable harm to the user and reflects the possible 
sentence that might arise for supply or possession of these illicit substances [3]. 
In recent years, new types of drugs have emerged in the illicit drugs market 
around the world called New Psychoactive Substances (NPS), “designer drugs” or 
“legal highs”.  Most NPS are not internationally controlled [4], but more than 100 
countries (Fig. 1) reported NPS to the United Nations Office on Drugs and Crime 
(UNODC) [4].  NPS were originally designed to avoid current illicit-drugs legislation 
by creating compounds with similar chemical structures and therefore similar 
pharmacological effects to the existing illegal drugs such as cannabis, LSD, and 




Fig. 1.  Global emergence of NPS up to December 2015. 
Source:  UNODC, Early Warning Advisory on NPS (2015), [5] 
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NPS are usually sold on the internet under different names, such as “research 
chemical”, “bath salt” or “legal high” [6, 7].  This global phenomenon of NPS use and 
supply has brought in to circulation many potent illicit drugs with serious health 
concerns related to their unknown pharmacology and toxicology.  Deaths (60) have 
been linked to the consumption of NPS in England and Wales in 2013 [8].  The term 
“New” refers to the availability of the illicit drugs in the black market and not as new 
inventions.  For instance, the synthetic drug ketamine was invented in the early 1960s, 
but its chemistry was modified recently (e.g. methoxetamine, MXE) to introduce new 
drugs with similar pharmacological effects to the original one [9].  Cathinone is a main 
core for the NPS synthetic cathinones which all carry a characteristic β-keto group on 
the side-chain of the phenethylamines (Fig. 2).  This NPS group was first reported 
occurring in the drugs market around 2005.  The earliest reported synthetic cathinone 
related to MDMA is methylone, 2005, followed by mephedrone (4-methylmeth-
cathinone) 2007, and then 3,4-methylenedioxypyrovalerone (MDPV), 2008.  Both 
methylone and mephedrone are among the most used drugs across Europe [10]. 
 
 
Fig. 2.  Synthetic cathinones and their structural similarities to cathinone, 
together with the cathinone-MDMA derivative methylone 
 
According to the European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA), 101 new NPS were detected in 2014 besides 349 previously reported, 
these include:  cathinones, cannabinoids, tryptamines, phenethylamines, opioids, 
benzodiazepines, arylalkylamines, and 13 substances not classified under any group 





Fig. 3.  Number of NPS reported to the EU Early Warning System (EWS) up to 2015. 
Source:  EMCDDA, NPS in Europe (2015), [11] 
 
The number of NPS was raised to 600 in December 2015 by the Early Warning 
Advisory (EWA) [4].  The NPS are classified into groups based on their similarity to 
the existing illicit drugs by the United Nations Office on Drugs and Crime (UNODC) 
including synthetic cannabinoids, synthetic cathinones, hallucinogens, dissociative 
anaesthetics, opioids, sedatives besides a group not as yet assigned.  These were 
invented to mimic the effects of the existing drugs, e.g. synthetic cannabinoids as a 
cannabis alternative, synthetic cathinones have stimulant effects similar to cathinone 
with similar empathy feeling, and phenylethylamines can show both stimulant, e.g. 
amphetamines, and hallucinogenic, e.g. 2,5-dimethoxy-4-bromophenethylamine (2C-B), 
2,5-dimethoxy-4-methylamphetamine (DOM) effects [4]. 
Over the last decade, the market in NPS has been growing very quickly 
producing challenges to the drugs control systems to monitor these drugs.  Among all 
the NPS, synthetic cathinones and synthetic cannabinoids are the most cause for 
concern with 1.6 and 1.1 tonnes respectively seized in Europe during 2013 (Fig. 4).  
Synthetic cathinones form the second largest NPS group monitored by the EMCDDA 
[11].  The number of new designer cathinones reported during 2014 was 31.  This 
serves to highlight the expansion and the dynamic growth of the NPS market.  The 
explanation of this phenomenon can be linked to different reasons such as more 





Fig. 4.  Number of NPS seizures by country in 2013. 
Source:  EMCDDA, NPS in Europe (2015), [11] 
 
1.2. Impurity profiling for investigation of NPS 
 
The high similarity between NPS can make the drugs identification challenging 
[12].  In the illicit drugs journey from the producer to the abuser, the drugs travel 
through different stages including trafficker, distributor and supplier.  At each of these 
stages, additional substances are commonly added to bulk-out the drugs and make more 
profit.  These substances are known as diluents and adulterants [13].  However, most 
street drugs contain other impurities beside these ingredients.  Impurities are usually due 
to inexperienced clandestine manufacture, impure starting materials, poor handling and 
storage conditions.  Remaining solvents, synthetic precursors, by-products, degradation 
and contaminations can provide valuable information relating to a specific route of 
synthesis.  Investigating impurities in illicit drug seizures, by means of identification 
and quantification, can help to link between different batches and possibly to their 
clandestine laboratories.  Consequently, impurities can be used as a “marker” or 
“signature” in the impurity profiling investigation [14]. Both chemical and physical 
profiling of illicit drugs in loose form, tablets and packaging can be sufficient for a 






Adulterants can be defined as any pharmacologically active ingredients added 
deliberately to enhance the drugs’ effect or to facilitate drug administration.  For 
instance, caffeine and procaine are commonly mixed with heroin to help vaporise the 
drug at a lower temperature [17].  Some adulterants are added by the users themselves 
during drug administration, e.g. mixing heroin (presumably the free base) with citric 
acid to make a citrate salt as an injectable formulation [18].  Moreover, drug dealers cut 
their drugs to mimic the effect of the main drug and/or to mask poor drug quality.  
Topical anaesthetics such as procaine and lidocaine mimic the numbing effect of 
cocaine and are used to cut cocaine or might even be sold (to the unwary) as cocaine 
itself.  Cocaine is commonly cut with phenacetin as it is similar to cocaine in its 
physical properties [18].  Drug dealers also use easily accessible benzocaine as a cutting 
agent [19].  Paracetamol gives a similar bitter taste to heroin and thus is used to cut 
heroin [20].  Caffeine is a stimulant frequently used to cut other stimulants, e.g. ecstasy, 
amphetamine, cocaine [18].  In diverted drugs or abused prescription drugs, the 




Inert substances that are used to bulk out the drugs are called diluents.  These 
usually have a similar physical appearance to the drugs themselves.  Sugars are mostly 
used due to their availability and weight.  According to Grabowski’s 1984 report [21] in 
the National Institute on Drug Abuse (NIDA), cocaine is mostly diluted with mannitol, 
lactose, or inositol [21]. 
 
1.3. Harm associated with drug adulterations 
 
The adulterants and impurities discussed above are usually introduced during 
manufacture, storage or distribution.  Typically, drug dealers attempt to cut their drugs 
with safe and available materials as they want to satisfy their customers and keep their 
business [22, 23].  The kind and the amount of the cutting agents are usually 
recommended by drug dealers themselves.  However, the safety of these adulterants 
vary and dangerous adulterants have occasionally been reported, e.g. rat poison, ground 
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glass [18, 22].  Heroin and cocaine are recounted to be the most adulterated drugs [20]; 
evidence on their cutting agents, licit use, and health consequences are listed in Table 1. 
 
Table 1 
Adulterants reported in street samples of heroin and cocaine together with their licit use 
and health risk consequences 
 




One of the adverse effects from drug abuse is overdose.  This can be as a result 
of poor quality and purity [18, 24].  When abusers are taking a non-pure (adulterated) 
drug for the first time, they may think that this is a suitable dose for them and then may 
suffer an overdose on the next use with a pure sample.  Also, users may attempt to 
exchange their experience on doses [25] and mixing their drugs, which could be 
dangerous as they can develop tolerance and this will most likely vary between them. 
In Canada, the main cause of death among drug addicts is overdose, and that 
especially among opioids users [26].  Poisonings and deaths have been reported due to 
the administration of adulterated cocaine, see Table 2 [18, 27, 28, 29].  Adulterants that 
are added to facilitate specific drug delivery, such as injection or smoking, are typically 
dangerous.  For example, some adulterants are added to facilitate smoking, e.g. caffeine, 
but users may inject them instead.  This can produce serious harm due to the presence of 
particles or bacteria, and even potentially the presence of other drugs leading to 
overdose [30].  Infection of users by bacteria, such as Bacillus and Clostridium species, 




Three adverse health effects caused by consuming adulterated cocaine 
Ref Year Location Details Analysis 
[27] 1992 USA 
One case of methemoglobinemia 
due to ingestion of street cocaine 




[28] 1982 Dublin, 
Ireland 
Eight cases of strychnine 
poisoning caused by the 
inhalation of a substance which 












Acute intoxication of cocaine 
adulterated with phenacetin (an 
analgesic) of a 25 year old male 
who had 24 packages of cocaine 
in his digestive tract 
Analysis of the 
cocaine and also 
urine, blood and 
gastric content 
confirmed cocaine 
with a 30% 
concentration of 
phenacetin 




1.4. Analysis of adulterants contributes to harm reduction 
 
Despite the serious risks associated with the presence of adulterants contributes 
to in the illicit drugs, these substances are normally neglected during analysis [18, 31].  
At minimal amounts adulterants are generally not life-threatening, but they might cause 
serious health risks at high doses.  Analysis of the adulterants present in drugs and 
identifying their patterns of occurrence could be extremely important to aid workers in 
hospital emergency departments.  Providing treatment to a person who has taken an 
adulterated drug can be critical and challenging.  Medical staff in the Emergency Room 
should have knowledge and training about the common adulterants used to cut drugs 
and their possible side-effects if mixed with drugs.  Furthermore, monitoring adulterants 
in drugs can aid law enforcement in their forensic investigation to tackle drug 
trafficking, distribution, and associated crime [32]. 
Due to the global impact of the drugs problem, including health costs, especially 
with the increase in the number of clandestine laboratories and variety of adulterants 
being used, strategies have been implemented to profile drugs and their impurities.  
These drug testing strategies have been adopted by several different countries.  In 2001, 
the international drug control leader, UNODC released a manual for 
characterization/impurity profiling of seized drugs to be used by international law 
enforcement and drug testing laboratories [13].  One of the most recognized drugs 
monitoring agencies in Europe is the EMCDDA.  This independent scientific research 
body was founded in 1993 to provide evidence related to illicit drugs and their health 
consequences, rates of addiction, and monitoring drugs trends across Europe [11]. 
Since the 1990s, the Drug Information and Monitoring System (DIMS) project 
in the Netherlands has been active in monitoring drugs and any associated harm related 
to the content of street drugs.  Over 100,000 samples have been handed in to this agency 
to be analysed, and users were informed if there was any harm associated with their 
sample [33].  Another international project, the Trans European Drug Information 
(TEDI) project was launched for drug testing in Europe; Austria, Belgium, Portugal, 
Spain, Switzerland, and the Netherlands collaborated in this project.  The analysis 
covered the main illicit drugs, besides NPS, between 2008 and 2013 with 45,859 
samples analysed.  The project findings show a similarity in the drugs market with some 
interesting differences related to NPS and MDMA [34]. 
The National Drug Treatment Monitoring System (NDTMS) is a Government 
Institution to monitor illicit drugs in England based on people receiving treatments for 
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drug misuse [35].  As a response to the emergence of NPS, the UK Home Office funded 
the Forensic Early Warning System (FEWS) in 2011.  The responsibility of the FEWS 
is to monitor NPS in the UK in order to inform the Advisory Council on the Misuse of 
Drugs (ACMD) about any suspicious NPS [36]. 
Drug abuse in England, Northern Ireland, Scotland, and Wales is also monitored 
by The United Kingdom (UK) Focal Point on Drugs which is based within Public 
Health England (PHE).  This national partner agency works in parallel with the UK 
Home Office and supports the EMCDDA by providing regular reports and 
questionnaires about drugs trends in the UK [37].  The Australian Government has 
launched the Australian Illicit Drug Intelligence Program (AIDIP) for illicit drugs 
chemical profiling and monitoring between the Australian Federal Police and the 
National Measurement Institute of Australia (NMIA).  This agency is also collaborating 
with many other national and international drugs institutes [38]. 
 
1.5. Understanding polydrug use 
 
Adulterants in illicit drugs can also be added by the last person in the drug chain, 
the users themselves.  It is common among drug users to mix their drugs during a single 
drug event to enhance effects or to facilitate drug delivery [39, 40, 41].  This practise is 
called polydrug use.  The risk of drug overdose [42], HIV and Hepatitis C [42], and 
drug dependence [44] is high among these kind of users.  Polydrug users’ attitudes can 
be categorized into three different types: 
i.! Mixing two different drugs to enhance the effects [45].  This is common among 
cannabis and cocaine users by combining these two drugs with alcohol.  Another 
example is a combination of heroin with benzodiazepines or an opioid such as 
methadone or oxycodone [46].  Ketamine polydrug users commonly use marijuana, 
alcohol, PCP (angel dust), and amphetamine (speed) [47].  This is possibly to try and 
reduce the unwanted effects of a drug by sequencing the amount of time between the 
first and second substance. 
ii.! Taking another drug in combination in order to reduce the dependence on other 
drug gradually.  For instance, using cocaine and heroin mixture to balance the 
withdrawal symptoms of heroin, this is known as “speedball” [44, 47]. 
iii.! Replace the drug with other drugs due to fluctuations in the price, availability, or 
regulation.  For instance, oxycodone and other opioids are sometimes consumed instead 
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of heroin.  MDMA is commonly replaced with mephedrone or any other available 
stimulant if the first one is not available [41]. 
Polydrug practise has been investigated by various studies.  A sequencing of 
polydrug use was reported by Lankenau and Clatts from among 40 ketamine injectors to 
understand the modes of administrating ketamine with other drugs [47].  Another 
investigation was conducted by the EMCDDA between 2009 and 2010 encompassing 
23 countries.  Opioid fatalities mostly accrue together with the presence of other 
substances including alcohol, benzodiazepines, and other opioids [48].  It is important to 
understand attitudes among polydrug abusers to predict the harm associated with these 
mixtures. 
 
1.6. Aims and Objectives 
 
Taken together, drug pharmaceutical analysis and impurity profiling contribute 
to a harm reduction approach.  Impurities in illicit drugs represent a complex problem 
that requires the sharing of knowledge from addiction studies, toxicology, criminology, 
and the pharmaceutical and forensic analysis of illicit drugs.  Furthermore, cutting 
agents are not often reported by the forensic community.  Thus, this analytical 
chemistry research project is aimed at deciphering the different aspects of impurities 
currently found in illicit drugs, by gathering information mainly from detailed 
pharmaceutical analysis of the contents of amnesty bins provided by the police from a 
Bristol night club and from the 2013 Glastonbury music festival, besides other samples 
seized by the police.  The research is focussed essentially on characterising NPS and 
determining their purity/impurity (adulteration) employing a wide range of 
spectroscopic and chromatographic methods namely, 1D and 2D NMR, ESI-MS, EA-
IRMS, GC-FID, and UHPLC-MS/MS.  Another aim arising from this approach is 
therefore to develop a routine, rapid, and quantitative analytical protocol to identify 
illicit drugs and their impurities (cutting agents) in seized street samples. 
These two major aims will be achieved through the following six objectives: 
1. Carry out a comprehensive, but critical review of the current literature 
with respect to the analytical chemistry aspects of illicit drugs and especially their 
cutting agents (chapter 2).  This literature review will have a focus on the global 
concern arising from the current and continuing emergence of NPS and their diverse 
public health effects. 
!21!
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2. Demonstrate evidence of illegal drugs, mainly so-called “legal highs” 
(NPS) available in the UK during 2013, by analysing the contents of amnesty bins using 
NMR spectroscopy as the main technique, but used together with HR-MS (chapter 3).  
An indicator of current regional drugs trends will be a valuable finding for staff working 
in hospital emergency departments with regard to the many different drug overdoses or 
drug-drug interactions with which they have to deal. 
3. Provide an accurate chemical assignment of flephedrone regioisomers 
and compare those with mephedrone by a combination of 1H, 13C, 15N, and 19F NMR 
spectroscopies (chapter 4). 
4. Impurity profiling, which includes chemical (spectroscopic) and physical 
(appearance) profiling, of street mephedrone samples and their adulterants using 1D, 
2D, and quantitative NMR (qNMR) spectroscopies (chapter 5). 
5. Investigate the possible link between mephedrone samples by applying 
PCA and HCA statistical methods to the 1H NMR data (chapter 5). 
6. Impurity profiling of seized ketamine samples by employing NMR and 
UPLC-TOF-MS/MS to provide evidence if there is any diversion of ketamine samples 
from legal sources, i.e. from doctors or veterinary surgeons, into the illicit drugs market 
in the UK (chapter 6). 
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Literature review:  Analytical aspects of illicit drugs 
 
The chemistries and the public health effects of NPS are diverse.  The global 
concern about NPS emergence was discussed recently in the UNODC publication The 
challenge of new psychoactive substances [1].  Their harmful effects, described by the 
WHO, include:  tolerance, dependence, overdose, hospitalisation, risk of Hepatitis C 
and HIV with injectable drugs, and fatalities.  Following seizures of NPS, they are 
reported frequently to be mixed with other controlled drugs (CDs), e.g. cocaine, 
methylenedioxymethylamphetamine (MDMA, ecstasy), amphetamine.  Considerable 
health risks are associated with the presence of NPS in mixtures in the absence of any 
scientific information about their purity and composition.  The increasing number of 
NPS seizures, casework in forensic science laboratories, and fatalities have given rise to 
the need for a reliable, accurate, and quick analytical methods approach in order to aid 
law enforcement to prevent abuse by potentially restricting supply [1]. 
The identification and reporting of NPS as a scientific evidence-base is 
challenging due to the high chemical similarity between NPS molecules and the broad 
absence of chemical reference standards, analytical methodologies and refereed 
literature about NPS analysis.  To confirm the identity of unknown substances normally 
requires synthesis of the drugs and then applying a wide profiling chemical analysis [2].  
This approach can be difficult and even impractical when dealing with such a dramatic 
rise in production as for the illicit drugs market such as NPS.  To address this problem, 
an international collaboration is required to share knowledge and exchange experiences 
in the analysis and monitoring of NPS.  Useful guideline protocols for the qualitative 
and quantitative illicit drug analysis were recently recommended by UNODC [3], the 
Scientific Working Group for the Analysis of Seized Drugs (SWGDRUG) [4], and the 
European Network of Forensic Sciences Institutes (ENFSI) [5]. 
Choosing a methodology for illicit drug analysis is based on various criteria 
including drug type, and availability of suitable instrumentation and reference materials.  
The basic requirement for the forensic analysis of illicit drugs in seized materials is to 
provide, to the law enforcement agency, an accurate identity with high confidence under 
professional practice.  According to SWGDRUG, analytical techniques can be placed in 
three categories:  A, B, and C based on their discriminating power (Table 1).  Category 




Categories of analytical techniques based on the SWGDRUG recommendations 
Category A Category B Category C 
Infrared Spectroscopy Capillary Electrophoresis Colour Tests 
Mass Spectrometry Gas Chromatography Fluorescence Spectroscopy 
Nuclear Magnetic Resonance 
Spectroscopy 
Ion Mobility Spectrometry Immunoassay 
Raman Spectroscopy Liquid Chromatography Melting Point 
X-Ray Diffractometry Microcrystalline Tests Ultraviolet Spectroscopy 
Source:  SWGDRUG (2011), [4] 
 
Based on the SWGDRUG recommendations for drug analysis, techniques from 
Category A should provide high professional analysis.  Though using this category is 
required, at least one other supportive technique from any of the three categories is also 
needed.  Using GC/MS is widely recommended and common in practice in illicit drug 
analysis as this combines two techniques:  GC (Category B) and MS (Category A) 
which addresses the requirements.  However, other techniques can be more suitable than 
GC/MS in analysing specific drug types or forms.  For instance, infrared spectroscopy is 
more suitable as a quick scan device for drugs in salt form possibly providing unique 
stereoisomer identification [4]. 
NPS identification using GC-MS requires comparing both the retention time and 
mass spectrum of the drug with reference materials and these are normally not available 
[3].  Furthermore, GC analysis requires a volatile and thermally stable analyte otherwise 
a derivatisation step is needed which can be time consuming [6].  On the other hand, 
NMR provides unique information related to chemical structure determination and 
drugs quantification, especially in the case of high similarity between the analytes, such 
as aromatic ring-substituted amphetamine derivatives, and even in the presence of 
impurities [3].  The Police often use colour test kits for illicit drugs detection.  This kind 
of analysis is not always reliable especially in the presence of other drugs.  For example, 
Scott Ruybal (2% cobalt thiocyanate (Co(SCN)2) in aqueous glycerine) is a presumptive 
colour test used to detect cocaine.  However, this test can provide false-positive results 
especially for drugs in mixtures such as lidocaine and ketamine, and likewise if there 
are adulterants present [7].  Other procedures should be taken into account when dealing 
with illicit drug analysis such as sampling and sample preparation.  In fact, as a small 
quantity of material is normally consumed in analysis, this amount should be 
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representative of the bulk sample.  Full details are available in national pharmacopoeias 
and from international organizations such as UNODC regarding the principle of 
sampling in drug analysis [8].  With respect to sample preparations, powders should be 
prepared at 1 mg/mL in methanol.  Tablets should be ground into a powder while the 
contents of capsules must be emptied and treated as for powder preparation procedures. 
Drug characterization and impurity profiling of illegal drugs are targeting three 
important components in seized materials:  the main active component, contaminants 
and adulterants.  In the analysis of illicit drugs, additives are known as adulterants or 
cutting agents while in pharmaceutical preparations they are known as excipients [9].  
The fact that most illicit drugs are synthetic, means that contaminants/impurities, by-
products, and even solvents can be detected in these samples.  Adulterants are another 
important content that might be present in illegal drugs.  It is debatable if these 
adulterants have been added to enhance the drugs effect, to facilitate administration, or 
to bulk-up drugs with a cheap adulterant in order to make more profit.  It is a powerful 
tool to use organic impurities and adulterants as a “marker” or “signature” to assist in 
detecting variations between different seized samples.  It is highly likely that different 
batches of drugs from a single producer are synthesized under the same conditions and, 
if the same starting materials and solvents are used, they might carry the same 
impurities [10].  Intelligence investigations can therefore be carried out in this aspect, 
employing these markers to connect between illicit drugs in different batches and even 
to their distributor networks and sources of manufacture [11, 12]. 
From an investigative perspective, chemical and physical drug 
characterization/impurity profiling can provide valuable information related to:  (a) 
determining a specific link between different seizures, (b) classifying illicit samples 
from different sources into groups, thus creating distribution patterns to monitor drug 
trafficking [13, 14], (c) determining the source of the geographical origin of the seizure 
[15].  Several research projects have been conducted worldwide and in Europe [16, 17, 
18], especially in Switzerland [19], where impurity profiling has been successfully 
conducted in monitoring illegal drug markets and trafficking investigation.  One 
example of the chemical profiling of methylamphetamine, by the National Measurement 
Institute of Australia (NMIA), is to provide intelligence to the Australian Federal Police 
that will be strategic in monitoring methylamphetamine.  Since the 1970s, sophisticated 
illicit drugs chemical profiling practises have been developed by the United States Drug 
Enforcement Administration (US DEA) and the German Bundeskriminalamt (BKA) in 
order to tackle heroin and cocaine networking and trafficking [11]. 
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2.1. Impurity profiling to determine any specific link between different seizures 
 
In the past, illicit drugs profiling was based on physical characterization only, 
such as tablet dimensions, mass, colour, and motif [6].  The first attempt to use physical 
profiling to link between seized tablets was by Gomm et al. in 1976 [6] who compared 
amphetamine and LSD tablets.  However, there are obvious limitations to this method in 
profiling illicit seized tablets, similar tablets might have different ingredients.  
Therefore, chemical profiling has emerged as a valuable tool, and is currently used 
alongside physical profiling for the impurity profiling of illicit drugs [20]. 
Techniques widely used in the impurity profiling of illicit drugs are Gas 
Chromatography, such as GC–MS [21, 22], and liquid chromatography techniques, such 
as High Performance Liquid Chromatography (HPLC) [23].  Indeed, HPLC is normally 
used to identify drugs and their impurities.  Non-destructive techniques such as 1H and 
13C NMR [24, 25], infrared (IR) [25], and ultraviolet (UV) [26] spectroscopies are also 
used. 
One of the first research projects in impurity profiling was reported by Neumann 
in 1985 in the forensic detection and impurity profiling of opium, morphine and heroin 
by using GC [26].  Ten years later, the interest in impurity profiling of illicit drugs 
started as a forensic tool to link between different drug seizures.  Signature profiles of 
alkaloidal impurities and manufacturing by-products present in processed coca leaves 
were determined using chromatographic methods [27].  This study included a wide 
variety of chromatography techniques using packed- and capillary-column GC and GC 
with flame-ionization, electron-capture, nitrogen-phosphorous, and mass spectrometric 
detection, and HPLC-UV [27]. 
An early illicit drug content and purity investigation was reported by King in 
1994 [28] where GC was used to test more than 4000 samples.  These were provided by 
the Police and Customs and had been seized over 4 years.  This impurity profiling 
investigation showed that almost all the amphetamine samples were imported from the 
Netherlands during 1993 [28]. 
In a following study [9], King examined the purity of illegal drugs in the UK and 
related to concerning when they were seized and the geographical region of the seizure.  
HPLC was used for quantitative analysis and these data were combined with the 
intelligence database of the Forensic Science Service (FSS).  A comparison has been 
made between imported illegal drugs (i.e. Customs seizures of imports) and street drugs 
(i.e. Police seizures of drugs being dealt) regarding their purity and adulterations [9]. 
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Abuse of amphetamine-type substances (ATS), e.g. amphetamine, 
methylamphetamine (MA), 3,4-methylenedioxyamphetamine (MDA), and 3,4-
methylenedioxymethylamphetamine (MDMA), is reported to be higher than both 
cocaine and heroin abuse added together [29].  In the case of synthetic drugs, 
contaminants, e.g. by-products, intermediates and impurities, can facilitate the 
identification of the synthetic route and sources of precursors.  This may link to the 
location of manufacture of these illicit drugs.  Other possible sources of impurity might 
be from packaging, poor handling, and/or degradation during storage [30]. 
Comprehensive studies have been done on the profiling of illicit MDMA tablets 
to determine their sources and link between different seizures [10, 30, 31, 32].  Cheng et 
al. examined the contents of MDMA tablets from 89 different seizures in Hong Kong 
between 2002 and 2004.  The impurity profiling was carried out using GC-MS after 
extracting the tablets in diethyl ether under alkaline conditions.  A total of 19 impurities 
were identified and used as a fingerprint to link between these different tablets.  Cutting 
agents were examined as well, e.g. caffeine.  The tablets were classified into different 
groups by Hierarchical Cluster Analysis (HCA) showing the capacity of this approach 
to discriminate between these seizures based on their sources [33]. 
Determining a specific synthesis route to MDMA by examining the impurities 
present in precursors and intermediates used, e.g. sassafras oil, safrole, isosafrole, 
piperonal, β-nitroisosafrole, piperonylmethylketone (PMK) was achieved by Gimeno et 
al. [32].  The target compound, MDMA, was synthesised using isosafrole via reductive 
amination and impurities were monitored by MS.  The results show the possibility of 
discriminating two main routes for PMK and MDMA samples by detecting traces of 
isosafrole glycol and β-nitroisosafrole in the final product. 
Research by Bora et al. [34] investigated the possible links between MDMA 
tablets by measuring elements present in the seized tablets using inductively coupled 
plasma optical emission spectrometry (ICP-OES).  A total of 248 seized MDMA tablets 
were subjected to ICP-OES analysis to measure 11 elements including:  Mg, Zn, Ca, Al, 
K, B, Na, Ba, Fe, Cu, and Pt after each sample was dissolved in nitric acid and heated in 
a microwave oven.  The results confirmed the presence of some elements that are used 
in MDMA tablet production such as Mg, Pt, and B.  Residual boron is most likely 
derived from borohydride which is used as a reducing agent, while Pt and Mg were 
potentially from PtO2 (catalyst) and magnesium stearate (tableting agent), respectively.  
It was concluded from the data that the presence of a specific metal might link to a 
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specific synthetic route.  This approach can be used to link between different tablets, 
together with the physical properties of the tablets [34]. 
In a separate study, Infante et al. [35] investigated metal contaminants derived 
from adulterants in illicit samples of heroin in southern Spain.  The contents of 198 
heroin samples were analysed focusing on 6 elements, Mn, Ca, Cu, Cd, Fe, and Zn.  
93.4% of the samples contained a high concentration of calcium.  This was mostly from 
excipients containing salts of this metal, e.g. calcium bicarbonate.  All the other listed 
elements are usually present in metal containers, where they have the potential to be 
introduced during morphine extraction from opium poppy, causing toxicity concerns 
especially in heavy users of heroin. 
Detailed analytical reference data on using three synthetic routes to MDMA 
were reported by Renton et al. [25].  Analytical chromatographic data of precursors, i.e. 
safrole and isosafrole, intermediates, namely:  isosafrole glycol, N-formyl-3,4-
methylenedioxy-amphetamine, PMK, N-formyl-3,4-methylenedioxymethyl-
amphetamine, and 1-(3,4-methylenedioxyphenyl)-2-bromopropane), by-products, and 
the final product MDMA were obtained by thin-layer chromatography (tlc) and GC-
MS.  Additional chemical structure confirmation data were determined by 1H- and 13C 
NMR, IR, and UV spectroscopies, and X-ray diffraction.  These data were used as a 
reference to monitor the synthetic route to MDMA by tracing the starting materials, 
intermediates and by-products in seized MDMA.  In a separate study by Bohn et al. 
[24], twelve impurities were characterized and used as “synthesis markers” to identify 
the synthetic route to MDMA.  They employed tlc, 1H NMR, and MS for the analysis of 
these impurities.  Similar procedures were used [30, 36] to link between MDMA tablets 
based on their impurity signature and, moreover, to identify their synthetic routes. 
A total synthetic method and impurity profiling of mephedrone were developed 
by Santali et al. [37].  In this method, mephedrone was prepared in both HCl and HBr 
salt forms.  The first chromatographic separation method was reported in this study to 
quantify mephedrone and possible adulterants; mephedrone characterization was 
supported by GC-MS, HPLC, NMR, IR, and UV data [37]. 
 
2.2. Adulterants and classifying illicit samples from different sources into groups 
 
Information related to illicit drug adulterants is usually neglected in toxicology 
or forensic laboratories, focusing only on illegal drugs identification and quantification, 
as these aspects are used by the judiciary [38].  Only really a few literature reports are 
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focused on adulterants except for those “high volume” drugs [39], e.g. heroin [40], 
cocaine [41], and amphetamine-type stimulants [16].  However, most investigations of 
adulteration are after fatality [42] or for use in judicial purposes.  One example of this is 
heroin cut with scopolamine, a medication used in the treatment of motion sickness, 
nausea and vomiting, which spread in New York City causing severe anticholinergic 
toxicity [42]. 
In their comprehensive review on adulterants in illicit drugs and their toxicity, 
Cole et al. [38] classified the reasons behind such adulterants into four causes:  to add 
bulk, to enhance or mimic biological effects, to facilitate administration, and as 
contaminants from poor manufacturing conditions.  Their review concludes that most 
common cutting agents used to cut drugs are legal, cheap, and available, e.g. caffeine, 
procaine, paracetamol, sugar (glucose, sucrose, mannitol).  Their findings confirm that 
drug dealers mostly cut drugs with benign substances, e.g. caffeine, sucrose.  Other 
adulterants are reported to be toxic at high doses and this is especially relevant in the 
case of injectable drugs [38]. 
HPLC-DAD was developed and validated to determine cocaine and its 
adulterants in seized street samples in Italy.  In this method, the authors identified 
cocaine, caffeine, lidocaine, procaine, phenacetin, and levamisole using a C-18 column 
with potassium phosphate buffer-acetonitrile mobile phase under isocratic conditions 
[43].  The method was introduced as a robust and rapid method for the routine analysis 
of cocaine and any impurities over the ranges 0.01-0.50 mg/mL with Limit of Detection 
(LOD) 0.004 mg/mL and Limit of Quantification (LOQ) 0.01 mg/mL.  The data were 
cross validated with previous results obtained by the GC-FID method reported by 
Schneider and Meys in 2011 [44]. 
Variation in illicit drugs trends can be tested by monitoring sedatives in seized 
samples.  Changes in contents of adulterants was detected between 1981 and 1992 in 
383 street samples of heroin when they were tested in a study conducted by Kaa in 1994 
in the western part of Denmark [45].  The purity of heroin samples was compared based 
on their origin and year of seizure.  Both heroin hydrochloride and heroin free base were 
gaining same popularity in the 1980s.  However, the free base form of heroin has 
become popular recently.  From the mid-eighties, heroin samples from Asia were 
discovered containing noscapine, predominantly at high concentrations, whereas 
caffeine, procaine, and sugar were more common adulterants at the beginning of the 
eighties.  Later in the eighties, heroin samples were cut with phenobarbital and 
methaqualone, and this practice then decreased to be replaced with adulteration with a 
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combination of paracetamol and caffeine during the early nineties.  The heroin samples 
were reanalysed to check the stability of these samples.  This heroin/adulterants trend 
could be extremely valuable to monitor changes in the market which then might also 
possibly link to the sources of manufacture of these cut samples.  Another long 
analytical study by Broseus et al. [18] investigated frequent adulterants of cocaine and 
heroin samples confiscated between 2006 and 2014 in Switzerland.  The study involved 
more than 6000 cocaine and 3000 heroin samples showing quite stable small variations 
in the combination of heroin adulterants compared with more dynamic changes in the 
cocaine samples.  In terms of number of adulterants, cocaine samples were cut with 
phenacetin, levamisole, lidocaine, and caffeine, while heroin samples were found to be 
adulterated with only two cutting agents, caffeine and paracetamol. 
Lapachinske et al. [14] developed a method to monitor international trafficking 
of cocaine by determining the cocaine purity in Brazil.  The method employed gas 
chromatography with nitrogen phosphorous detection (GC-NPD) to quantify cocaine 
and its adulterants in the seized samples.  The cocaine samples were found to be laced 
with caffeine, 4-dimethylaminoantipyrine, levamisole, lidocaine, and phenacetin.  The 
data show that cocaine intended for international trafficking was impure before leaving 
Brazil with purity ranging from 16.5% to 91.4%.  This important finding changed the 
belief that most illicit drugs are cut by distributers.  It is in agreement with a previous 
detailed investigation by Coomber, reported in 1999, about the nature of heroin 
adulterants in use in the US in the 1990s [40].  Changes in adulteration practices can 
therefore be used to monitor international illegal drugs trafficking. 
Lurie et al. [46] have developed a sensitive, rapid, and reproducible 
chromatographic method for impurity profiling of heroin and its adulterants using ultra-
high-performance liquid chromatography (UHPLC).  The following compounds:  
morphine, acetylcodeine, codeine, O3-monoacetylmorphine, O6-monoacetylmorphine, 
noscapine, and papaverine were successfully separated on reversed-phase (RP) 
chromatography using a 1.7 µm Acquity UPLC BEH C18 (2.1 mm x 150 mm) column 
which a phosphate buffer-acetonitrile mobile phase.  The separation was achieved 
within 20 min.  A different column was used, a 1.7 µm Acquity CSH Fluoro-Phenyl 
(2.1 mm x 150 mm), where adulterants interfered with the target compound heroin.  
This method was able to detect specific impurities within the heroin samples as low as 
0.02% [46]. 
Illicit drugs can also be cut with other psychoactive substances to enhance or to 
reverse the unwanted effects of an ingested drug.  MDMA tablets, sold in the UK, were 
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examined by Sherlock et al. [47].  The tablets were grouped based on their physical 
appearance and analysed by GC-MS.  Some tablets contained no MDMA and others 
were shown to contain various types of psychoactive substances, e.g. amphetamine, 
methylamphetamine, and ketamine.  Two ketamine tablets were found to contain 186 
mg and 197 mg respectively, which is equal to about 2.5 mg ketamine/kg body weight.  
If the ketamine is administered orally, then only one sixth of this amount reaches the 
body’s circulation [48].  A report suggests that analgesia is produced by oral doses of 
0.5 mg/kg [49].  Therefore, in this case, there is a high risk of toxicity if a user 
consumes more than two tablets thinking they may contain MDMA.  Other adulterants 
detected in MDMA tablets were caffeine and paracetamol.  As a mark of illicit drug 
manufacturing practice, the concentration of MDMA between the tablets varied from 0 
to 160 mg even for tablets sold under the same brand name.  This variation can produce 
considerable toxicity and therefore harm. 
Recently (late 2015), Gama et al. [50] reported methodology for routine illicit 
drug analysis using No-deuterium proton NMR (No-D NMR).  The method was tested 
on 71 cocaine samples, one MDMA and one of methylone seized by the Police from 
different areas in Brazil from January 2012.  The LOD value of cocaine in this method 
was ≈2 mg/mL.  Cutting agents, namely lidocaine, caffeine, and phenacetin, were well 
resolved from cocaine signals.  Sample purity and adulterants were used to map the 
samples based on their cutting agents.  This method was introduced as a non-
destructive, inexpensive and fast technique compared to GC [50]. 
Full 1H NMR assignment and two-dimensional diffusion-ordered spectroscopy 
(2D DOSY) 1H NMR of 24 seized heroin samples was carried out by Balayssac et al. 
[51].  Other 2D NMR experiments were applied to allow unambiguous assignment, e.g. 
homonuclear correlation spectroscopy (COSY), heteronuclear single quantum 
coherence (HSQC), and heteronuclear multiple-bond correlation spectroscopy (HMBC).  
The study provides clear characterization of heroin samples in the presence of related 
impurities, e.g. 6-acetylmorphine, acetylcodeine, morphine, noscapine, and papaverine.  
Also, this analysis was tested in the presence of adulterants, e.g. caffeine and 
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To test the applicability of quantitative NMR (qNMR) method in this area of 
illicit drugs analysis, heroin, its impurities and adulterants were assayed by qNMR.  The 
data analysis shows good agreement with GC for quantification.  This study therefore 
shows the viability of qNMR to establish a signature profiling of illicit drugs [51].  The 
NMR method also allows the simultaneous detection of drugs in mixtures with 
impurities and adulterants using a single screening technique of high fidelity.  Another 
non-destructive method to determine illicit drugs with their adulterants was reported by 
Rodrigues et al. in 2013 [52]. They combined both attenuated total reflection Fourier 
transform infrared spectroscopy (ATR-FTIR) and principal component analysis (PCA).  
The study was designed to build a statistical model using the ATR-FTIR data to classify 
cocaine samples based on their purity/impurity contents.  The model split the samples 
into three principal components.  The first component discriminated between the 
adulterated sample with lidocaine, caffeine, and benzocaine.  The second, PCA2, was 
classified between cocaine free base and cocaine salt.  Both cocaine and its cutting 
agents were quantified as well using GC-MS.  These kind of classification models are 
valuable tools for a rapid non-destructive method to support criminal investigators. 
There is no evidence in the literature related to the impurity profiling of 
ketamine and its adulterants.  Cole et al. found [38] that both ketamine and GHB have 
little in the literature about their adulteration and that they are mostly diverted from 
legal sources [53, 54].  However, as set out above, ketamine is used as an adulterant for 
other drugs such as MDMA [47].  A summary of the adulterants used to cut illicit drugs, 
illicit use, and their detection techniques is presented in Table 2. 
 
2.3. Isotopic analysis for identifying the origin of drug samples 
 
In recent years, the clandestine manufacture of illegal drugs has developed and 
many different illegal drugs are now available in high quality grades.  This means that 
using impurity profiling to obtain intelligence information to aid law enforcement has 
become correspondingly less useful [55].  The use of isotope ratio analysis for drug 
profiling is increasingly appreciated by the forensic science community in cases where 
drugs are more pure and so less impurity is present in the seized samples [56-60].  
Isotope profiling can be used as a powerful technique in this case for forensic 
investigation to link between seized samples and so possibly to identify their origin of 
manufacture.  Measurements of stable-isotope ratios (!) have been used to track back to 
the geographical origin of species in other fields such as migrating butterflies [61].  This 
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technique has also been used in other non-biological materials applications, e.g. to 
determine emerald trade routes [62] and environmental issues [63].  The application of 
this technique has recently been used to identify the origins of natural and synthetic 
illicit drugs [64]. 
 
2.3.1. Naturally occurring illicit drugs 
 
In naturally occurring substances, stable-isotope ratios of !2H, !13C, !15N, !18O, 
and !32S are effected directly by their growth environments, e.g. soil and climate.  These 
variable factors are referred to as geo-location effects [65].  They have been used to link 
back to their geographical origins certain naturally occurring illicit drugs, e.g. cannabis, 
cocaine, morphine (for heroin) [66]. 
Cocaine samples were linked successfully (96%) to their geographical regions 
by using their carbon and nitrogen isotope ratios in a study by Ehleringer et al. in South 
America [56].  A combined model of carbon (!13C) and nitrogen (!15N) isotope-ratio 
alkaloid traces was used to classify the cocaine samples.  Other alkaloids in the samples 
were successfully employed for more discrimination between the samples, e.g. truxilline 
was correlated positively with cocaine !15N, while a negative correlation was observed 
between cocaine !13C and trimethoxycocaine.  This strategy can be used to trace the 
origin of cocaine samples and potentially to monitor their trafficking routes. 
Morphine (for heroin) is usually harvested in different regions in the world 
where soil and humidity are suitable for its growth.  Most heroin comes from Asia, 
Colombia, or Mexico.  To differentiate between the sources, isotope ratio analysis was 
used to measure the values of !13C and !15N [67].  Casale et al. [68] examined the 
sources of 20 samples from different packages in HCl form seized from the North 
Korean-flagged cargo vessel, Pong Su and examined by both the Australian and the US 
authorities in 2003.  Impurity and manufacturing by-products were previously tested.  
The chromatographic profile signature of these samples showed unusual impurities 
which is consistent with a new processing method or even a new region of production.  
The isotope ratios were measured for the heroin samples and compared with over 200 
authentic heroin samples obtained from known sources:  Southeast Asian, Southwest 
Asia, Mexico, and South America.  Elemental analysis-isotope ratio mass spectrometry 
(EA-IRMS) and gas chromatography-isotope ratio mass spectrometry (GC-IRMS) 
techniques were used to measure !15N and !13C respectively [68].  The origin of the 
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heroin samples did not match any of the known origin isotopic signatures and this 
therefore suggests a new source of heroin samples. 
 
2.3.2. Synthetic illicit drugs 
 
Although stable isotope ratio analysis has been applied successfully to determine 
the origin for such natural product drugs as cocaine and morphine, this analysis can also 
be applied to synthetic drugs.  This analysis is carried out on their natural precursors 
[69, 70].  For example, MDMA is a synthetic drug, but natural product starting 
materials are used in its synthesis.  They can be traced using their isotope ratio, e.g. 
safrole [71].  Furthermore, the variations in the natural abundance of the isotopes can be 
used to discriminate between different seizures.  The ability of the stable-isotope ratio 
measurement to uncover any possible link between different synthetic drugs was tested 
by Collins et al. in their study investigating a number of cathinones [55].  Most 
cathinones share the same synthetic method, starting with a β-ketoarylalkane followed 
by bromination alpha to the keto group, and finishing with an amination step.  Isotope 
ratios of δ13C, δ15N, and δ2H vary from one seizure to another.  These variations were 
used to classify the seized cathinone samples into groups [55] in part depending upon 
the synthetic routes used, mainly a substitution reaction of the "-bromoketone to afford 
the substituted amine. 
Further analysis can be done by using this variation in the isotope values 
technique to determine a specific synthetic route [60, 67, 72].  A comprehensive review 
was recently presented by Collins and Salouros on measuring the stable isotope ratios of 
carbon, hydrogen, and nitrogen in methylamphetamine to identify the origin of the 
starting materials [73].  This was successfully achieved by measuring the isotope ratios 
of the precursors ephedrine and pseudoephedrine for samples synthesised from known 
sources.  These data were then compared to the isotope ratios of more than 1600 seized 
methylamphetamine samples to establish a link between them and their synthetic 
precursors [73].  The samples could successfully be linked to their precursors; the 
authors believe this to be a powerful technique that can be used for a routine analysis of 
cathinone profiling, assessing the variations between seized samples in order to find any 
possible linkages. 
Buchanan et al. [60] provide evidence that, in the synthesis of MDMA using 
Pt/H2 reductive amination, the !2H values of MDMA-HCl are sensitive to the length of 
imine stir time.  Moreover, the !15N values can be changed based on the molar excess of 
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methylamine used during the reaction.  These variations can therefore be measured to 
differentiate between batches according to the specific methods used along their 
synthetic route and hence aid in identifying seized batches prior to cutting (adulteration) 
and supply. 
 
2.4. General conclusions 
 
Generally, different strategies have been used for impurity profiling of illicit 
drugs in intelligence investigations.  One of these strategies is to identify the illegal drug 
source by combining purity and adulteration analysis findings with the intelligence 
database.  While another links the presence of specific impurities as “markers”, e.g. 
synthetic precursors and chemical intermediates, to a particular synthetic route for a 
possible link to their source and potentially to their manufacture.  Further approach is to 
classify the seized illicit drugs into groups based on variations in their impurities using 
statistical data analysis, e.g. Principal Component Analysis (PCA) and Hierarchical 
Cluster Analysis (HCA).  Determining the origin of illegal drugs in seized materials has 
been successfully achieved for both naturally occurring and synthetic illicit drugs.  
Other analytical studies have identified adulteration as their focus in order to help to 
understand the reason for using and the harm associated with these introduced 
substances.  Long-term studies monitoring the frequent adulterants in seized heroin and 
cocaine have also been undertaken. 
A wide range of chromatographic and spectroscopic methods have been reported 
for the investigation and impurity profiling of illicit drugs.  After critically reviewing 
the literature, the most frequently used analytical techniques for illicit drugs impurity 
profiling are gas and liquid chromatography, e.g. GC-MS, GC-FID, and LC hyphenated 
with MS or with UV diode-array detection.  In fact, as most illicit drugs are in salt form, 
when using GC it is required to form a volatile drug free base or carry out a 
derivatization step.  For the LC approach, a MS detector is useful or pure reference 
materials are needed.  Another difficulty related to MS detection is that some highly 
similar NPS can have the same molecular mass. 
Metal contaminants have been investigated in seized heroin and in MDMA 
tablets using ICP-OES.  Only a few studies have been reported using 1D and 2D NMR 
spectroscopic techniques for impurity profiling.  Other non-destructive spectroscopic 
methods to determine illicit drugs with their adulterants are ATR-FTIR and handheld 
Raman spectrometers.  Possible links between seized samples and their geographical 
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origin have been investigated by measuring the isotope ratio of δ13C, δ15N, and δ2H 
using isotope ratio (IR)-MS. 
Illicit drugs chemical profiling is not a new innovation; a few agencies 
worldwide have adopted this strategy for specific drugs, e.g. cocaine, heroin, 
methylamphetamine.  In practice, more efforts should be made especially with NPS in 
order to monitor national and international illicit drugs trafficking.  Impurity profiling of 
illicit drugs contributes to harm reduction procedures.  It is also important for policy 
makers, emergency departments, addiction treatment providers, and forensic 
investigations to aid law enforcement.  At this time, the reporting of impurities such as 
adulterants is not a common practice in illicit drugs analysis, especially for NPS. 
To fill this gap, these research studies will therefore investigate the impurity 
profiling of NPS such as mephedrone, flephedrone, and ketamine and aim to shine a 
spotlight on any new emergence of toxic drugs, e.g. dimethyltryptamine (DMT) and the 
2C-X family.  As stated above, the most challenging part of accurate and reproducible 
NPS analysis is the absence of reference standard materials and the application of 
analytical techniques that provide accurate chemical assignments of the drugs.  Most 
NPS are similar in chemical structure or they occur within mixtures with other drugs or 
adulterants.  In this case, NMR spectroscopy can give unique patterns for each drug and 
its impurities.  This investigation will explore the advantages of NMR as a powerful 
technique in drug characterization and impurity profiling.  Findings from these studies 
will be used to:  provide accurate drug assignments in the presence of their impurities 
(flephedrone, chapter 4), classify illicit samples into groups based on their impurities 
(mephedrone, chapter 5, and ketamine, chapter 6), determine the source including 
geographical origin of the seizure (ketamine, chapter 6), and obtain distribution patterns 
for some areas in the UK, then being able to provide these data to the Police (amnesty 
bins, chapter 3).  Thus, the laboratory-based pharmaceutical research aspects begin with 
detailed analysis of amnesty bin contents and other seized samples from the South West 
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In the UK, drug users represent 8.9% of the population (2011-2012 data) [1], 
and the widespread use of drugs is estimated to cost society £15.4 bn annually [2].  
The internet plays an important role in the emerging drugs “marketplace” especially 
for NPS, sometimes referred to as “legal highs”.  Responding to this phenomenon, 
the Forensic Early Warning System (FEWS) was established and funded by the UK 
Home Office in 2011 [3].  Monitoring illicit drugs, i.e. monitoring the change in their 
availability over time, can improve our understanding of the use of these substances.  
Profiling NPS availability in the European Union (EU) has been monitored by 
“Internet snapshot surveys”, a study conducted by the European Monitoring Centre 
for Drugs and Drug Addiction (EMCDDA) [4].  Understanding regional drug use 
and trends is a valuable finding to staff in hospital emergency departments who have 
to be able to deal with many different drug toxicity situations [5]. 
Analysis of urine in wastewater to identify regional variations in recreational 
drugs use has recently been reported [6, 7].  Estimates of drugs consumption can be 
made by measuring the amount of illicit drugs and their metabolites in urine [8, 9].  
This approach might be limited by the stability of drugs and their metabolites in 
sewage and taking into account other factors that might affect the analysis, e.g. drug 
concentration, impact of bacterial metabolism [10].  A questionnaire survey was 
employed as well for drug monitoring [11].  However, surveys are limited, and 
subject to various confounding factors [12]. 
Using an amnesty bin to track current drug consumption has been recently 
reported in other independent studies [13-15].  This method was first introduced by 
Ramsey and others as a new method for monitoring illicit drugs use in a dance venue 
[13].  These amnesty bins are usually located at night club and music festival 
entrances; people can discard their drugs without any comeback.  Therefore, 
pharmaceutical analysis of amnesty bins can provide reliable sources of data by 
yielding information about the drugs’ physical description (crystalline, liquid, 
powder, tablet, and herbal), method of administration (a salt being typically water 
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soluble and so a solution can be injected, or a freebase being sufficiently volatile on 
heating to smoke), and packaging systems (plastic bag, folded paper, tablets with a 
logo).  Further analysis may lead to identifying manufacturing methods by detecting 
by-products, solvent residues, and especially impurities.  This methodology could 
also be used to monitor purity, adulterants, and production batches for possible links 
between different seizures for forensic investigation. 
For detecting unknown drugs in seized materials, GC-MS and LC-MS are 
both employed.  Both methods require reference materials [16, 17].  Colour tests, e.g. 
the Marquis reagent, are mostly used by the Police [18].  However, such a test can 
give false negative results in the presence of adulterants or on changing the pH of the 
water that was used to dissolve the illicit samples [19].  Recently, many analytical 
methods have been developed and introduced to the Police as quick, non-destructive, 
and reliable techniques, e.g. hand-held Raman, benchtop FT-IR, and benchtop NMR 
[20, 21].  However, all of these methods are presumptive tests and the results need 
additional methods to be finally confirmed [16].  High-resolution magic angle 
spinning (HR-MAS) NMR spectroscopy was used successfully to identify illicit 
drugs in seized tablets and blotter papers [22].  Using NMR for illicit drugs analysis 
in seized materials is listed as a recommended technique under Category A by the 
Scientific Working Group for the Analysis of Seized Drugs (SWGDRUG) [23]. 
The purpose of this chapter is to determine what illicit drugs are currently 
available, to provide a quick snapshot to aid law enforcement focusing on NPS, and 
to corroborate the data with other regional drugs analysis.  The main analytical 
technique that will be used in the analysis of the contents of amnesty bins is 1H and 
13C NMR spectroscopy supported by electrospray ionisation-mass spectrometry 
(ESI-MS) and ATR-FTIR spectroscopic analysis.  2D NMR (HMBC, HSQC, DEPT, 
15N HMBC, 19F, H2BC) spectroscopic analysis is run in some cases to provide 
additional analytical data.  The research in this chapter will show the viability of 
using NMR spectroscopy for the analysis of illicit drugs on a large scale, i.e. in large 
numbers such as from amnesty bins, and especially with minimal sample preparation.  
Further investigations will then be applied to drug purity and adulterants.  Impurity 
profiling of illicit drugs will provide a better understanding of the harm associated 









 All solvents (HPLC grade 99%), deuterium oxide (99.8 atom % D), dimethyl 
sulfoxide ACS reagent, ≥99.9%, mephedrone hydrochloride salt; ketamine 
hydrochloride, creatine monohydrate, and monosodium glutamate were purchased 
from Sigma-Aldrich (UK).  Deuterated methanol (99.8 atom % D) was purchased 
from Cambridge Isotope Laboratories (USA).  Reference standards for flephedrone 
hydrochloride salt were purchased from LGC Standards (UK) and for benzocaine 
B.P. from J. M. Loveridge plc (Southampton, UK).  A pure sample of MDMA from 
the amnesty bin was recrystallized, analysed by NMR, and used as a reference 
material.  Ten sealed evidence bags from the Glastonbury music festival (2013) and 
one from a Bristol night club were obtained from the Drug Expert Action Team 
(DEAT), Avon and Somerset Constabulary, UK.  The illicit drugs were contained in 
glass bottles, plastic containers, and samples as crystals and powders in plastic bags, 




All measurements were run at 20-25 °C on Bruker 400 and 500 MHz NMR 
spectrometers, and Electrospray Ionisation Mass Spectrometry (ESI-MS) on a Bruker 
Daltonics micrOTOF.  ATR-FTIR spectroscopic analysis was performed on a Bruker 
FT-IR spectrometer (Bruker Optics, Billerica, MA, USA) equipped with the 
TICTAC drugs identification database.  The data were processed using OPUS 
software. 
 
3.2.3. Analysis protocol 
 
The Police provided 207 tablet and powder samples from an amnesty bin in a 
Bristol (UK) nightclub (2013) plus 279 samples from the Glastonbury music festival 
(2013) in addition to ~62 herbal samples that were not analysed further.  Substances 
were received within a big evidence bag containing small bags which were each 
sorted separately.  Tablets with the same colour and logo within the same bag were 
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labelled with the same code.  One tablet from each batch was then analysed.  MDMA 
tablets were ground, dissolved (50 mg/mL), vortexed for 1 min and centrifuged (3 
min), then an aliquot submitted to 1H NMR analysis.  The samples identities were 
also confirmed by ESI-MS.  All MDMA tablets were scanned and identified 
correctly from the TICTAC Library using Attenuated Total Reflectance Fourier 
Transform Infrared (ATR-FTIR) spectroscopy.  Pharmaceutical tablets (Modalert 
and Diazepam), cannabis (herbal and resin) and herbal samples were not further 
analysed.  The powders and crystal samples were weighed separately, labelled and 
analysed without any initial purification.  Samples (30 mg) were dissolved in 
deuterated solvent (0.6 mL) for NMR spectroscopy, as well as being analysed by 
ESI-MS.  Complete assignments of 1H and 13C NMR chemical shifts were achieved 
by means of 1D and 2D NMR techniques, including H-H COSY, HSQC, HMBC, 
and DEPT experiments.  Further 2D NMR (15N HMBC, 19F NMR, H2BC) 
experiments were run in some cases for additional investigation.  Detection of 
adulterants and drug determination against authentic standards were also performed 
using NMR and ESI-MS. 
 
3.3. Results and discussion 
 
3.3.1. Samples description and physical profiling 
 
Amnesty bins can be a valuable source of information in relation to route of 
administration, packaging system, doses and drugs availability, e.g. powder, tablets, 
capsules, herbs, liquid, and stamp.  Samples in the amnesty bins were received in 
small plastic bags, folded paper, bomb (twisted cigarette paper) and capsules.  Tools 
such as cannabis grinders, snorters, and spoons were found, some examples are 
shown in Fig. 1.  These tools might give information about the method of 
administration, e.g. two ketamine samples were placed with inhalers (Fig. 1, c).  The 
most common administration route of illicit ketamine is the intranasal method by 
snorting the powder of ketamine [24].  Drugs that are twisted in a cigarette paper 
suggest oral administration.  Also, each of these small twisted samples is one dose of 
the drug.  Samples in a yellowish liquid form are the freebase of the drug, while a 
salt is supplied either as crystals or as powders.  The freebase form is more likely to 
be smoked as it is much more volatile than the corresponding salt, i.e. crack cocaine 
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is usually smoked, and cocaine (salt) is more likely to be injected or snorted.  This 


















Fig. 1.  Samples as received in the amnesty bin in (a) small plastic bags, (b) folded 
paper, tablets, (c) inhalers, and (d) tools such as cannabis grinders 
 
3.3.2. Analysis of a 2013 Bristol amnesty bin 
 
Most samples in the Bristol amnesty bin (2013) were crystals or powdered 
forms 88% (196 samples) compared with 24 tablets (11%) and only 3 liquid samples 
(1%) (Fig. 2).  A total of 13 different drug types from Classes A and B as well as 
drugs under the Psychoactive Substances Act (2016) were found in the Bristol 
amnesty bin (Table 1).  Despite the emergence of further new NPS, established illicit 
drugs such as cocaine and MDMA are still readily available and popular.  Class A 
drugs represent 75% of the Bristol amnesty bin contents.  A crystalline form of 
MDMA was clearly the dominant drug 64.3% (133 samples) (Fig. 3) alongside 2.9% 





drug is still very popular as a party drug.  Indeed, MDMA users in the United 
Kingdom are reported to be the highest in Europe [25]. 
 
 
Fig. 2.  Physical forms of substances identified in the Bristol amnesty bin 
 
Table 1 
The number and percentage occurrence of different drugs and their classes found in 
the Bristol amnesty bin 
 Name Number Percentage 
Class A Cocaine (salt) 6 2.9% 
Crack cocaine 1 0.5% 
MDMA (crystals) 133 64.3% 
MDMA (tablet) 6 2.9% 
2C-B 1 0.5% 
Amphetamine 2 1% 
DMT 1 0.5% 
LSD 1 0.5% 
Flephedrone 4 1.9% 
Class B Mephedrone 13 6.3% 
Ketamine (salt) 19 9.2% 
Cannabis - - 





Fig. 3.  Bristol amnesty bin:  sample names, numbers, and their percentage occurrence 
3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) is typically 
available in crystal form as the hydrochloride salt of the racemate.  In tablet form, 
MDMA contains other compounds, including excipients, e.g. tableting agents, 
binders; in both tablet and crystal forms there are potentially (and potentially toxic) 
adulterants [26].  The synthesis of MDMA usually begins with a starting material 
containing a methylenedioxyphenyl ring, e.g. safrole, isosafrole, piperonal, or 
piperonylmethylketone (PMK) [27] and their possible impurities, e.g. of the 
aldehydes their corresponding carboxylic acids and even their primary alcohols, may 
be carried through.  The so-called golden ecstasy may possibly be a result of using 
isosafrole or safrole as a starting material.  MDMA tablets identified in the amnesty 
bin displayed a variety of different shapes, sizes, colours, and logos (Fig. 4).  MDMA 
samples in crystalline form were found to be highly pure by NMR spectroscopy (Fig. 
5).  A total of 6 tablets were found to contain MDMA; identification followed 1H 
NMR and was confirmed by ESI-MS.  Chemical shifts, coupling constants, number 
of protons, and peak multiplicity of MDMA were measured:  1H NMR (500 MHz, 
D2O) δ 1.27 (d, 3JHH = 6.5 Hz, 3H, H-3´), 2.71 (s, 3H, H-4´ (N-CH3), 2.82 (dd, 2JHH = 
14.0, 3JHH = 6.5 Hz, 1H, H-1´ (a)), 2.97 (dd, 2JHH = 14.0, 3JHH = 6.5 Hz, 1H, H-1´ 
(b)), 3.47 (sextet, 3JHH = 6.5 Hz, 1H, H-2´), 5.95 (s, 2H, H-3), 6.78 (d, 3JHH = 8.0, 
1H, H-5), 6.82 (s, 1H, H-2), 6.87 (d, 3JHH = 8.0 Hz, 1H, H-4).  MS data in positive 
ion mode gave [M+H]+ found 194.1184, C11H16NO2 requires 194.1181.  MDMA 
crystal samples were also analysed with an ALPHA-ATR-FTIR and the sample 
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Fig. 6.  ATR-FTIR spectrum of a crystal sample of MDMA (blue), and the matching 
MDMA spectra from TICTAC database (red), together with the MDMA details 
 
Ketamine, a drug recently upgraded from Class C to Class B, was present at 
9.2% (19 samples) as its salt.  Cathinone derivatives, mephedrone (methcathinone) 
and its fluorinated derivative, flephedrone (4-fluoromethcathinone) were detected at 
levels of 6.3% (13 samples) and 1.9% (4 samples) respectively (Fig. 3).  In the case 
of mephedrone, 9 out of 13 samples were cut with monosodium glutamate (MSG).  
All the flephedrone samples were cut with benzocaine.  Two samples (1%) of 
amphetamine (N,α-methylphenethylamine), a synthetic phenethylamine, were 
identified in the amnesty bin.  Both samples contained caffeine and (table) sugar as 
adulterants.  Other samples found as fine white powders contained cocaine salt 2.9% 
(6 samples).  One brownish sticky sample (0.5%) of crack cocaine (freebase) was 
detected; this freebase having been prepared by neutralisation of the salt. 
White powders, simply presented in folded paper, were identified as 
dimethyltryptamine (DMT) freebase, a hallucinogenic drug.  Such tryptamine is 
substituted indole compounds (Fig. 7a) and occur naturally in several plants.  They 
display pharmacological effects similar to those of LSD and magic mushrooms [28].  


























































































































Fig. 9.  (a) ESI-MS spectrum of extract ion mass of DMT and 









Fig. 10.  Key HMBC correlations in DMT 
 
Table 2 







Position 1H 13C HMBC (C→H) 
   2J 3J 
1´ 2.88-2.93(m, 2H) 24.2 H2´  
2´ 2.58-2.64 ( m, 2H) 61.4 H1´ H3´ 
3´ 2.29 (N-(CH3)2) 45.4  H2´, H3´ 
1 10.20 (s, NH)    
2 7.07 (s, 1H) 123.0  H1´ 
3 - 113.5 H1´, H2 H2´ 
3a - 128.6 H4 H2, H1´ 
4 7.31 (d, 3JHH = 7.5 Hz, 1H) 112.2 H5 H1´ 
5 6.99 (t, 3JHH = 7.5 Hz, 1H) 119.1 H4  
6 7.92 (t,3JHH = 7.5 Hz, 1H) 122.2 H7  
7 7.51 (d, 3JHH = 7.5 Hz, 1H) 119.5 H6  


































Fig. 12.  (a) MS spectrum of 6-DMAPB with proposed possible fragmentations, 
(b) simulated pattern of [M+Na]+, (c) expansion of the [M+H]+ MS ion, and 











Indeed, tryptamines like DMT are substituted indole compounds which are 
both naturally occurring and synthetic.  Many tryptamines, including DMT and LSD, 
have hallucinogen properties and are therefore listed as Class A.  DMT is present in 
many plants and their seeds, including Mimosa hostilis, M. teniflora Willd. Poir, and 
Psychotria viridis.  DMT can be abused by smoking, injecting, or ingestion either of 
the plant material or their crude or purified extracts, either alone or in combination 
with other extracts, e.g. Ayahuasca.  Despite their controlled status, a number of 
DMT-containing natural products, including M. hostilis, are openly marketed on the 
internet.  The historical use of DMT goes back many years to a tribe in the Amazon 
who boiled the plant, M. teniflora Willd. Poir, and then drank the resulting tea as a 
part of their tradition and religious customs.  For these herbal and historical reasons, 
people might consider this drug as safe [28]. 
DMT was identified by total assignment of 1D and 2D NMR spectroscopic 
data (Fig. 7, Table 2), and comparing these with the literature [30].  The 15N HMBC 
NMR was measured to determine the 15N-1H coupling in the DMT (Fig. 8).  The 
molecular formula was then confirmed by ESI-MS (Fig. 9).  The key HMBC 
correlations in DMT is also illustrated in Fig. 10. 1H NMR (500 MHz, methanol-d4) 
δ 2.29 (s, 6H, H-3´), 2.58-2.64 (m, 2H, H-2´), 2.88-2.93 (m, 2H, H-1´), 6.99 (t, 3JHH 
= 7.5, Hz, 1H, H-5), 7.07 (s, 1H, H-2), 7.92 (t, 3JHH = 7.5 Hz, 1H, H-6), 7.31 (d, 3JHH 
= 7.5 Hz, 1H, H-4), 7.51 (d, 3JHH = 7.5 Hz, 1H, H-7), 10.20 (s, NH, H-1).  ESI-MS 
(positive ion mode) [M+H]+ found 189.1348, C12H16N2 requires 189.1386 (1.1 ppm). 
“Benzofury” is a brand name for 6-(2-aminopropyl) benzofuran (6-APB).  
This had been marketed as a “research chemical” or a “legal high” until it was 
banned, in May 2013, under a temporary class order [31], and rescheduled in May 
2016 under the Psychoactive Substances Act [32].  Since 2011, 10 deaths and 
hospitalisations have been connected to the consumption of Benzofury in the UK 
[33].  The sample was commercially packaged as 6-APB with a note written on it 
“not suitable for human consumption”.  However, detailed analysis of the NMR and 
MS data of the sample showed that the package contained 6-DMAPB and not the 
claimed (marketed) 6-APB (Fig. 11).  This molecule has also not been previously 
reported in the literature.  1H NMR (500 MHz, methanol-d4) δ 1.26 (d, 3JHH = 6.5 Hz, 
3H, H-3´), 2.50 (s, 6H, 2 x CH3, H-4´), 2.91 (dd, 2JHH = 13.5 Hz, 3JHH = 7.0 Hz, 2H, 
H-1´(a)), 3.08 (dd, 2JHH = 13.5 Hz, 3JHH = 7.0 Hz, 2H, H-1´(b)), 3.64 (sextet, 3JHH = 
6.5 Hz, 1H, H-2´), 6.82 (d, 3JHH = 2.5 Hz, 1H, H-3), 7.14 (d, 3JHH = 8.0, Hz, 1H, H-
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5), 7.42 (s, 1H, H-7), 7.69 (d, 3JHH = 8.0 Hz, 1H, H-4), 7.73 (d, 3JHH = 2.5 Hz, 1H, H-
2).  ESI-MS (positive ion mode) [M+H]+ found 204.5365, C13H17NO requires 
204.1388 and for [M+Na]+ found 226.9508 requires 226.1202 (Fig. 12).  
Furthermore, the sample is impure with signals from several impurities, these might 
be by-products, remaining starting materials, or/and solvents. 
A folded piece of paper contained a crystalline drug that was identified as 
2,5-dimethoxy-4-bromophenethylamine (2C-B), a ring-substituted phenethylamine 
that is similar to MDMA (Fig. 13, a).  Since 2001, this drug was subjected to control 
under Class A in the UK.  This designer drug, 2C-B is reported to be a powerful 
hallucinogenic substance besides its stimulant effects; the abuse of 2C-B has been 
reported [34].  Overdosing on this drug can cause frightening hallucinations besides 






















































1H NMR (400 MHz, D2O) δ 2.89 (t, 3JHH = 4.0 Hz, 2H, H-1´), 3.16 (t, 3JHH = 
4.0 Hz, 2H, H-2´), 3.75 (s, 3H, O-CH3, H-7 (a)), 3.79 (s, 3H, O-CH3, H-7 (b)), δ 6.78 
(s, 1H, H-2), 7.13 (s, 1H, H-5) (Fig. 13, a); [M+H]+ C10H15NO2Br found 260.0288, 
requires 260.0286 (0.7 ppm).  The MS spectra of 2-CB (Fig. 13, b) is showing a 
unique 1:1 isotope pattern of 79Br and 81Br with the M+1, M+2, M+3, and M+4 
isotopic peaks.  A base peak (100%) at 242.9876 is due to the loss of ammonium 
group followed with the loss of methyl group from one of the methoxy substituents.  
Further loss of the second methyl group led to the ions at m/z 227.9648.  This is 
followed with the ions at m/z 212.9602 as a result of the loss of another methyl 
group.  The 1:1 79:81Br isotopic patterns are showing in all these ion fragments. 
 
3.3.3. Analysis of the 2013 Glastonbury amnesty bin 
 
Of 270 samples identified in the Glastonbury amnesty bin (Fig. 14), 86 
(30.8%) were MDMA in tablet form, 77 (27.6%) were MDMA crystals, 41 (14.7%) 
were ketamine as powders and crystals, and 30 (10.8%) were cocaine powder.  Three 
amphetamine samples (1.1%) were all cut with combinations of caffeine and sucrose.  
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A cathinone derivative, 4-methylethcathinone (4-MEC) was detected in one 
crystal sample (0.4%), cut with benzocaine.  Another cathinone derivative was also 
found in the amnesty bin, methylone (2 samples, 0.7%).  These cathinones have been 
marketed as relatives of mephedrone, known as “the second wave of synthetic 
cathinones” [35]. 
Two compounds from the 2C family of drugs were identified as 2CB (5 
sample, 1.8%) and 2CE (2 samples, 0.7 %), both in tablet form.  The composition of 
the 2CE street tablets was characterised by NMR and ESI-MS (Fig. 15, a).  1H NMR 
(500 MHz, methanol-d4) δ 1.15 (t, 3JHH = 10.0 Hz, 3H, H-8), 2.60 (q, 3JHH = 10.0 Hz, 
2H, H-7), 2.91 (t, 3JHH = 5 Hz, 2H, H-1´), 3.11 (t, 3JHH = 5.1 Hz, 2H, H-2´), 3.78 (s, 
3H, O-CH3), 3.80 (s, 3H, O-CH3), 6.78 (s, 1H, H-5), 6.80 (s, 1H, H-2); [M+H]+ 
found 210.1492, C12H20NO2 requires 210.1489 (1.6 ppm); [M+Na]+ found 232.1263, 
C12H19NO2Na requires 232.1308 (19.3 ppm) (Fig. 15, b).  Peaks at 0.90 (t), 1.28 (s), 
1.58 (m), and 2.17 (t) are from a stearic acid (CH3-(CH2)16-COOH), usually a 
magnesium or calcium#stearate.  It is a soap.  Such supplements are often used in the 
manufacture of pharmaceutical tablets as lubricants and tableting agents to prevent 
ingredients from sticking to the equipment. 
Two types of hallucinogenic drugs were identified in the Glastonbury 
amnesty bin, Lysergide (LSD) and DMT with 6 samples (2.2%) and 1 sample 
(0.37%), respectively.  LSD is a very potent semi-synthetic hallucinogen and 
internationally controlled [36].  This kind of drug normally is supplied as or on a 
stamp (Fig. 16, c).  The samples are prepared by dipping or spotting the dose in small 
square paper units (2-3 mm) characterised by different coloured designs.  LSD is 
taken orally by placing the stamp or paper on the tongue.  This CD is highly 
biologically active and therefore only very small (µg) doses are required.  The dose is 
usually between 20-100 µg, but can be as high as 500 µg [37].  For analysis, the 
stamps were soaked in methanol for 24 h then submitted for the ESI-MS which 
confirmed their identity as LSD, in positive ion mode [M+H]+ found 324.2055, 
C20H26N3O requires 324.2070 (4.6 ppm) (Fig. 16, a and b). 
Caffeine and benzocaine were detected in two separate samples, both 
represented 1% of the samples in the amnesty bin.  Benzocaine is a topical 
anaesthetic that can give a numbing effect similar to that caused by cocaine.  This 


















Fig. 15.  (a) 1H NMR assignment of the 2CE (30 mg/mL in methanol-d4) with 











































Fig. 16.  (a) Extract ion MS of LSD with (b) its simulated MS pattern, and  









A large quantity of diazepam (Class C) (123 samples) was identified in tablet 
form (Fig. 17, a).  Illicit-drugs users attempt to take this kind of medication to help 
them “come down” after a heavy night (on “uppers”).  Other medication found was 
Modalert (a 10 tablets strip), a psychostimulant drug.  Nitrous oxide or “laughing 
gas” was found in the amnesty bin as well.  People who abuse this gas are seeking a 
euphoric and relaxing feeling [38].  “Magic mushrooms” (0.9 g) were detected in the 
amnesty bin.  Users abuse this mushroom because it has a hallucinogenic effect (Fig. 
17).  “Magic mushrooms” are a Class A CD which means that possession of this 
mushroom can result in up to seven years in jail [39]. 
Four clear to yellowish liquid samples (Fig. 17, d), in brown glass bottles, 
were found to contain alkyl nitrite, a highly volatile liquid.  The samples were 
identified by ATR-FTIR and 1H NMR (Fig. 18).  Both isopropyl nitrate and 
isopropyl alcohol were detected in the liquid samples.  In the streets, the alkyl nitrite 
is known as “poppers” and is available in “headshops”.  The “poppers” are usually 
used in dance venues and can cause relaxation and a “rush”.  The liquid sample can 
be isobutyl nitrite, isopropyl nitrite, n-butyl nitrite, nitrous acid butyl ester, or amyl 





Fig. 17.  (a) Packets of diazepam tablets, (b) nitrous oxide metallic cylinders,  
























































































3.3.4. Comparative analysis and profiling of a Bristol night club and Glastonbury 
amnesty bins (2013) 
 
The analysis of amnesty bins covered samples from two different geographic 
locations (Fig. 19).  The first one was from a night club in Bristol and the second 
from Glastonbury music festival, both in 2013.  People who attend these kinds of 
festivals are mostly youngsters.  The data showed similarities but with some 
interesting differences.  The most noticeable similarity is that MDMA is still a drug 
of choice in both amnesty bins.  However, the formulation was different, with the 
crystalline form more prevalent in the night club, but a more even mix of tablets and 
powders/crystals at Glastonbury.  The data show that all ketamine samples were as 
salt forms, no freebase was detected.  These were present in both amnesty bins with 
nearly 1.5-fold (14.7%) at Glastonbury compared to the Bristol night club (9.4%).  
This indicates the growing popularity of ketamine among young abusers.  From these 
amnesty bin data, cocaine as a salt more prevalent among festival goers by nearly 4-
fold (10.8% surrendered) compared to those samples from a Bristol night club 
(2.9%). 
Locally, in the Bristol amnesty bin, mephedrone was the fourth most common 
drugs (6.3%).  On the other hand, a variety of cathinone derivatives was found in the 
Glastonbury amnesty bin, including:  mephedrone, methylone, and 4-MEC.  
Synthetic cathinones are reported to be the second largest illicit drugs group that are 
monitored by the EMCDDA with a total of 77 cathinone derivatives [40].  This 
group is characterised by the presence of a β-keto functional group on the side-chain 
of the phenethylamine (Fig. 20).  In 2005, methylone, an MDMA derivative, was 
first reported as a synthetic cathinone in the Netherlands according to the EMCDDA 
[40].  The potent hallucinogenic drug LSD was present more in the Glastonbury 
amnesty bin (2.2%, 6 samples) compared to one sample in the Bristol night club 
amnesty bin.  All the 2C-X family (2CE and 2CB) were identified as tablets.  These 
are comparatively new to the black market and so are not yet widely available.  









Fig. 19.  Comparison between the contents of Bristol (upper) and Glastonbury 
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Fig. 20.  Compounds identified in the Bristol and Glastonbury 2013 amnesty bins 
 
3.3.5. Adulterants identified in the amnesty bins 
 
To gain more profit and/or enhance the drug’s effects, drug dealers usually 
add adulterants and diluents to the controlled substance [20].  The kind and the 
amount of the cutting against can be used to link between different samples and 
might link to different drugs seizers.  For instance, flephedrone, a cathinone 
derivative, was found to be cut with benzocaine, a topical anaesthetic (Table 3).  
Benzocaine is a well-known cutting agent of cocaine and this might link the 
flephedrone to cocaine dealers [23].  Another suggestion is that benzocaine in the 
flephedrone samples can mimic the numbing effect of cocaine and might be sold as 
cocaine, and there is a concern about overdosing on redosing [24].  Mephedrone was 
also found to be impure and this drop in quality probably reflects the effect of recent 
control of cathinones [21].  Of the mephedrone samples, 9 out of 13 were cut with 
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monosodium glutamate (MSG) either as an easily accessible compound or due to it 
being similar in physical appearance.  Ketamine samples were cut with stimulants, 
e.g. mephedrone and MDMA.  Fillers such as sucrose and creatine were also used.  
These findings show the increasing popularity of ketamine.  All amphetamine 
samples were cut with combinations of caffeine and sucrose.  Few drugs were pure 
by NMR, but some were.  This might be because a drug is not common, e.g. 2CB, 
2CE, DMT.  A few samples contained an adulterant or diluent alone, e.g. benzocaine, 
creatine, sugar, or caffeine. 
 
Table 3 
Adulterants identified in the amnesty bins 
 
Sample ID Adulterant 
MDMA crystals Sucrose 
Amphetamine Caffeine + sucrose 
Cocaine Benzocaine + sucrose 




Ketamine Methoxetamine + creatine + MDMA + mephedrone 














3.3.6. Benchtop NMR (NMReady) evaluation for the analysis of illicit drugs in 
seized materials 
 
Nanalysis manufactures a benchtop NMReady™ 60e spectrometer.  The 
instrument is a compact, portable NMR with no liquid helium required, 60 MHz (1.4 
T) operating frequency, 40:1 (ethyl benzene 1% single scan) sensitivity (SNR) and 
resolution at 50% = 1.2 Hz line-width.  It has a permanent magnet and can be 
plugged directly into any normal wall power socket.  One and two dimensional NMR 
can be measured on this machine, 1H, 19F, 1H/19F and COSY.  The instrument offers 
simple data processing features.  The NMReady™ 60e spectrometer was therefore 
evaluated for use in illicit drug analysis, three samples were tested on this 
instrument:  flephedrone, ketamine, and cocaine (Figs. 21, 22, and 23 respectively) at 
100 mg/mL in D2O (1 mL) in standard 5 mm NMR tubes.  All samples required such 
a high concentration. 
The 1H NMR of flephedrone (Fig. 21) can be identified.  However, the 
spectroscopic data of other more structurally complex drugs, e.g. ketamine (Fig. 22) 
and cocaine (Fig. 23), were of poor quality that cannot be accurately or even easily 
interpreted.  Furthermore, illicit samples in mixtures will be more complicated still 
and very difficult to analyse using this instrument.  This instrument is more suitable 





















Detailed analysis of amnesty bin contents can provide potentially useful 
information for the Police and law enforcement, specifically providing detail about 
currently abused drugs, drug availability, and their impurities.  Class A CDs are still 
readily available, e.g. cocaine, MDMA.  The latter was by far the most common drug 
in tablet or powder/crystalline form in both the night club and Glastonbury music 
festival amnesty bins, accounting for more than 58% of all samples tested.  
Mephedrone (readily available), flephedrone, and 4-MEC, cathinone derivatives, 
were found to be impure with benzocaine, sucrose, creatine, MDMA, and MSG.  
This confirmed the belief that drug purity is more likely to drop after biologically/ 
pharmaceutically active compounds, e.g. legal highs, have been banned.  Other drugs 
were found to be pure by NMR, the reasons for this are not clear, though each of the 
drugs is not common, e.g. 2CB, 2CE, DMT.  The data show that ketamine was the 
second most common drug in both amnesty bins despite concern about harm 
associated with long term abuse of ketamine, with irreversible damage to the bladder. 
These analytical results show the application of NMR spectroscopy in drug 
detection with no need for sample preparation, reference material, or internal 
standard.  Police or forensic intelligence information may be gained from this kind of 
analysis to aid law enforcement.  Findings from this analysis can provide information 
about the abuse of both illegal and legal drugs (medication), e.g. diazepam.  
Furthermore, identifying new drugs early can help predict potential health 
consequences of abuse.  On the national level, a drug abuse map can be created by 
collaborating such drug disposal bin analysis with other findings from different 
regions in the UK.  Internationally, a better picture can be provided about illicit drug 
trends by collaborating, sharing findings from amnesty bin analysis with other 
current information sources, e.g. waste water analysis, the Internet based system, 
Forensic Early Warning System (FEWS). 
With minimum sample preparation, illicit drugs in crystal, powder, tablet, and 
liquid forms were successfully analysed by NMR spectroscopy.  Using this technique 
for amnesty bin analysis allowed the vast majority of drugs, a few unknowns remain, 
including complex mixtures and cutting agents, to be correctly identified.  This is in 
contrast with other analytical techniques, e.g. FT-IR, where mixture analysis is not 
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Chemical assignments and impurity profiling of flephedrone 
 
4.1. Introduction and overview 
 
The close similarity between cathinone derivatives (Fig. 1) makes the specific 
identification of these drugs and their regioisomers challenging and could lead to 
mislabelling or accidental misidentification or deliberate deception as in the nature of the 
illicit cutting of street drugs.  Flephedrone (4-fluoromethcathinone, 4-FMC) (Fig. 1c) was 
first synthesized in 1952, but surprisingly there is a paucity of published data for this 
compound.  Compared with cathinone (Fig. 1a) and mephedrone (4-methylmeth-
cathinone, 4-MMC) (Fig. 1b), the C-F bond on the aromatic ring of 4-FMC (Fig. 1c) has 
a specific polarity effect.  This may influence receptor binding and therefore influence the 
biological activity [1, 2].  The biological effects of cathinone ring-substituted derivatives 
are claimed to be similar to cocaine, amphetamine, or MDMA (ecstasy) [3].  In the UK, a 
question about a decrease in the purity of cathinones has arisen after they were banned as 




Fig. 1.  (a) cathinone, (b) mephedrone, and (c) flephedrone 
 
As routine analytical techniques, e.g. as used by the police, GC-MS [5, 6, 7] or 
Gas Chromatography-Flame Ionisation Detection (GC-FID) [6], infrared (FT-IR) [7], and 
Raman spectroscopy are widely used for the detection of controlled substances [8].  
Nevertheless, standard reference materials for detecting what may be present in unknown 
samples are required.  Using GC–MS alone would potentially not distinguish between the 
2-, 3-, and 4-regioisomers of FMC, all the isomers having been reported in elegant 
synthetic work with full characterisation by Archer [7].  Electron ionisation-mass 
spectrometry (EI-MS) also leads to uncertainty in distinguishing between flephedrone 
!80!
!
isomers [7].  More recently, screening methods for the detection of new (illicit) 
psychoactive drugs in urine were reported that use liquid chromatography coupled with 
tandem mass spectrometry (LC–MS/MS) [9], HPLC [6], and ultra-performance liquid 
chromatography-quadrupole time-of-flight-mass spectrometry (UPLC-QTOF-MS) [5]. 
NMR spectroscopy is an established analytical tool for the identification of 
controlled substances without the need for sample derivatisation or the need to remove 
any impurity.  Also, distinguishing between regioisomers, between salt and free base, 
determining percentage purity and impurity ratios are successfully and rapidly achieved 
using NMR spectroscopy.  Police or forensic intelligence information may be gained 
from this kind of analysis to aid law enforcement.  The aim of this part of the research 
project is to develop a routine, rapid, and quantitative analytical approach to detect 
flephedrone as well as the impurities (cutting agents) present in street samples. 
Four 4-FMC samples (from a Bristol nightclub, 2013) were analysed using 1H, 
13C, 15N HMBC, HSQC and 19F observe NMR spectroscopy together with results from 
GC-FID, and Electrospray Ionisation-Mass Spectrometry (ESI-MS).  Further 
investigation of the flephedrone and mephedrone aromatic regions using Nuclear 
Overhauser Effect Spectroscopy (NOESY) and Hetero-nuclear Overhauser Enhancement 
Spectroscopy (HOESY) NMR were performed.  Analysis showed that they all contained 
benzocaine as the cutting agent, present in differing amounts from 5-12%.  Using these 
methods, we successfully differentiated between flephedrone regioisomers and 
mephedrone in an analytical method validated for flephedrone as a substituted cathinone. 
These data show that this now illegal cathinone-derived stimulant (high) is now being cut 
and users cannot be certain of the purity of the drug they are taking.  Furthermore, there 







4.2.1. Chemicals and materials 
 
Four creamy coloured crystal samples, as part of an amnesty bin provided in a 
Bristol, UK nightclub (2013), were identified as flephedrone.  A reference standard of 4-
FMC HCl was purchased from LGC Standards, UK.  An analytical standard of 4-MMC 
HCl was purchased from Aldrich, UK.  Deuterium oxide (99.8 atom % D, Aldrich, UK), 
per-deuteriated!methanol (99.8 atom % D, Cambridge Isotope Laboratories, USA),!and 
all other solvents were of HPLC grade, ≥99.9% purity (Aldrich, UK).  Benzocaine B.P. 
was purchased from J. M. Loveridge plc (Southampton, UK). 
 
4.2.2.  Experimental procedures and instrumentation 
 
Each sample of 4-FMC was weighed, dissolved, and analysed at 20-25°C without 
any purification.  NMR spectra were recorded on Bruker 400 or 500 MHz spectrometers, 
referenced to residual protons in the deuteriated solvents.  Samples (30 mg each) were 
vortexed for 2 min in D2O (0.6 mL).  Identification of 4-FMC samples and their 
impurities followed NMR analysis including:  1H, 13C, 15N (HMBC), COSY, NOESY, 
HSQC, HMBC, HOESY, and 19F. 
A GC-FID method was optimised to analyse authentic flephedrone and 
benzocaine B.P. dissolved in methanol (0.50 mg/mL).  GC separation was performed on a 
CP-9003 (Chrompack, Middelburg, The Netherlands) using a capillary column ZB-WAX 
(polyethylene glycol, 10 m x 0.25 mm x 0.25 µm, Phenomenex, UK).  An injection 
volume (1-2 µL) was carried by helium gas at a flow rate of 23-27 mL/s.  The oven 
temperature was programmed with 250 °C injector and detector temperature, 110 °C (2 
min) oven initial and 230 °C (4 min) final temperatures with 40 °C/min rate of heating, 
therefore the total run time was 9 min.  The samples were injected directly into the GC-
FID without any prior chemical derivatisation.  Positive ion [M+H]+ mode MS was 
performed, on samples dissolved in methanol, using a Bruker Daltonics micrOTOF 
LC/MS equipped with an ESI source.  Attenuated Total Reflection (ATR)-FTIR was 





4.3. Results and discussion 
 
4.3.1. 1H NMR spectroscopy 
 
Whilst the 1H NMR spectrum of 4-FMC is similar to that of 4-MMC (Fig. 2), ring 
numbering is shown in Fig. 3, the absence of a 4-methyl aromatic substituent peak, and 
the coupling from the 19F atom are diagnostic.  The aromatic peaks in the 1H NMR of 
mephedrone appear as doublets while in flephedrone they are dd and triplet due to 
coupling with the fluorine atom; 1H, 13C, and 19F NMR spectral data are reported in Table 
1.  NMR spectra are further discussed and compared to the closely related cathinone 
derivative 4-MMC (Fig. 2).  The structures were confirmed by comparing the NMR data 
with an authentic sample of flephedrone and the literature values [7], establishing the 
regioisomer as para-disubstituted.  The 1H NMR of flephedrone:  (500 MHz, D2O):  δ 
1.62 (d, 3JHH = 7.5 Hz, 3H, H-3!), 2.81 (s, 3H, N-CH3), 5.09 (q, 3JHH = 7.5 Hz, 1H, H-2!), 
7.35 (t, 3JHH 3JHF = 9.0 Hz, 2H, 3 and 5), 8.10 (dd, 3JHH = 9.0 Hz, 4JHF = 5.5 Hz, 2H, 2 
and 6).  Mephedrone 1H NMR (500 MHz, D2O):  δ 1.61 (d, 3JHH = 7.0 Hz, 3H, 3!), 2.45 
(s, 3H, 4-CH3), 2.81 (s, 3H, N-CH3), 5.08 (q, 3JHH = 7.0 Hz, 1H, H-2!), 6.22 (d, 3JHH = 8.5 
Hz, 2H, 3 and 5), 7.92 (d, 3JHH = 8.5 Hz, 2H, 2 and 6). 
 
4.3.2. 13C and 19F NMR spectroscopy 
 
The chemical structure of 4-FMC was supported by 13C NMR spectroscopy with 
nine separate carbon signals evident (Fig. 4).  The 13C NMR of flephedrone is also 
compared with mephedrone.  Flephedrone 13C (500 MHz, D2O):  δ 15.2 (3!), 30.9 (N-
CH3), 59.5 (H-2!), 128.8 (C1), 132.4 (C2, 6), 116.4 (C3, 5), 167.7 (C-CH3), 196.0 (CO), 
and mephedrone 13C (500 MHz, D2O):  δ 15.3 (3!), 20.9 (4-CH3), 30.8 (N-CH3), 59.4 (H-
2!), 129.0 (C2, 6), 129.6 (C4), 129.8 (C3, 5), 147.3 (C-CH3), 197.1 (CO) ppm.  
Unfortunately, two lines in the literature 13C NMR spectroscopic assignment table have 
been transposed [7], and the correct aromatic region assignment is given below in Table 1 
for δ 116.4 (d, 2JCF 25.1 Hz) and 132.4 (d, 3JCF 12.5 Hz) ppm, where the coupling 
constants are diagnostic for ortho to F (C3, C5) and meta to F (C2, C6) respectively (Fig. 
3).  The 13C-19F splitting patterns around the entire aromatic ring, e.g. 167.7 ppm, d, 1JCF 
251.5 Hz; 128.8 ppm, d, 4JCF 2.5 Hz in the 13C spectra (Table 1) are also significant.  19F 
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NMR spectroscopy proves the presence and position of a fluorine atom in such samples.  
Comparing with the literature data [7], the 19F NMR chemical shift values for the each of 
the four 4-FMC samples show para-substitution:  19F NMR showed -102.1 ppm (tt, 3JHF 
9.0 Hz, 4JHF 5.5 Hz) (Fig. 5) with the d 1JCF 251.5 Hz easily visible only in the 13C NMR 












Fig. 3.  Numbering of mephedrone (X = CH3) and flephedrone (X = F) 
 
Table 1 
1H (400 MHz), 13C (100 MHz), and 19F (470 MHz) spectral data of flephedrone (D2O) 
 
 
" Flephedrone Mephedrone 
Position 1H 13C 19F 1H 13C 
1 - 
128.8 (d, 4JCF 
2.5 Hz)  - 147.3 
2, 6 
8.10 (dd, 3JHH 9.0 
Hz, 4JHF 5.5 Hz) 
132.4 (d, 3JCF 
12.5 Hz)  7.94 (d, 3JHH 8.5 Hz) 129.0 
3, 5 
7.35 (t, 3JHH =3JHF 
9.0 Hz) 
116.4 (d, 2JCF 
25.1 Hz)  7.47 (d, 3JHH 8.5 Hz) 129.8 
4 - 
167.7 (d, 1JCF 
251.5 Hz) 
-102.1, 
tt, 3J 9.0, 
4J 5.5 Hz - 
129.
6 
1! - 196.0  - 197 
H-2! 
5.09 (q, 3JHH 7.5 
Hz) 59.5  5.08 (q, 3JHH 7.0 Hz) 59.4 
3! 
1.60 (d, 3JHH 7.5 
Hz) 15.2  1.61 (d, 3JHH 7.0 Hz) 15.3 
N-CH3 2.81, s 30.9  2.81, s 30.8 









Fig. 4.  13C NMR of mephedrone (upper) and flephedrone (lower) 
 
(d, 1JCF 251.5 Hz) 
(d, 3JCF 12.5 Hz) 





Fig. 5.  19F NMR spectrum (1H coupled) of flephedrone (D2O) 
(in the presence of ~7% benzocaine) with relevant coupling from 1H NMR also given 
 
4.3.3. HMBC and 15N HMBC NMR spectroscopy  
 
The 2D NMR techniques, HSQC (Fig. 6) and HMBC (Fig. 7) were employed for 
flephedrone and mephedrone, allowing unambiguous assignment of carbons and protons.  
Focusing on the aromatic signals, the order of the two aromatic peaks in flephedrone 
HSQC spectrum (Fig. 6) compared to those of mephedrone 1H NMR were swapped.  C3´ 
and C5´ are deshielded, due to the high electronegativity of the substituent, fluorine atom.  
In the mephedrone HMBC spectrum (Fig. 7), C2´ and C6´ are assigned as more 
deshielded because of the electron withdrawing effect of carbonyl group (C1).  All 
HMBC correlations of flephedrone and mephedrone (Fig. 8) with 2J and 3J correlations 
are shown in Table 2.  15N NMR HMBC was recorded to detect the number, kind, and 
position of the nitrogen atoms proving the presence of a secondary amine coupled with 






J 5.5 Hz)  








































Fig. 8.  Key HMBC mephedrone and flephedrone correlations 
 
Table 2 
HMBC 2J and 3J correlations of flephedrone and mephedrone (D2O). 
 
 
 Flephedrone Mephedrone 
Position HMBC HMBC 
 2J 3J 2J 3J 
1  C3, C5 C2, C6  
2, 6 - C2, C6 C3, C5 C2, C6 
3, 5 C2, C6 C3, C5  C3, C5, 4-CH3 
4 C3, 5 C2, C6 C3, C5, 4-CH3 C2, C6 
1´  C2, C6, C2´, C3´ C2´ C2, C6 - C3´ 
2´ C3´ N-CH3 C3´ N-CH3 
3´ C2´ - C2´ - 
N-CH3 - C2´ - C2´ 






Fig. 9.  15N-HMBC (500 MHz) spectrum of flephedrone (D2O) showing 
two 15N-1H couplings (with peak assignments) 
 
4.3.4. NOSEY and HOSEY NMR spectroscopy 
 
The classical NOSEY NMR data of both flephedrone and mephedrone were 
observed (Fig. 10).  However, the H-H correlation between 4-CH3 protons with H-3 and 
H-5 seen in mephedrone disappeared in flephedrone spectrum, confirming the absence of 
the p-substituted methyl group.  Furthermore, the aromatic correlation in NOSEY has no 
differences between flephedrone and mephedrone (Fig. 10).  However, HOESY has been 
used to assign the interaction between the fluorine atom and the aromatic protons, H-3 
and H-5 in flephedrone.  The 19F-1H HOESY NMR results of flephedrone (Fig. 11) 
indicate the cross-peaks between the fluorine and H-3 and H-5.  These observations are 
consistent with the 1H, 13C, and 19F NMR spectroscopic data which confirm the 







































Fig. 10.  NOESY NMR (500 MHz) spectrum of mephedrone (upper) 


















Fig. 11.  HOESY NMR (500 MHz) spectrum of flephedrone (D2O) 
with the aromatic region expanded 
 
4.3.5. ESI-MS and impurity profiling 
 
The protonated molecular ions [M+H]+ were observed by ESI/QTOF-MS,!at 
182.0976 and 182.1006 for the 4-FMC samples and the authentic hydrochloride saltof 
flephedrone respectively, C10H13FNO requires 182.0981 thus confirming the identity of a 
regioisomer of flephedrone.  The sodium adduct [M+Na]+ C10H12FNONa requires 
204.0800, found 204.0800.  C10H12FNONa ESI-MS spectra also gave [M+H]+ 166.0874.  
Benzocaine C9H12NO2 [M+H]+ requires 166.0868; [M+Na]+ C9H11NO2Na found 
188.0689, requires 188.0687.  Both ESI-MS fragments patterns of flephedrone and its 
cutting agent benzocaine are shown in Fig. 12.  The characteristic ions (m/z) of 
flephedrone were reported by Zuba [10] as 123, 95, and with base peak 58 (m/z).  
Flephedrone 58 represent CH3−CH=NH+−CH3, formed with the flephedrone cation 
C6H4F−C≡O+ (m/z 123).  Loss of CO from the later gives a 4-fluorobenzoyl cation 
























Fig. 12.  Fragmentation patterns of flephedrone (upper) obtained by ESI/QTOF-MS 





4.3.6. Impurity profile of flephedrone samples by NMR and GC-FID 
 
Analysis of the 4-FMC samples by both NMR and ESI-MS showed that they were 
impure (Figs. 13 and 14).  The 1H and 13C NMR data of the impurity are:  1H NMR 
(D2O):  δ 1.36 (t, 3JHH = 7.0 Hz), 4.33 (q, 3JHH = 7.0 Hz), 6.83 (H3 and H5, t, 3JHH = 7.6 
Hz), 7.86 (H2 and H6, d, 3JHH = 7.6 Hz) [11]; 13C NMR (D2O):  δ 14.7 (C7), 61.3 (C6), 
114.3 (C3, C5), 118.8 (C1), 132.4 (C2, C6), 154.6 (C4), 168.8 (C5) ppm [12].  The NMR 
data are consistent with benzocaine.  A GC–FID method was then developed to resolve 
flephedrone and benzocaine in mixed samples, achieved with retention times of Rt= 2.8 
min and 4.9 min respectively (Fig. 15).  The benzocaine levels in these 4-FMC samples 
were quantified by GC (5, 6, 7, and 12%), impurity levels which are in agreement with 
those determined from the (more approximate) 1H NMR integration data (4, 6, 7, and 
10%).  Benzocaine has previously also been quantified by HPLC [13]. 
 
 
Fig. 13.  1H NMR (500 MHz) spectrum of flephedrone (D2O) (seized sample) 
with the benzocaine (~7%) signals clearly visible (upper) and of authentic flephedrone 




























Fig. 14.  ESI-MS of (a) flephedrone and (c) benzocaine in a seized sample of flephedrone 




Fig. 15.  GC-FID of flephedrone samples impure with benzocaine 







4.3.7. Evaluating benchtop ATR-FTIR for profiling flephedrone and its adulterants 
 
The IR spectra of the street samples of flephedrone were measured using the 
benchtop ATR-FTIR instrument equipped with the spectra of drugs and “legal highs” 
database TICTAC.  The procedure for using the ATR-FTIR for drugs analysis 
measurement has few easy steps including; cleaning the crystal surface, measuring the 
background and then placing a small quantity of a sample on the crystal.  After each 
measurement, the instrument automatically searches to database suggesting likely 
compounds.  A percentage “match” is provided between the sample spectra and the 
match find in the database (in this case the TICTAC database).  Each hit provides a 
percentage matching between the sample and the library search.  If the IR band do not 
match any signal compounds in the database, e.g. intensity, symmetry and bands width, a 
Mixture Search should be applied.  The number of component is chosen manually, with 
two or three a good place to start.  For example, the ATR-FTIR was used with authentic 
flephedrone (Fig. 16).  The result of the mixture analysis is displayed as a library match 
with its content % (blue), sample spectrum (“composite spectrum”, maroon), and residual 
spectrum (green).  The residual spectrum indicates the matching level between the library 
and the compound spectrums, flat line means high similarity.  Based on the result, the 
authentic flephedrone was 100% pure by ATR-FTIR.  The software shows details about 
drug name, form, use, UK control, and provides any alternative name of the drug under 
investigation. 
The same procedures were applied to the street samples of flephedrone, sample 
codes:  AI1, AI2, AI5, and AI16.  These were previously analysed by 1H NMR and all 
indicated the present of benzocaine in different ratios, 4%, 6%, 7%, and 10% 
respectively.  The results from the ATR-FTIR study showed that all flephedrone and their 
cutting agent (benzocaine) samples were identified correctly by the TICTAC library 
search.  Atypical result, representative of the mixture analysis of sample AI16 is shown in 
Fig. 17.  The samples were run, 2, 3, and 4 components input into the mixture search.  
The analysis confirmed the presence of benzocaine, but was not able to identify correctly 
the ratio of benzocaine, e.g. flephedrone to benzocaine (sample code AI16), suggesting 
27.2% benzocaine compared to 10% found by 1H NMR, 27.2:72.8 benzocaine: 
flephedrone.  The 1H NMR of AI16 is shown as adulterant compared to 88.1% and 10.5% 
flephedrone to benzocaine by 1H NMR integration (Fig. 18).  The instrument was not 
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able to detect impurities ≤ 3% (creatine) while this can be identified in the 1H NMR at 








Fig. 17.  Street sample of flephedrone (AI16) cut with benzocaine and their matching 





Fig. 18.  Confirming the presence of flephedrone and benzocaine in AI16 




4-FMC is a designed cathinone derivative either designed to side-step the banning 
of the “legal highs” 4-MMC and/or with one eye on the potential pharmacological 
enhancement from incorporating a fluorine substituent in a biologically active small 
molecule as “there is also evidence that single, carbon-bound fluorine substituents, 
particularly when on an aromatic ring, can exhibit specific polarity influences, including 
H-bonding, that can strongly influence binding” [1].  The human toxicology of 
flephedrone is not well established [14].  Lipophilicity is significant as it often controls 
the absorption, transport, or receptor binding of a compound and so can enhance its 
bioavailability.  The effect on the lipophilicity of fluorine substituents on an aromatic ring 
was calculated by Dolbier showing that CF3 ("x = 0.88) is greater than CH3 ("x = 0.56) 
following from the respective n-octanol/water partition coefficients [1].  So, perhaps 
counter-intuitively, the presence of the most powerful electronegative atom, a fluorine 
substituent, gives rise to enhanced lipophilicity. 
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Benzocaine is a well-known topical anaesthetic.  However, the FDA has reported 
that using a gel or spray containing benzocaine could cause a serious blood disorder, 
methemoglobinemia [15, 16].  Similar concerns are raised elsewhere, e.g. Taleb and co-
workers review the evidence where, even following topical application of benzocaine, 
oxidized haemoglobin might increase the chance of methemoglobinemia [17].  Recently, 
a case of acquired methemoglobinemia due to the frequent use of the legal high “Pink 
Panthers” was reported in parallel with the increasing prevalence of “legal highs” 
particularly those containing added benzocaine [18]. 
Benzocaine is currently being used in the illicit drugs market as a common 
adulterant (cutting agent) to increase profit [19].  Indeed, it is now commonly found in 
cocaine HCl [19-21], which might link the supply of such adulterated flephedrone to that 
of other commonly cut illicit drugs.  Drug dealers may use benzocaine as it is easily 
accessible and similar in physical appearance to flephedrone.  In sufficient quantity, 
benzocaine might be added to flephedrone in order to mimic the initial numbing 
(anaesthetic) effect of cocaine [22] and possibly even to sell the mixture, not as 
flephedrone, but as cocaine. 
Our rapid analysis and quantification of 4-FMC and benzocaine compares well 
with the literature methods [7, 13]. After our analyses were complete, Kerrigan and co-
workers reported [23] on the thermal degradation of synthetic cathinones including 
flephedrone and the implications of this for forensic toxicology.  They stated that such 
thermal degradation had received little attention.  In situ thermal degradation during GC–
MS analysis was by oxidative degradation, by the loss of two hydrogens, yielding a 
characteristic 2 Da mass shift.  Such degradation products were characterized by prominent 
iminium base peaks with mass-to-charge (m/z) ratios 2 Da lower than the parent drug.  As 
the degradation was thermal, it was minimized by lowering injection temperatures and/or 
residence time in the inlet during GC analysis [23].  Research is also on-going to replace 
aspects of wet-chemistry based quantitative analysis on minimal trace amounts of illegal 
drugs with rapid in situ, e.g. potentially on-site analysis in a nightclub, screening using 
handheld (therefore portable) spectrophotometers [24, 25].  The use of Raman 
spectroscopy to detect counterfeit medicines [24] may be extended to the analysis of street 
drugs, whilst discrimination between simple drug mixtures has been achieved using a deep 
ultraviolet-visible (DUV-Vis) reflected optical fibre sensor [25].  Both techniques can 
detect and possibly quantify known drugs for which standard spectra are available, but they 
are not suitable for the analysis of new drugs. 
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The combination of 1H, 13C, 15N, and 19F NMR spectroscopy was used to identify 
and decipher between flephedrone regioisomers and other cathinones such as mephedrone.  
2D NMR techniques, 15N HMBC and HOSEY were reported for flephedrone and 
mephedrone, allowing unambiguous assignment of the aromatic regions.  We have 
separated flephedrone and benzocaine with base-line resolution by GC-FID and quantified 
the amount of benzocaine adulterant in four (nightclub) flephedrone samples by GC, the 1H 
NMR integration was in broad agreement.  The street samples of flephedrone were also 
analysed by ATR-FTIR and compared with 1H NMR.  ATR provides an excellent fast 
scanning technique for street flephedrone samples with no sample preparation needed.  
However, 1H NMR proved to be more powerful and accurate with regard to impurity 
profiling analysis.  These data show that this now illegal cathinone-derived stimulant (a 
high) is now being cut by 5-12% with benzocaine, so drug users cannot be certain of the 
purity of the drug they are taking.  Indeed, another recent paper, published this month, on 
the diffusion of NPS in the illicit drugs market (2013-15) into Italy, shows that flephedrone 
is a problem for public health in Italy [26].  Benzocaine as an adulterant can cause serious 
health problems, potentially more harmful than flephedrone.  Therefore, there are risks 
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The worldwide emergence of cathinones as new psychoactive substances 
(NPS) was recently underlined in the Early Warning Advisory on New Psychoactive 
Substances UNODC [1].  Mephedrone (4-methylmethcathinone, 4-MMC) is a 
synthetic cathinone, a β-keto phenethylamine, derived from cathinone which 
naturally occurs in Khat.  The first cathinone derived NPS were controlled as single 
compounds and cathinone derivatives were synthesised to avoid the law by adding 
substituents at different positions of the cathinone molecule (Fig. 1) [2].  Synthetic 
cathinones are claimed to have both sympathomimetic and stimulation effects with 
easy access to the brain across the blood-brain barrier [3] producing a psychoactive 
amphetamine- or cocaine-like stimulant effects [4].  Mephedrone is reported to have 
undesirable side effects including, but not limited to:  anxiety, high blood pressure, 
nosebleeds after snorting, insomnia, hallucinations, and abdominal pain, 
hospitalisations are also reported [5].  Dependence and tolerance are reported in 
mephedrone abusers [6]. 
Mephedrone has no history of medical use.  This drug is abused for its 
stimulants and euphoric effects [7].  “Meow/Miaow”, “Bubbles”, “Crab”, “Blow” are 
some of the many street names of mephedrone [8].  Mephedrone was synthesised in 
1929 and first appeared on the market as an illicit drug in 2007 in part due to the 
shortage of MDMA [9].  After that, the popularity of mephedrone rose in Europe, 
especially over the internet, to become one of the most popular drugs in the last 
decade [7]. 
In the UK, mephedrone was recently controlled under the Misuse of Drugs 
Act as a Class B drug in April, 2010.  Despite the control, mephedrone abuse has 
been increasing in England [10].  Deaths related to the consumption of mephedrone 
have been reported [5].  These have increased from 1.0% (n = 22) to 1.5% (n = 34) 
between 2014 and 2015.  While deaths involving MDMA use increased from 1.1% 




are related to mixing mephedrone with other drugs such as cocaine, amphetamine, 
methamphetamine, heroin, γ-hydroxybutyrate, and MDMA [11]. 
 
   
   
  
 
Fig. 1.  Cathinone and its structural similarity to amphetamine and related cathinone 
derivatives 
 
A wide variety of quick and simple tests have been used for mephedrone 
analysis including Zimmerman colour test [12], a high sensitive microcrystal test 
[13], Raman and infra-red IR [14].  The later two techniques have been used for 
illicit drug analysis, (as non-destructive techniques) though both methods need 
statistical analysis to interpret the data [15].  Chromatographic technique, gas-
chromatography mass-spectrometry (GC-MS) [16], GC-FID, and liquid 
chromatography with high resolution mass spectrometry-mass spectrometry (LC-
MS/MS) have been widely used for detecting mephedrone [17, 18, 19].  GC-MS is 
considered an established method for illicit drugs analysis in forensic science labs by 
providing a chromatographic separation and mass identity of the drugs [20].  
However, MS cannot differentiate between isomeric structures with high degree of 
certainty [21] and reference standard material is needed to confirm each drug’s 
identity [12].  On the other hand, NMR spectroscopy allows exactly this kind of 




[18, 19, 22].  Furthermore, in NMR spectroscopy, there is no need to test a detections 
response factors, while this is required for each instrument in other spectroscopic and 
spectrometric quantitative methods [23]. 
NMR spectroscopy has a wide history of use in illicit drug profiling [24] and 
impurity/purity profiling [25].  It has also been used to determine geographic origin 
by Site-specific natural isotopic fractionation (SNIF) measurement [26].  The 
capability of NMR for quantitative measurement as a “primary” method was 
discussed by Holzgrabe et al. in 2005 [27].  Quantitative analysis by NMR (qNMR) 
has consequently been used for quality control and drug discovery [27, 28], natural 
products [23], excipients [29], and in food production [30].  A comprehensive study 
by Yang et al. compared the qNMR technique to HPLC [31].  One limitation of 
qNMR is overlapping peaks, however this problem can be tackled as all protons 
across the spectrum are equally sensitive [23].  Despite the lower sensitivity level of 
NMR compared to mass spectrometry, quantitative analysis by NMR does have an 
advantage in that it does not require reference materials [23].  Indeed, there have 
been noticeable developments in modern qNMR spectroscopic technique leading to 
sensitivity enhancement. 
Regarding impurity determination of mephedrone samples, the first purity 
study was conducted by Singh in 2010 [32].  The analysis performed on samples 
were bought from the Internet and the mean purity reported was 80%.  However, the 
purity was not accurate because no reference standard of mephedrone was available 
and samples with high purity were considered as 100% pure [32].  Two samples with 
street names “Recharge” and “Doves Original” were marketed as bath salts and plant 
food containing mephedrone at 42% and 12%, respectively [33].  Another study in 
2014 by Miserez et al. investigated mephedrone purity in 119 samples that had been 
collected in an amnesty bin from South Wales in the UK between November 2011 to 
March 2013, a year after the banning of mephedrone.  The purity was determined by 
GC-MS and the adulterants were profiled by FT-IR.  In this study, the purity dropped 
from 80% at the beginning of the analysis to 50% for the last 10 samples [34]. 
In this chapter work using different analytical techniques will be described.  
In particular, the use of NMR and MS for mephedrone purity/impurity profiling with 
the implementation of quantitative NMR (qNMR) to identify and quantify 
mephedrone in street samples.  Diffusion-Ordered Spectroscopy (DOSY) NMR is 




The impurity assessments were cross-validated by applying statistical analysis; PCA, 
scree plots and dendrogram plots on the NMR data.  These were applied to classify 
the samples based on their similarity and/or differences to extract information to aid 






Authentic mephedrone, creatine monohydrate (≥98%), benzocaine B.P. and 
L-glutamic acid monosodium salt hydrate (MSG, ≥99%, TLC), deuterium oxide, 
D2O and maleic acid as a standard for quantitative NMR, TraceCERT® were 
purchased from Sigma-Aldrich, UK.  Sodium 3-trimethylsilylpropionate, TMSP-2, 2, 
3, 3-D4 (D, 98%) was purchased from Cambridge Isotope Laboratories, Inc., USA.  
Caffeine (98.5%, USP/BP) was purchased from ACROS Organics™, USA.  All 
other solvents were of HPLC grade and purchased from Fisher or VWR, UK. 
 
5.2.2. NMR analysis 
 
5.2.2.1 Sample preparation and data processing 
 
1H, 13C, HSQC, HMBC, COSY, DOSY, qNMR and DEPT NMR spectra 
were recorded on a 500 MHz Bruker Spectrometer.  Samples for impurity profiling 
were powdered and 30 mg were dissolved in 0. 6 mL D2O.  To quantify mephedrone 
in the street samples of mephedrone a qNMR experiment was performed.  An 
internal standard (IS) of maleic acid (1 mg/mL, 1.0 mM) was prepared in D2O 
containing 0.25 % TSP for 0 ppm reference.  Each sample was ground and accurately 
weighed, 10 mg then vortexed in the D2O mixture until the sample dissolved and 
made up in a 5 ml volumetric flask.  Any sample with insoluble materials was gently 
warmed before the qNMR analysis to ensure all material was dissolved.  Maleic acid 
has been chosen as internal standard as it is soluble in water, chemically stable, has 
one peak in D2O at 6.2 ppm which does not overlap with the mephedrone or impurity 
signals.  The IS (maleic acid, 1 mg/mL in D2O) was quantified (qNMR) four times to 




by measuring (in triplicate) the different weights of a few samples chosen at random.  
All spectra were manually baseline-corrected and processed by using MestReNova 
(Version 10.0.2) and Bruker TopSpin software for the NMR data processing.  The 
analytical balance was a Sartorius Microbalance SE-2F, precision 0.1 µg; Sartorius 
AG, Goettingen, Germany. 
 
5.2.3. Mass Spectrometry 
 
The High Resolution Time-of-Flight (TOF) mass spectra were obtained on a 
Bruker Daltonics “micrOTOF” mass spectrometer using electrospray ionisation 
(ESI) (Bruker Daltonik GmbH, Bremen, Germany).  The positive [M+H]+ and 
negative [M-H]⁻ mode of MS-ESI data of mephedrone seized samples and their 
impurities were measured.  The mephedrone samples for the ESI-MS measurement 
were prepared in 10 µg/mL concentration in methanol.  The mephedrone and their 
impurities peaks were extracted by using the data Analysis software version 4.3 
(Bruker Daltonik GmbH, Bremen, Germany). 
 
5.2.4. Chemometric analysis of the 1H NMR 
 
The 1D 1H NMR spectra of the 21 mephedrone samples were processed by 
MNOVA.  All samples were referenced to TSP (0.0 ppm), baseline corrected and 
normalized to the sum values of the signals excluding the solvent and the IS peaks.  
After that each spectrum was sliced into 0.04 ppm parts between 0 and 9 ppm and 
data exported as comma/colon separated values (CSV) format to MestReNova 
(Version 10.0.2) and R statistic software.  Different statistics tests were applied on 











5.3. Results and discussion 
 
5.3.1 Chemical profiling of mephedrone samples and their impurity 
 
5.3.1.1. 1H NMR and Mass Spectrometry results 
 
21 samples of mephedrone from South West police seizures (7 samples, 2013 
and 2015), a Bristol night club (12 samples, 2013) and the 2013 Glastonbury music 
festival (2 samples, 2013) were obtained from the Drug Expert Action Team 
(DEAT), Avon and Somerset Constabulary, UK.  Mephedrone street samples ranged 
from creamy needles to dark brown sticky powder/crystals (Fig. 2).  1D and 2D 
NMR assignments of mephedrone were discussed previously in chapter 3. 
Mephedrone can be mixed with drinks, sniffed, injected and smoked.  
Impurity profiling can provide valuable information related to a method of 
administration.  Mixed routes are also reported to be used within a drug taking 
session:  oral and nasal, oral and rectal [7], e.g. samples cut with sucrose are more 
likely to be mixed with a drink or sniffed, because if this mixture is smoked, it will 
burn.  Adulterates are deliberately added either as bulking agents, e.g. sugar, or to 
enhance the drug’s effect, e.g. caffeine as a stimulant.  Topical anaesthetics, e.g. 
benzocaine, lidocaine are reported to be used as drug adulterants to mimic the effects 
of cocaine and might even be sold as cocaine [35].  In 2013, over than 2 tonnes of 
benzocaine, lidocaine, and phenacetin were seized at the border [35].  Samples with 
the same cutting agent in the same ratios might come from same drug dealer.  While 








The data from the 1H NMR illustrates that only 11% of the mephedrone 
samples were pure (Fig. 3) and this shows how!legal control has affected 
mephedrone purity.  Reduction in drugs purity can be dangerous in terms of 
overdoses, where users cannot be certain about the correct dose [34].  In this analysis 
all signals in mephedrone samples were identified and assigned, then confirmed by 
comparing these with an authentic mephedrone sample.  Mephedrone samples were 
found to be cut with MDMA, MSG, creatine, benzocaine (BZ), and sucrose (Fig. 4).  
Both MDMA and mephedrone share the same physical effects [36] and this might 
the reason why drugs dealer cut mephedrone with MDMA.  A list of the cutting 
agents identified within the street samples of mephedrone with their 1H NMR 
chemical shifts are given in Table 1.  A list of the positive and negative MS values of 
the impurities identified within the mephedrone samples are given in Table 2. 
The most frequent cutting agents were MSG and creatine with 14% and 11% 
respectively (Fig. 3).  This is due to the availability and the crystal forms of these are 
almost identical to mephedrone crystal shape.  The 1H NMR assignment of creatine 
monohydrate are shown in Fig. 5.  The samples and their impurities are also 
confirmed by ESI-MS.  The ESI-MS analysis for mephedrone cut with creatine 
confirm the presence of mephedrone and creatine with an [M+H]+ peak at 178.1239, 
C11H16NO requires 178.1226 (7.2 ppm); [M+Na]+ C11H15NONa requires 200.1046, 
found 200.1046 confirming the identity of mephedrone Fig. 6.  For the creatine 
monohydrate, the [M+H]+ C4H10N3O2 requires 132.0767, found 132.0768; [M+Na]+ 
C4H9N3O2Na requires 154.0587, found 154.0597; [M-H]- C4H8N3O2 requires 
130.0622, found 130.0635.  The extracted MS spectrum of a mephedrone cut with 
creatine is illustrated in Fig. 6.  The MSG was difficult to detect by ESI-MS as this 
molecule can be converted by cyclization to pyroglutamate under acidic, alkaline, 
and/or high temperature conditions [37].  However, MSG can be characterized 



















































Characteristic chemical shifts in1H NMR of mephedrone and impurities/cutting 





The positive and negative MS values of the impurities identified in the mephedrone 
samples 
 
 ESI-MS Positive mode ESI-MS Negative mode 
 Found Requires Found Requires 
Impurity [M+H]+ [M+Na]+ [M+H]+ [M+Na]+ [M-H]- [M-H]- 
MDMA 194.1219 - 194.118 216.1000 - - 
Benzocaine 166.0874 188.0689 166.0868 188.0687 - - 
Sucrose - - - - 341.1106 341.1089 
Creatine 132.0781 154.0597 132.0767 154.0587 130.0635 130.0622 
 
Impurity 1H NMR chemical shift of the impurities in D2O 
Mephedrone 
1.50 (CH3), 2.30 (CH3), 2.70 (CH3), 4.90 (CH), 7.30 (CH2), 7.80 
(CH2) ppm 
MDMA 
1.26 (d, CH3), 2.68 (s), 2.83 (m), 3.46 (m), 5.60 (s), 6.78 (t), 6.82 (s), 
6.87(d) 
Benzocaine 1.33 (t), 4.29 (q), 7.26 (d), 7.75 (d) 
MSG 2.08 (m, CH3), 2.35 (t, CH3), 3.75 (t, CH) 
Sucrose 5.41 (s, CH) 





Fig. 5.  1H NMR spectrum of mephedrone cut with creatine monohydrate (peaks for 


















Fig. 6.  Mass spectra of (a) mephedrone cut with creatine monohydrate with 









Fig. 7.  1H NMR assignment of mephedrone cut with MSG in D2O, the structure of 
MSG is also shown with the 2.33 and 3.73 ppm peaks expansion 
 
Both MSG and creatine are likely to have been chosen by drug dealers as 
cheap, safe and readily available cutting agents [34].  In this case mephedrone with 
these fillers can be smoked, or mixed with drink but not sniffed because creatine will 
convert into a gel in the nose while MSG is a salt and harsh in a nose if it is sniffed.  
Sucrose as a safe filler choice is also used, 3% of the mephedrone samples were cut 
with sucrose (Fig. 3).  MDMA was identified in four mephedrone samples that also 
contained further cutting agents.  The first two mixtures contained mephedrone, 
MDMA, MSG and sucrose in very similar ratios, 23:50:16:0.5 and 23:44:17:0.4 for 
AM7-1 and AM7-2 respectively (Fig. 8, AM7-1 and AM7-2).  The high similarity in 
impurities including their ratios, might suggest these come from same source.  The 
second mixtures contained: MSG, benzocaine, and sucrose in different ratios, (Fig. 9, 
AQ14-1), and the third one contain MDMA, creatine, benzocaine, sucrose, and MSG 
(Fig. 10, AI6-1).  These impurities were confirmed by comparing the spectrum with 
authentic samples of the adulterants.  The impurity profiling of AQ14-1, and AI6-1 
(Fig. 9 and Fig. 10) indicate that these two samples were initially cut with 
benzocaine, creatine, or/and MDMA.  While the large amount of MSG adulterant 

















Fig. 8.  Stacked spectrum of mephedrone, AM7-1 (1) and AM7-2 (2) cut with the 
same mixtures and similar ratios of MSG, MDMA and sucrose 
 
 
Fig. 9.  1H NMR stacked spectrum of (a) AQ14-1 (50 mg/mL, D2O) with the 
comparison conformation with authentic (b) mephedrone, (c) MSG (d) benzocaine, 










Fig. 10.  Stacked 1H NMR of (a) mephedrone sample (AI6-1, 50 mg/mL, D2O), 
and compared with authentic (b) mephedrone, (c) MDMA, (d) MSG, (e) benzocaine, 
















The 1H NMR spectral signature of the mephedrone samples were compared 
to determine their similarities and differences in terms of impurities and adulterants.  
The stacked 1H NMR spectra of mephedrone samples (Fig. 11) allows good 
comparison between the batches.  Samples with MSG, creatine, sucrose and MDMA 
can be picked out easily.  This stacked spectrum will be used at the end of this 
chapter to apply the chemometric analysis. 
 
 
Fig. 11.  Stacked 1H NMR spectra of mephedrone samples grouped based on their 
impurities (D2O peaks excluded) 
 
5.3.1.2. 2D DOSY NMR for impurity separation in mixture of mephedrone 
 
Illicit drugs can be impure with adulterants, by-products and solvents and this 
can make drug identification difficult and might lead to mislabelling.  The NMR 
diffusion experiment (DOSY) is claimed to have the ability to separate chemical 
species in a solution.  This technique has been used in mixture analysis for 
supermolecular samples [39, 40] and in food chemistry [41].  DOSY NMR was first 








was to measure the diffusion coefficients in solution, and was not employed in 
mixture analysis until early 1990s and this follows the development of NMR 
spectrometers.  Recently, this technique has been used to characterize heroin in 
seized materials [43]. 
Basically, molecules or ions have what so called self-diffusion, which is 
random translational motion, and this is based on their thermal energy.  The diffusion 
behaviour is related to the physical properties of the target molecule (molecular 
weight, size, charge, etc.) and other factors related to the surroundings, e.g. 
temperature, concentration, and solvent.  Based on this concept, compounds in 
mixtures can be pseudo-separated based on their individual diffusion coefficients 
which are inversely proportional to their molecular weight and can be measured in 
m2/s [44].  This means, molecules of different MW and similar chemical shift, will 
diffuse at different rates and can be separated.  It is also described as “NMR 
chromatography” but without sample preparation or method optimization [38]. 
DOSY NMR is measured as a collection of NMR spectroscopic experiments 
where the translational diffusion coefficient is measured in gradient mode using a 
specific pulse sequence called pulsed field gradient stimulated echo (PFGSE).  In this 
technique, a series of pulse strength is gradually increased and a series of PFGSE 
NMR spectra are recorded.  The resulting spectra appears as series signals decaying 
based on the compounds diffusion (D, m2/s) and this can be converted into 2D-
DOSY.  The most common nucleus used for DOSY NMR measurement is 1H and 
13C has been used as well.  The horizontal dimension is a chemical shift and the 
vertical one for the diffusion coefficients of molecules in solutions (D, m2/s) [45]. 
For DOSY analysis of mephedrone samples, the total run for each experiment 
was 13.28 min.  The experiments were recorded under the following parameters: 
spectrometer frequency 500.13 MHz, acquisition time 6.8682 Sec, number of scans 
16, pulse width 10.0 and relaxation delay 4.0 s.  Two impure samples of 
mephedrone, AI6-1 and AQ14-1, were tested to check the applicability of this 
technique to separate mephedrone from the mixture and identify their impurities.  
Before applying the DOSY analysis, the impurities were identified by 1H NMR as 
previously described, see Fig. 12 and Fig. 13 for AI6-1 and AQ14-1 respectively.  In 
practice, the 1H DOSY NMR spectrum displayed as a series of spectrum decay over 
the time.  Fig. 14 and Fig. 15 b show the results of a series of 1H-NMR diffusion 




The 1H gradient spectrum of the DOSY NMR can be transformed and aligned 
themselves into 2D DOSY spectrum, (Fig. 14 and Fig. 15 b).  The horizontal axis 
represents the chemical shift, while the vertical for a diffusion coefficients values (D, 
m2/s).  However, in the case of mephedrone samples (Fig. 14 b), two signals are 
detected on the left axes.  The first one is overlapped peaks for the mephedrone and 
the adulterants while the second one for the water (D2O).  The DOSY experiment is 
also a quantitative method by integrating the diffusion traces. 
The DOSY experiment, samples were prepared in D2O and two different 
gradient pulses tested, 1000 and 1800.  Signals which belong to the same molecule 
will diffuse at the same rate.  Solvents, e.g. water and acetone will diffuse more 
rapidly than any other molecule in the mixture followed by heavier molecules.  The 
impurities, benzocaine, MSG, creatine and MDMA in AI6-1 sample can be separated 
and characterised based on previous knowledge from impurity profiling and their 
traces intensity and ppm values (Fig. 14 a).  Despite the complexity in the 2D DOSY 
spectrum AQ14-1, the cutting agents, creatine, MSG, benzocaine, and sucrose can be 
identified.  Unfortunately, the quantitative analysis cannot be applied in the case of 
AI6-1 and AQ14-1 samples due to the signals overlapping.  The overlapping in these 
DOSY spectrums is owing to the similarity in the molecular weight/size of the 


















Fig. 12.  1H NMR spectrum of mephedrone sample (AI6-1) contained impurities in 




Fig. 13.  1H NMR spectrum of mephedrone AQ14-1 sample in D2O contained: 


















Fig. 14.  (a) 1D PFG-STE experiment of mephedrone sample AI6-1 and 
















Fig. 15.  (a) 1D PFG-STE experiment of mephedrone sample AQ14-1 and 












Essentially, the ideal sample mixture for DOSY experiment is to have 
components with different molecular weights present in similar concentrations.  In 
such a case the rate of diffusion of each impurity is inversely proportional to their 
molecular weight only, heavier molecules will diffuse more slowly.  Unfortunately, 
this is not the case in real practise, street samples are mostly impure with different 
impurities and adulterants and in different concentrations.  Nevertheless, the DOSY 
experiments were tested on two impure samples of mephedrone with 4 impurities in 
different ratios and in both cases the cutting agents could be identified.  Furthermore, 
based on the impurity profiling of mephedrone samples, the street samples are 
commonly cut with one or two cutting agents.  Samples with one and two adulterants 
with 50:50 ratios to the mephedrone could be ideal for this kind of separation. 
Another two samples of mephedrone (Meph-1 and AK6) cut with creatine 
and MSG were tested by DOSY.  Sample Meph-1 was cut with 1.5:2 creatine to 
mephedrone.  Fig. 16 shows that the impurity (creatine) can be distinguished easily 
from the mephedrone traces in the 2D DOSY.  However, only two peaks are showing 
on the vertical axes, one for the mixture of mephedrone and creatine and the other 
one for D2O signal.  Mephedrone in the second sample, AK6, was diluted with MGS, 
with 1.3:1 to MSG mephedrone.  In the AK6 2D DOSY spectra (Fig. 17), the 
mephedrone traces are appeared first followed with the three peaks signals of MSG 
and finally the D2O signal.  In both examples the adulterants were presented at 1.5 
and 1.3 ratios and were successfully distinguished from the mephedrone signals.  
DOSY was first introduced with optimist application to separate impurity in a 
mixture and this found to be useful to separate adulterants in street samples of 
mephedrone.  This technique is the first time to be employed on separation and 









































Fig. 17.  2D DOSY spectra of mephedrone sample (AK6, D2O) cut with MSG, 











5.3.1.3. Quantitative NMR (qNMR) analysis of mephedrone samples and 
their adulterants 
 
The major advantage of quantitative NMR (qNMR) over other spectroscopic 
techniques is that the integral intensity of the analyte protons directly represent the 
molar ratios of the molecules (Fig. 18).  This is true when special care is taken on 
signal processing, e.g. the target molecule signals are not overlapping with any other 
impurity signals.  To maximise accuracy, the spectrum should have a high signal-to-
noise ratio (S /N) to reduce the integration error.  This can be achieved by applying a 
suitable number of scans or use a sufficient amount of analyte [46].  For a precise 
quantification, the following requirements must be taken into account, sample purity, 
satellite peaks or heteronuclear decoupling, sample concentration, phase correction, 
baseline correction.  The standard values of S/N for quantification are ≥ 150 for error 
value !1% for using reference materials [47].  The accuracy of the integration 
procedure depends sensitively on the signal-to-noise ratio (S/N). For a high precision 
(standard deviation (sdv) <1%), S/N ratios of >250:1 for 1H, >300:1 for 19F, and 




Fig. 18.  qNMR of mephedrone sample (10 mg/mL in D2O) cut with MSG in the 




For quantitative analysis using NMR there are two main methods, relative 
(ratio measurements) and absolute methods.  In the ratio measurements of a mixture, 
the following equation is used [47]: 
 !"!# = %"%# . '(')         (1) 
and the fraction can be determined by: 
 
        (2) 
Where:  n is the molar ratios of the two compounds x and y, 
I:  the integrals 
N:  number of nuclei 
 
In international pharmacopoeias, this method is used as standard method for drug 
mixture evaluation [48].  Furthermore, this is also used successfully for isomer 
quantification ratio [49]. 
On the other hand, for quantitative calibration approaches are used for 
absolute quantification, these are:  Relative (Rel) 100% without calibration, Internal 
calibration (IC), External calibration (EC) and External calibration of the internal 
solvent signal (ECIC).  In this study, the IC method was used for mephedrone 
quantification.  The ECIC method was excluded as TMSP has been reported to be 
absorbed onto glass [43].  The IC method involves adding a known concentration of 
a calibrant to an accurate weight of the samples (mx).  The sample signals should be 
well separated from the internal standard (IS) (Fig. 18).  The absolute quantitation 
can be calculated as following [46]: 
 
       (3) 
where: 
I is the integrals of the analyte (Ix) and the standard (IIS), respectively. 
M is the molecular weight, 
P is the internal standard purity, 




To calculate the number of moles (nx) for each component in the qNMR spectrums 
the following equation was used: 
 nx = IS × /0//1 × 2/123 ×V       (4) 
Where: 
[IS] is the concentration of the internal standard and V is the volume in 1mL. 
 
The integral retained in the equation eq. 3 for the mephedrone quantification 
was the mean integral values of the six mephedrone signals protons at the following 
positions:  1.50 (CH3), 2.30 (CH3), 2.70 (CH3), 4.90 (CH), 7.30 (CH2), and 7.80 
(CH2) ppm.  The singlet peak of the maleic acid at 6.20 ppm (2H) (methine protons) 
was integrated manually and quantified using eq. 3.  All satellite peaks were 
excluded.  The impurities detected within the mephedrone samples were also 
quantified, MSG, benzocaine, MDMA, sucrose, and creatine (see Table 1 for the 1H 
NMR assignment values of mephedrone and its impurities).  In cases where signals 
overlapped the integral value was excluded.  The one-dimensional (1D) 1H qNMR 
analysis was recorded using classical 1D pulse sequence (relaxation delay-pulse 
acquisition) parameters:  Acquisition time 3.18 s, Number of Scans (NS) = 16, pulse 
width 10273 Hz, and 298 K data points.  Basically, there is no specific rule related to 
the number of points is required for the quantitative analysis by qNMR.  For 
instance, one peak is appropriate in identification of sugar in fruits while all signals 
are required in the case of a similar drug [50]. 
Integral reducibility was absorbed within a spectrum by producing similar 
values of the integral of each signals and IS can be calculated.  To check the 
instrument accuracy, the internal standard purity for the maleic acid was measured.  
A quantitative NMR of a blank sample containing only maleic acid was tested and 
gives the value of 99.0% which equates to the purity provided by the manufacturer 
(Aldrich).  The practical values from the integral obtained for the maleic acid at 6.20 
ppm is 8.64± 0.07 mM which is equal to 1.002 mg/mL.  The signal to noise (S/N) 
values were ≥30 000 measured for all the qNMR spectrums of mephedrone and these 
were far bigger than 20 000 (S/N) which is equal to the relative uncertainty 





The street mephedrone samples were presented in various levels of purity, 
ranging from 87.3% to as low as 2 % (Table 3).  For instance, GA6 mephedrone 
samples contained 87.3% mephedrone, while K2 has just 7.8% mephedrone (Fig. 
19).  Purity profiling more or less reflects the impurity values of the samples e.g. if 
the sample has 40% impurity that means the purity for the target compound is 60%.  
However, the purity/impurity correlation does not always reflect the total content of 
samples.  Undetectable materials e.g. inorganic impurities and overlapping signals 
can make the impurity profiling difficult.  Materials such as silica gel, NaCl, and 
some polymers can escape the NMR investigation.  Results from the qNMR results 
of the purity/impurity percentages and the mM ratios are shown in Table 3. 
Samples with high purity, close concentration values, same impurity amount, 
and different sources may link to each other and to a manufacture.  Samples GA6 
and AM3-1 were from separate amnesty bins, Glastonbury and Bristol night club, 
respectively.  Both samples are pure with close concentrations values, 39.8 mM and 
39.3mM of mephedrone.  This similarity can be used to advocate that GA6 and 
AM3-1 might link to the same manufacture as pure batches.  The purity of the 4 pure 
samples of mephedrone were between 71 and 87 %, one from Glastonbury, and one 
from Bristol night club besides two seized samples from Bristol.  Drug dealers 
usually received their drugs in bulk amounts and attempt to split them into small 
bags to be delivered, and this might explain the high similarity between them.  The 
sam explanation can be expressed on samples AM7-1 and AM7-2 from the Bristol 
night club amnesty bin.  The qNMR confirmed that these two samples have close 
mephedrone purity percentage, 17.6% and 21.9 % respectively.  Moreover, the same 
adulterants were detected and in very similar values, see Table 3.  With respect to 
impurity quantification in AQ14-1 and AI6, both samples have many overlapping 
peaks and few were used for the calculation. 
Regarding to the mephedrone dose, this is dependent on the method of 
administration, body weight and other factors.  For example, the insufflation dose of 
mephedrone is between 20 to 80 mg and can as high as 125 mg [12].  A typical 
single dose of mephedrone is between 5-250 mg, and re-dosing with 0.5-1 g is 
normally desired due to the short effects of mephedrone.  The effects are seen a few 
minutes after insufflation and longer after ingestion, 15-45 min and last about 2-3 h 
[7].  From the qNMR results in Table 3, mephedrone concentration ranged from 0.2- 




quantifying mephedrone and its impurities.  However, very low quality mephedrone 





























Fig. 19.  1HNMR spectrum of (a) GA6 87.3% pure, and 



























1 GA6 0.23 39.8 8.5 87.3 - 
2 AM3-1 0.10 39.3 8.4 85.8 - 
3 M.t 0.24 32.29 6.9 71.3 - 
4 Se.15 0.49 37.2 7.9 79.6 - 
5 AK4 0.26 36.9 7.8 80.8 MSG 0.40 








8 AC6-1 0.39 26.1 5.6 56.6 MSG 24.4 
9 AK6 0.15 22.5 4.8 48 MSG 34 
10 AK2-1 0.44 3.87 0.82 7.8 
MSG 80.1 
Creatine 3.7 
11 GE9-1 0.46 8.41 1.8 18.2 
Creatine 3.7 
MSG 58 
12 AK11-1 0.35 1.66 0.35 3.7 MSG 4.4 
13 M1-1 0.54 18.3 3.9 38.2 Creatine 45 
14 M1-2 0.29 18.6 4 38.6 Creatine 50.4 
15 M2-1 0.6 16.4 3.5 35.4 Creatine 42 
16 M3-1 0.28 17.1 3.6 35.7 Creatine  51.6 
17 Se.15-2 0.66 20.13 4.3 43.0 Creatine 41.8 




19 AS4 0.6 37 7.9 80.6 Sucrose 6.7 





Although the mephedrone samples look pure in the 1H NMR, the purity was low, 
e.g. mephedrone sample code AK11 (Fig. 19 a) shows to be pure by 1H NMR but the 
calculated purity was 87.3%.  This might be due to water in the mephedrone.  The 
average purity of the mephedrone samples from a Bristol night club amnesty bin was 
39.3%, while Glastonbury amnesty bin was higher with 52.7%.  Seized samples of 
mephedrone from two different areas in Bristol were 43.8% (2013) and 61.3% 
(2015). 
 
5.3.2. Chemometric analysis of the mephedrone samples 
 
As the levels of drugs and impurity vary between seized illicit drugs, this can 
be used to link between different seizures.  Visual comparison between NMR spectra 
of seized samples can be difficult, and time consuming.  Integrating both impurity 
profiling and data mining (chemometric) could help toward building a national and 
international database for illicit drug production and trafficking [52].  First 
chemometric model was made by Johnston and King in 1998 to predict the origin of 
heroin [53].  For impurity profiling of illicit drugs various statistical and 
chemometric techniques have been used as exploratory classification methods [52].  
The most common techniques are principal component analysis (PCA) and 
hierarchical cluster analysis (HCA).  Unlike PCA, HCA presents all variations on a 
data set and not only the percentage values. 
Mephedrone samples were classified based on their impurity/purity by 1H 
NMR.  Although it is possible to visually differentiate between mephedrone samples 
by using 1H NMR, minor differences might be missed.  PCA and HCA analysis were 












for PCA and HCA test, all the spectra had to be referenced, normalised to the sum 
values, solvent and IS peaks were excluded and a range adjust from 00 to 9.  Each 
spectrum was cut into small parts, each equal to 0.04 ppm.  The 1H NMR spectra 
were then converted into numeric sets of data to apply the PCA and HCA analysis.
The data were analysed by using PCA to determine whether there is one main 
component that can account for the correlated variance among the samples.  The 
PCA is usually tested in sequential steps to know how many components to extract in 
the analysis.  The scree plot was performed showing a break after the first four 
components, i.e. four components described the majority of the samples (Fig. 20, a).  
The scree plot looks at variance versus number of factors.  Basically, the components 
on the steep slope are extracted.  The result shows that 71.8% of the 21 mephedrone 
samples are similar and arranged under a main cluster, PCA1 (Fig. 20, b).  While 
PCA2, 3, and 4 presented at 10.4, 5.9, and 3.6% of the variance among the data, 
respectively.  The components are allocated on the shallow slope are contribute little 
to the solution.  Further analysis is required to test whether the component 4 might be 
worth extraction or not. 
Pattern matrix component is can be useful to identify and understand the 
nature of the components (Table 4).  The first eight samples are loaded quite nicely 
on the first component, "0.90, that means the variations between these samples are 
quite low.  The impurity profiling of the samples included in PCA1 was examined by 
1H NMR and all these samples were  " 48% pure or contained MSG as cutting agent 
(Fig. 21 (a and b)).  Samples AK11, AM7.1, and AM7.2 are less pure, than the other 
samples load on PCA1.  The PCA analysis has successfully grouped the samples 
based on their cutting agents.  All mephedrone samples AI6.1, AI6.2 and AQ14 are 
loaded better on the second component PCA2.  The first two samples in PCA2 were 
cut with a combination of MSG, creatine, MDMA, and benzocaine, while AQ14 was 
cut with MSG, sucrose, and benzocaine.  Component 3 has 5 major positive loading 
for samples cut with creatine.  While samples cut with creatine and MSG are loaded 
on PCA4.  Both GE9 and AK2 are loaded negatively on the first three components, 
but allocated strongly on the component 4 and the 1H NMR shows the samples were 










Fig. 20.  (a) Scree plot of the dataset of mephedrone showing the main component 











1 2 3 4 5 
M.t .986 -.075 .044 -.001 .048 
AM3 .984 -.097 .047 .005 .002 
GA6 .984 -.096 .048 .003 .001 
Se.15 .983 -.089 .027 -.002 .052 
AS4 .982 -.077 .052 -.005 -.019 
AK4 .981 -.090 .054 .002 .001 
AC6 .912 .141 .057 -.011 -.012 
AK6 .903 .110 .034 .058 -.110 
AK11 .780 .163 .031 .007 .386 
AM7.2 .737 .316 -.012 .111 -.255 
AM7.1 .679 .349 -.026 .115 -.298 
AI6.1 -.103 .964 .072 .007 -.070 
AI6.2 .001 .904 .048 .082 -.148 
AQ14 .043 .879 -.053 .033 .217 
M1.3 -.090 -.015 1.027 .000 -.092 
M1.1 .027 -.025 .966 -.001 -.091 
M3.1 -.034 .076 .892 .014 .207 
Se.15.2 .158 -.042 .886 .003 -.086 
M2 .088 .026 .841 .003 .063 
AK2 -.122 -.036 -.024 1.052 .042 























Fig. 21.  Mephedrone samples in the first component (PCA1), (a) pure sample of 

















To identify possible linear correlations between different PCA, scatterplot 
matrix is a great starting point.  The plot is showing the correlation between the 
variables (PC scores) on the vertical aces with the horizontal one.  There is a positive 
correlation between PCA2 and PCA3 showing gradual distribution from top right to 
the bottom left.  Other possible negative correlation is showing between PCA3 and 
PCA1.  There are no clear correlations between PCA5 and the other PCA in the plot 
matrix.  Based on the information extracted from the scatterplot matrix, the data can 
be presented better by using a 3D correlations PCA1, PCA2 and PCA3. 
In the 3D PCA scores plot, all pure samples were grouped together with 
samples cut with MSG only.  GE9 and AK2 scatter differently with GE9 allocated 
closer to the pure PCA1 (pure samples and samples cut with MSG), while AK2 
scatter closer to PCA3 (less pure mephedrone sample).  NMR specters of GE9 (Fig. 
22, a) and AK2 (Fig. 22, b) show that both are containing same cutting agents but in 
different mephedrone concentration.  One explanation of this that GE9 has more 
mephedrone (18.2%) while AK2 contain only (7.8%).  The rest of the samples 




































Fig. 24.  PCA scores plot of PA1, PCA2, and PCA3 
 
More discrimination can be achieved between the mephedrone samples by 
applying the HCA analysis, dendrogram.  The vertical axis represents the sample 
names and clusters.  The dissimilarity between clusters are defined based on the 
distance on the horizontal axis.  The first noticeable clustering in the dendrogram 
results (Fig. 25) that all the pure mephedrone samples (" 80 % purity), are branched 
in one separate cluster.  While the other impure samples are cluster into subgroups 
based on their similarity and differences. 
The dendrogram tree can be cut at two different places, 15 and 5 with two 
and four clusters, respectively.  The cut at 15 will divide the data into two main 
clusters, one including the mephedrone samples with " 80 % purity and the other 
representing the less pure mephedrone samples.  Samples in the second cluster (using 
the cut at 5) are divided into two sub-clusters representing samples cut with creatine 
only at different percentages (Se.15-2, M1.3, M1.1, M2, and M3.1).  The third 
cluster contain two sub-groups (two samples each) are fused at higher distances.  
Both of these groups are sharing MSG as cutting agent, but AM7.1 and AM7.2 have 
less mephedrone concentration besides sucrose and traces of MDMA.  The last 
cluster contain 6 sets of samples are branched into two groups.  All these samples in 








to 2.0%.  The second group in the last cluster AI6.1 and AI6.2 were cut with MSG 
(67 and 60.6%) creatine (2.8 and 3.2%) MDMA (2.56 and 1.37%) Benzocaine (0.6 
and 0.57%), AQ14 was cut with MSG (38.5%), Sucrose (14.2%), Benzocaine (%), 
and AK11 cut with MSG (4.4%).  Visual investigation of AK11 samples (Fig. 26) 
gives no clear explanation for clustering this with AI6.1, AI6.2, and AQ14.  The 
possible answer is that AK11, AQ14, AI6.1, and AI6.2 are presenting at low 
mephedrone levels or other the similarity could be due to minor compounds were 
presented in the samples.  The dendrogram was successfully distinguished between 
the pure and impure mephedrone samples. 
 
 











Unique and a powerful NMR analytical techniques were introduced for impurity 
profiling of street mephedrone sample using 1H NMR, 2D DOSY and quantitative 
NMR (qNMR).  Both mephedrone and their adulterants were successfully identified 
and quantified without calibration, reference materials, sample preparation and this 
cannot be offered by any chromatography.  Molecules not detected by NMR are 
limited compared to other chromatography and spectroscopy methods.  The qNMR 
performed illustrates the capabilities of this technique for both quantitative analysis 
(purity/impurity quantification) and structure characterisation.  The qNMR analysis 
of the mephedrone samples could be further improved by decoupling the sidebands 
(13C satellites peaks) to simplify the spectrum and facilitate assignments.  Going 
forward, it will be important to quantify these mephedrone samples using 
chromatographic techniques.  Hence, method development in these other technique 




2D DOSY NMR proved to be a promising method in terms of impurity separation 
with limitations linked to the overlapping peaks.  In reality, most of the mephedrone 
samples were cut with only one or two adulterants.  Consequently, this increases the 
chances of separating the impurities in the mephedrone when using DOSY. 
Mephedrone samples were received in powered and crystal forms as samples 
seized by the police and as a part of the analysis of amnesty bins (Bristol night club 
and Glastonbury music festival).  Our impurity profiling data of mephedrone suggest 
that the drug dealers cut the mephedrone with safe, available and cheap materials e, g 
creatine, MSG and sucrose.  However, pharmaceutical agents e.g. benzocaine, a 
tropical aesthetic, is also used, perhaps to mimic the numbing effect of cocaine on 
the tongue/lips so that it might sold as cocaine.  Moreover, benzocaine is reported to 
be used to cut other cathinones, e.g. flephedrone and this might link the mephedrone 
to other drugs distribution and production.  The most common administration method 
of mephedrone is insufflation with high and multiple doses and harm associated with 
adulterants such as benzocaine and MSG and creatine must be taken into account.  
Other recreational drugs e.g. MDMA are also used as adulterants for mephedrone in 
small quantities. 
Simultaneous determination and quantification of street mephedrone samples 
and their adulterants by NMR was cross-validated with statistic visualization 
examinations.  The principal component analysis (PCA), scree plot, and dendrogram 
effectively classified mephedrone samples with good agreement with the 1H NMR 
impurity profiling analysis.  This kind of analysis of mephedrone street samples 
(impurity profiling, quantification and statistical analysis) can provide valuable 
information about availability and purity with possible link between samples and 
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Ketamine is a unique anaesthetic and analgesic due to possessing a wide 
margin of safety in its use and the ease of its administration [1].  The WHO rate 
ketamine highly, listing it in the Model List of essential anaesthesia medicines for 
surgery and required in Emergency Departments for use in humans and animals [2, 
3].  Ketamine has various medical uses ranging from anaesthesia [2], treatment of 
heroin and alcohol addiction [4], to more recent promising applications in the 
treatment of resistant depression and severe asthma [5, 6, 7, 8].  Ketamine was 
introduced in 1965 as a veterinary and human anaesthetic [9].  This was made as an 
alternative to phencyclidine (PCP, “angel dust”), in the hope of providing a new 
anaesthetic with shorter psychosis and less delirium.  The advantages of ketamine 
over phencyclidine (Fig. 1) are that ketamine can produce deep analgesia and 




Fig. 1.  Phencyclidine (left) and its derivative ketamine (right) 
 
Following use over the last 51 years, ketamine is still a drug of choice in pain 
management [11].  However, this drug is abused for its hallucinogenic effects [12].  It 
can also produce euphoric effects similar to cocaine and cannabis [13].  The non-
medical use of ketamine was reported in the1960s [14], but it was not common in 
Europe until the 1990s when it appeared as an adulterant to ecstasy tablets [15].  
Ketamine has become a common recreational drug, especially at rave parties [16, 17].  
Street names of ketamine include:  Special K, Kit Kat, Cat Valium, etc.  Among 




damage to the bladder, urinary tract, kidneys [18], and addiction [19].  It has also 
been reported that ketamine combined with other drugs, including alcohol, can lead 
to death [10].  Ketamine is still not internationally controlled and this is to ensure the 
accessibility of ketamine for medical uses [20]. 
According to the British National Formulary (BNF), the currently authorized 
hospital formulation of ketamine in the UK is KetalarTM (ketamine hydrochloride, 
provided by Pfizer Ltd, Kent, UK) [21].  While veterinary ketamine is available in 
nine trade names:  Ketavet®, Narketan®, Anaestamine®, Anesketin, Nimatek, Ketaset, 
Ketamidor®, Ketastesic, and VetalarTMV [22].  Commonly, in the UK, ketamine is a 
racemic mixture, composed of equal amounts of levorotatory enantiomer, R-(−)-
ketamine and dextrorotatory, S-(+)-ketamine.  In controlling the pain of postoperative 
patients with ketamine, drug conformation (i.e. 3D shape) and, in this case, absolute 
configuration (i.e. optical isomers) play a major role, with a four-times more potent 
S-enantiomer compared with the R-(-)-ketamine enantiomer and so approximately 
twice (1.6-fold) the potency of the racemic mixture [20].  However, whilst the R-(-)-
ketamine enantiomer is significantly less biologically active as an anaesthetic, it is 
not more toxic, and therefore using the racemic mixture clinically does not give rise 
to more side-effects.  In the UK, ketamine is available as racemic mixtures [20] while 
a single enantiomer product is usually imported.  In this case, the required pain relief 
effect can be achieved with a much lower dosage (of one enantiomer) and a quicker 
recovery time from the anaesthetic [23].  The production of ketamine by Pfizer Ltd, 
the only provider in the UK, has been discontinued (June 2014), and so other sources 
might be a potential source of S-ketamine, e.g. as Ketanest®-S.  Therefore, there is a 
chance to import S-ketamine [24]. 
The dose of ketamine is varied between individual patients depending on 
bodyweight and route of administration.  Analgesia can be produced by intravenous 
injection of 0.2-0.75 mg/kg.  If ketamine is injected directly into a vein at 2 mg/kg, 
this can cause surgical anaesthesia within 30 s and that effect will last for 5-10 min.  
While injecting 10 mg for every kg bodyweight into a muscle can last longer, from 
12 to 25 min with onset within 3 to 4 mins [25].  Psychotropic effects are also 
produced by intramuscular (i.m.) injection of high dose of ketamine, between 25 to 
200 mg in humans [26].  Generally, low doses of ketamine can cause dreamy 
thinking, euphoria, and mild hallucinations with separation of time and space.  At 




completely detached from their body and surroundings.  This is often called a “near-
death experience” or “entering the k-hole” [27].  Abusers attempt to evaporate 
ketamine solution to form crystals and then grind the residue into a powder before 
inhaling it or mixing it with alcohol [28], or the liquid can be injected i.m. [1].  
Abusers are reported to snort between 60 and 250 mg at a time [15].  Oral 
administration is rare; ketamine is metabolized to norketamine (N-demethylation), 
which produces more sedation and is less hallucinogenic [1]. 
Ketamine is produced commercially by various pharmaceutical companies.  It 
was first made by Stevens in 1962, Belgian Patent 634208 (1963).  The synthesis of 
the optical isomers is also described by Hudyma et al., German patent 2062620 (1971 
to Bristol-Myers) [29].  Nevertheless, the absolute stereo-structures of S- and R-
ketamine hydrochloride were first described by Ratti-Moberg et al. in 1991 by using 
tartaric acids as resolving agents [30]. Other syntheses of ketamine and analogues are 
reported [31, 32] including those employing thermal re-arrangement [33]. 
Ketamine is a prescribed drug and reported to be difficult to synthesise which 
partly explains why it is often stolen from pharmaceutical companies, veterinary 
practices, and hospitals as happened in Mexico and France [20, 34].  The Advisory 
Council on the Misuse of Drugs (ACMD) reported that “Data on the diversion of 
ketamine from human or veterinary practice are not collected nationally.  However, 
there have been reports from Controlled Drug Local Intelligence Networks that have 
evidence of diversion of ketamine from health and veterinary settings in some 
localities” [35].  In recent times, the illicit production of ketamine has been shown to 
occur in China on a village-wide 0.5 ton scale in Boshe [36].  Clandestine ketamine 
laboratories are also reported in India, Indonesia, and the Philippines [37]. 
To the best of our knowledge, there has not been any study to investigate the 
sources of ketamine within the UK using impurity profiling and preservative 
detection of street and legal ketamine samples by combining NMR and ESI-MS.  A 
specific analytical method has therefore been developed by using 1H NMR to detect 
preservative as low as 30 µg/mL in legal and illicit ketamine.  The information 
obtained from this investigation can be used to aid law enforcement in tracking the 
diversion of ketamine from legal sources and/or illegal production to establish drug 












Fig. 2.  Street ketamine sample forms and ketamine powder inhalers from 
Glastonbury and a Bristol night club, 2013 
 
       
 
Fig. 3.  Preservatives present in ketamine hospital and veterinary formulations 
available in the UK, (a) BZC, (b) EDTA, and (c) p-chlorocresol 
 
Ketamine samples (59) were supplied by the police from amnesty bins 
provided in a Bristol UK night club and the Glastonbury music festival (both in 




Street ketamine samples were received as crystalline needles and powders of 
different colours.  These samples were received in different amounts in small plastic 
bags and two samples came in inhalers with ketamine placed inside them (Fig. 2). 
Two different batches of ketamine hydrochloride (KT HCl) (Lot 
#SLBH9550V and Lot #SLB4519V, India), D2O (99.8 atom % D), and all other 
solvents of HPLC grade (≥99.9% purity) were purchased from Sigma Aldrich, UK.  
All preservatives and antioxidants within the pharmaceutical formulations of 
ketamine in the UK were purchased from Sigma Aldrich (UK) as reference materials:  
p-chlorocresol (4-chloro-2-methylphenol, preservative and antiseptic, 99.8%); 
ethylenediaminetetraacetic acid disodium salt dihydrate (EDTA disodium salt, 
antioxidant, 98.5-101.5%), and benzethonium chloride (BZC, preservative, ≥98% 
HPLC) (Fig. 3).  Hospital and veterinary ketamine, used in the UK, were purchased 
as colourless liquid solutions in vials ready for injection, pictures of KetalarTM and 




Fig. 4.  Hospital and veterinary ketamine in vials ready for injection. 
 
Names of hospital and veterinary ketamine medicinal products together with 
their formulations’ content and suppliers are given in Table 1.  All of these are 
available as clear solutions in vials ready for injection [21, 22].  Based on the VMD 
brand name, Anesketin 100 mg/mL solution for injection for dogs, cats and horses is 
produced in Denmark, France, Germany, Netherlands, Spain, and the UK.  The same 
formulation Nimatek 100 mg/mL solution for injection for dogs, cats and horses is 
manufactured in Austria, Belgium, Ireland, Italy, Poland, Portugal, and the UK.  The 





Summary of veterinary and hospital ketamine product characteristics and their 
suppliers in the UK 









1 Anaestamine® 100 115.33 CHLOR (1 mg/mL) Animalcare 
2 Anesketin 100 115.4 CHLOR (1 mg/mL) Dechra 
3 Ketavet® 100 115.36 BZC (0.10 mg/mL) Zoetis UK Ltd 
4 Narketan®-10 100 100 
BZC (0.10 mg/mL) and 
EDTA (0.1 mg/mL) 
Vétoquinol 
5 Ketamidor® 100 100 BZC (0.10 mg/mL) Chanelle 
6 VetalarTMV 100 100 BZC (0.01% w/v) Pfizer 






1 KetalarTM 50 50 BZC (1:10000) Pfizer 
Nimatek is discontinued; Ketaset® is the same as ketavet®;  
CHLOR:  p-chlorocresol; BZC:  benzethonium chloride;  
EDTA:  ethylenediaminetetraacetic acid disodium salt dihydrate 
 
6.2.2. Instrumentation and experimental procedures 
 
6.2.2.1.  General procedure 
 
The crystalline and powder in the seized and amnesty bins ketamine samples 
were labelled after being identified by 1H NMR and confirmed by ESI-MS.  Each 
sample was ground into a powder.  The hospital and veterinary samples of ketamine 
were poured on to glass plates and allowed to evaporate in a fume cupboard for 2-3 h.  
The resulting crystals were dried under a stream of anhydrous nitrogen, ground, 
labelled, and stored in a safe at 18 ⁰C.  The analytical balance was a Sartorius 
Microbalance SE-2F, precision 0.1µg; Sartorius AG, Goettingen, Germany.  UV 





6.2.2.2.  LC-ESI-MS analysis 
 
Positive and negative ion modes were reported on a liquid chromatography 
mass spectrometer (LC/MS, a Bruker Daltonics micrOTOFmass spectrometer) fitted 
with an electrospray ionisation (ESI) source.  The samples were dissolved in 
methanol (~10 µg/mL) and ketamine, their impurities and preservatives were 
detected. 
 
6.2.2.3.  NMR analysis 
 
The 1D and 2D NMR experiments 1H, 13C HSQC, HMBC, H2BC, DEPT, and 
15N-HMBC were performed on the 500 MHz spectrometer.  1H NMR were measured 
for the ketamine samples in D2O (50 mg/mL) on a Bruker (500 MHz) spectrometer.  
The pharmaceutical formulations of ketamine contained preservative, antiseptic, and 
antioxidant ingredients alongside the active component, ketamine hydrochloride 
(Table 1).  The experiment has been optimized to be detect:  benzethonium chloride 
at 5 µg/mL and 50 µg/mL, EDTA at 50 µg/mL, and p-chlorocresol at 500 µg/mL.  
Full NMR assignment is also reported for the authentic ketamine and each 
preservative.  Each spectrum was referenced and rescaled by adjusting the residual 
HOD signal (in D2O) to 4.79 ppm.  All spectra have been processed using Topspin 
1.3, 2.0, or 2.1 program suite (Bruker Biospin GmbH, Rheinstetten, Germany) and 
MestReNova (Version 10.0.2). 
 
6.2.2.4.  Optical activity of ketamine samples 
 
The optical profiling for all ketamine samples was tested on an ADP-220 
polarimeter (Bellingham and Stanley, Tunbridge Wells, UK).  Each ketamine sample 
was prepared in MeOH (1 mg/mL).  In each measurement, a sample was placed in a 
1 mL cell and measured after subtracting the background of the solvent, MeOH.  If 
any of the street ketamine samples has predominant or even a single enantiomer S, 
this is evidence that the sample is not necessarily an illegal synthetic ketamine, but it 






6.2.2.5.  Isotope profiling of ketamine samples 
 
Table 2 
Identification of KT samples by origin 
Sample Country of origin Supplier 
VTMVetalar Germany Zoetis UK Ltd 
TMKetalar Ireland Pfizer Ltd, Kent, UK 
Ketamine HCl India Sigma Aldrich (authentic) 




festival amnesty bin 
(2013) 
Avon and Somerset 
Constabulary, UK 
AH9, AS5, AV1 
A night club in Bristol, 
UK (2013) 
Avon and Somerset 
Constabulary, UK 
K2, K3 
Seized samples, Avon and 
Somerset Constabulary 
Drug Expert Action Team 
(DEAT), UK 
 
Eleven different ketamine street samples, together with three authentic 
samples (Table 2) (including hospital Ketalar and veterinary Vetalar), were subjected 
to Elemental Analysis-Isotope Ratio Mass Spectrometry (EA-IRMS) analysis. 
The %C and %N elemental compositions were determined by elemental 
analyser (Dumas combustion).  The analysis was carried out on a Carlo Erba 
NA1500 Mk 1 elemental analyser coupled to a PDZ Europa CF-IRMS.  In this 
technique, the sample is combusted, the gaseous products separated by GC, and the 
peak area of each determined by thermal conductivity.  The system is calibrated 
using primary (NIST) standards of known % N and C.  All the stable isotope ratios δ 
(‰) and % element data are traceable to the National Institute of Standards and 
Technology (NIST) primary references.  δ (‰) 15N calibrated to  IAEA-N1 
ammonium sulfate and 13C calibrated to reference IAEA-CH-3 cellulose.  Sample 
(2.0-2.5 mg) of the ketamine samples were accurately weighed and submitted in tin 
capsules for EA-IRMS.  The δ values are subject to various correction factors, but in 
essence they are derived from the following equation: 
!(‰) = [(RSample/RStd) – 1] x 1000     (1) 




6.2.2.6.  Single-crystal X-ray diffraction 
 
X-Ray diffraction was measured for one of the seized ketamine samples that 
was confirmed to have no optical activity by polarimetry.  The crystals were formed 
from drops of methanol and hot cyclohexane and left for 3 days at 18 oC.  The 
crystals were collected, and submitted for X-ray diffraction analysis (University of 
Bath). 
 
6.3. Results and discussion 
 
6.3.1. NMR assignments of ketamine and their pharmaceutical preservatives 
 
 
(R)-Ketamine                   (S)-Ketamine 
Fig. 5.  Optical isomers of ketamine 
 
Legal ketamine is available as ketamine hydrochloride solution ready for 
injection in different formulations and concentrations (Table 1).  Medical ketamine in 
the UK is available as the racemic mixture (Fig. 5).  The molecular structure of 
ketamine (authentic) as well as its preservatives and antioxidant were confirmed by 
NMR.  The 1H and 13C chemical shifts in D2O were assigned using COSY, HSQC, 
HMBC, 15N HMBC and H2BC experiments.  The data also show good agreement 
with the literature [38].  1H NMR (500 MHz, D2O) δ 1.64-1.77 (m, 2H, H4eq, H5eq), 
1.84-1.91 (m, 2H, H3eq, H4ax), 2.04-2.11 (m, 1H, H5ax), 2.37 (s, 3H, N-Me), 2.50-
2.61 (m, 2H, H6ax, H6eq), 3.26-3.33 (m, 1H, H3ax), 7.52-7.59 (m, 3H, in the 
ascending order H5′ then H4′ then H3′ following from HSQC), 7.83 (dd, J = 7.0, 2.0 
Hz, 1H, H6′).  13C (500 MHz, D2O) δ 21.0 (C4), 26.6 (C-N-Me), 30.0 (C5), 35.9 
(C3), 39.3 (C6), 72.4 (C2), 127.0 (C1′), 128.3 (C4′), 131.7 (C6′), 131.8 (C3′), 132.6 
(C5′), 133.9 (C2′), 211.2 (C1) (Fig. 6).  Exact mass ion patterns of ketamine, 



















Fig. 7.  MS for ketamine and the simulated pattern for the formula C13H17ClNO 
showing the 3:1 35Cl:37Cl isotope ratio 
 
The aromatic proton peak pattern for ketamine clearly shows a 1,2-
disubstituted benzene pattern:  multiplet (7.55 ppm, 3H), a doublet (7.83 ppm, 1H) 
(Fig. 6 (a)).  The 13C NMR spectrum of ketamine contained 13 carbons, four of them 
are quaternary as no signals are detected in HSQC, one aliphatic quaternary (C2, 72.4 
ppm), two aromatic quaternary (C1´ = 127.0 and C2´ = 133.9 ppm) and one ketone 
(C1 = 211.2 ppm) (Fig. 6 (b)).  The HSQC spectrum shows the correlation between 
each carbon and its corresponding proton.  Two protons from different carbons are 
responsible for each of the two first peaks around 1.70 and 1.88 ppm (Fig. 8), these 
were assigned later by HMBC as 4eq, 5eq, and 3eq, 4ax, respectively (Fig. 10).  In the 
dihedral angle in cyclohexanone, spin-spin coupling can occur through 2, 3, and 4 
bonds.  Axial protons typically resonate 0.5-1.5 ppm downfield from equatorial ones, 
and not all proton signals are split by their close protons.  The NH proton in NH-Me 
is exchangeable due to its acidity, therefore usually no coupling will occur between 
this and other protons.  The presence of the N-Me is observed by 1H 2.37 ppm, 13C 
26.6 ppm, COSY, HSQC, and confirmed by a 15N HMBC NMR experiment.  The 


















Fig. 9.  15N-HMBC NMR experiment of ketamine in D2O showing the correlation 
between the N-atom and the singlet at 2.38 ppm, 3H, confirming the presence of the 
N-methyl group 
 
Starting with the quaternary signals, the HMBC (Fig. 10) shows correlations 
between the aromatic quaternary C1´ with 6′, 5′, and the 3 equatorial (eq) and axial 
(ax) protons at 1.84-1.91 (m) and 3.30 (dd) ppm, respectively.  These correlations 
show that C1´ is bonded to, or very nearby, the 6′, 5′ aromatic carbons and carbon-3 
in the cyclohexanone.  In addition, the carbonyl carbon at 211 ppm is coupled with 
H3ax, H6ax, H6eq, and the nearby proton of C5, H5ax.  The quaternary carbon at 72.5 
ppm is identified as C2 as the only aliphatic quaternary besides the carbonyl.  The 
chemical shift indicates it is bonded to a strong electron withdrawing group, in this 
case to the cyclic ketone, the N-atom, and the aromatic ring.  C2 correlates with H3ax, 
H6ax, H6eq, N-Me, and H3eq.  All other HMBC assignments are illustrated in Fig. 10 









































Assignments of 1H and 13C NMR chemical shifts of ketamine 
Position 13C (ppm) 1H (ppm, J) and HSQC HMBC 
1 211.2 - 3ax, 6 ax, 6eq, 5ax 
2 72.4 - 6´, 3ax, N-Me, 3eq 
3 35.9 1.84-1.91 (m, H3eq, 1H), 3.30 (dd, J = 
14.0, 3 Hz, H3ax, 1H) 
5ax, 5eq, 3ax, 3eq 
4 21.0 1.64-1.77 (m, H4eq, 1H), 1.84-1.91 (m, 
H4ax, 1H), 
3ax, 3eq, 5eq, 6 ax, 6eq 
5 30.0 1.64-1.77 (m, H5eq, 1H), 2.04-2.11 (m, 1H, 
H5ax) 
4ax, 4eq, 3ax, 5eq, 6 ax, 
6eq 
6 39.3 2.50-2.61 (m, 2H, H6 eq, H6 ax) 3eq 
1´ 127.0 - 3eq, 3ax, 6´, 5´ 
2´ 133.9 - 3´, 4´, 5´, 6´ 
3´ 131.8 7.57 (d, J = 2.5 Hz H3′, 1H) 4´, 5´ 
4´ 128.3  7.55 (d, J = 2.5 Hz H4′, 1H) 3´, 5´ 
5´ 132.6 7.53 (d, J = 2.5 Hz H5′, 1H) 6´ 
6´ 131.7 7.83 (dd, J = 6.0, 2.5 Hz, 1H) 4´, 5´ 
N-Me 26.6 2.37 (s, N-Me, 3H),  
 
Benzethonium chloride 1H NMR (500 MHz, D2O) δ 0.6 (s, 9H, 1), 1.21 (s, 
6H, 5), 1.50 (s, 2H, 3), 3.01 (s, 6H, 17), 3.41 (s, 2H, 11), 3.82 (s, 2H, 13), 4.01 (s, 4H, 
10, 12), 4.53 (s, 2H, 15), 6.75 (d, J = 2.5 Hz, 2H,7), 7.09 (d, J = 10.0 Hz, 2H, 17), 
7.14-7.20 (m, 3H, 18, 19), 7.42 (d, J = 2.5 Hz, 2H, 8) (Fig. 11); "max = 276 nm.  [M]+ 
of base C27H42NO2 requires 412.3210 found 412.3224 (3.3980 ppm). 
EDTA 1H NMR (500 MHz, D2O) δ 3.64 (d, J = 2.5 Hz, 4H), 3.86 (d, J = 2.5 
Hz, 8H) (Fig. 12). 
p-chlorocresol 1H NMR (500 MHz, D2O) δ 2.14 (s, 3H, CH3), 6.78 (d, J = 
10.0 Hz, 1H, 6), 7.11 (dd, J = 10.0, 5.0 Hz, 1H, 5) 7.16 (d, J = 5.0 Hz, 1H), (Fig. 13); 

















Fig. 13.  1H NMR (D2O) assignment of p-chlorocresol (aromatic area expanded) 
 
6.3.2. 1H NMR method validation of ketamine preservatives detection 
 
Standard 1H NMR (number of scan, NS = 16) was run first to identify 
ketamine within the seized and amnesty bins samples.  The second aim was to search 
if any of the street samples contained pharmaceutical preservatives (BZC, EDTA, 
and CHLOR), Fig. 14.  Based on the impurity profiling of the street ketamine 
samples by 1H NMR, most of the samples were preservative free, e.g. sample code 
AL9, Fig. 15 (a).  Nevertheless, MDMA impurity can be identified by increasing the 
NS from NS = 16 to 1024 and expand the spectrum (Fig. 15 (b)).  To enhance the 
sensitivity and to get better signal to noise (S/N), different NS scan were applied on 
one of the pharmaceutical ketamine samples, VetalarTMV, to determine the NS 
needed to be able to detect the lowest concentration of preservative BZC at 30 µg/mL 
(Fig. 16).  The NS = 64 has been chosen as priority of time vs peaks detection.  It can 
be seen from Fig. 16 that peaks at δ = 0.6 ppm (3CH3), δ = 1.15 ppm (2CH3), δ = 





NMR assignment Fig. 11) and easily distinguished from the ketamine peaks.  The 
lowest concentration of the preservative, BZC, is present in VetalarTMV (100 mg/mL) 
at 0.1 mg/mL.  Both ketamine and BZC in a VetalarTMV sample are detected in 
positive ion electrospray with molecular ion [M]+ at m/z 238.0992 (0.4201 ppm) and 


























Fig. 14.  Stacked spectra of the three preservatives identified within the medical 








Fig. 15.  1H NMR spectrum (D2O) of ketamine (code AL9) showing the differences 























Fig. 16.  1H NMR of VetalarTMV samples showing how NS effects the detection of BZC at 
a particularly low concentration (30 µg/mL), and (a) the exact ion mass of ketamine, 











1H NMR spectrum of two medical ketamine samples, Anesketin and 
Ketamidor were compared with their authentic preservatives, Fig. 17 and Fig. 18 
respectively.  A shift occurs in the CHLOR and BZC peaks positions.  This is due to 
the presence of ketamine or as a result of a change in pH.  An authentic ketamine 
sample (50 mg/mL, D2O) spiked with benzethonium chloride (1 mg/mL) (Fig. 19) 
was prepare to simulate the pharmaceutical formulation of medical ketamine, 
Ketavet®, Ketamidor®, KetalarTM and VetalarTMV.  Stacked 1H NMR spectrum of the 
hospital and the veterinary samples show preservative peaks can be detected in the 1H 
NMR in D2O, Fig. 20.  Medical ketamine is available two strengths 50 mg/mL for the 






Fig. 17.  1H NMR (D2O) spectra of (a) Anesketin (30 mg/mL) containing p-











Fig. 18.  1H NMR stacked spectrum of (a) Ketamidor (30 mg/mL, D2O) showing the 

































Fig. 20.  Stacked 1H NMR (D2O) of the hospital and veterinary ketamine 
formulations that are available in the UK showing expansion in the preservatives 
areas 
 
6.3.3 1H NMR impurity profiling of street ketamine samples 
 
The chemical composition of the ketamine samples was investigated by 1H 
NMR and mass spectrometry.  The optimized number of scans, NS = 64 were used in 
order to allow for preservative determination.  Different NMR experiments were 
applied for further investigation of the impurities.  The 1H NMR data show that all 
the street ketamine samples (63) were preservative-free.  This indicates that none of 
the illegal ketamine samples seized and from amnesty bins were diverted from 
hospitals and veterinary suppliers in the UK.  Furthermore, it is likely that the drug 
being abused is synthetic rather than diverted from B.P. or VMD samples due to the 
absence of any preservative.  Impurity profiling by using 1H NMR spectroscopy can 
be used for discriminant analysis, where it is possible to differentiate between 












Although the ketamine samples were preservative-free, other adulterants, 
solvents and impurities were detected and identified by 1H NMR.  A summary of the 
adulterants and fillers that were identified in the street ketamine samples is shown in 
Fig. 21.  No evidence was found of the presence of synthetic precursors in the 
ketamine samples.  However, solvents and contaminants were detected and the 
analysis of individual samples will be discussed below in detail.  Impurities are more 
likely to be precursors or solvents introduced in to the samples during production.  
While, adulterants are commonly found in illicit drugs and are added at any stage of 
drug distribution to increase profit.  Ketamine is reported to be mixed or cut with 
other drugs such as methamphetamine, MDMA (ecstasy), cocaine, heroin, and 
benzodiazepines [39].  Many studies have cited ecstasy tablets cut with ketamine that 
might be sold as ketamine [15, 28, 34, 40].  Ketamine in tablets is usually sold as 
ecstasy [28].  Other drugs were that detected in ketamine tablets are 
methamphetamine, amphetamine, pseudoephedrine, ephedrine, caffeine, and MDMA 
[28].  Other investigations have reported that ketamine is normally pure and not 
adulterated and this might be because the drug is diverted from legal sources, 













44 samples out of 63 of the illicit ketamine have found to be pure by NMR, 
purity ≥ 95%, Fig. 21.  Mephedrone was detected in 3% of the samples.  1H NMR 
assignment of mephedrone, and confirmatory mass spectra are displayed in Fig. 22.  
Mephedrone and ketamine are also used as adulterants in MDMA, 2% (one sample) 
of the ketamine samples contained MDMA.  The samples were compared with 
authentic MDMA and ketamine 1H NMR spectra to confirm their identity, see Fig. 
23.  Sucrose as a diluent is a safe choice for those cutting the ketamine.  Sucrose 
crystals are similar in weight, as heavy as ketamine crystals, easily obtained and not 
harmful to users, and discussed as being soft (not abrasive) for snorting ketamine. 
Such aspects of sucrose being a safe choice are found e.g. on www/bluelight blogs. 
One sample of ketamine from the Glastonbury amnesty bin (GG-4) was 
adulterated with creatine and methoxetamine (MXE).  1H NMR confirmed by 
comparing the spectra with the literature [38].  MXE is a designer psychoactive 
substance chemically related to ketamine and PCP, the dissociative anaesthetics.  
MXE chemical structure is compared to ketamine in Fig. 24, the 2-chloro and the N-
methylamine groups are replaced by a 3-methoxy and an N-ethylamine group [41].  
According to the Advisory Council on the Misuse of Drugs (ACMD) and the 
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), MXE was 
first advertised on the internet into the UK market in September 2010 as a legal 
alternative of ketamine [42].  From February 2013, MXE was made illegal in the UK.  
Yet, MXE is not internationally controlled and remains legal in Brazil, Japan, Russia, 
Germany, France, and in eight states in the US.  Until now, there are no reports on 
MXE availability and distribution [41]. 
Ketamine has been discovered to cause serious bladder damage in long-term 
heavy users [43, 44].  MXE was introduced as a safe alternative and marketed as 
‘‘bladder friendly’’ [17], yet very little is known about the long term effects of MXE, 
and it may have the same effects on the bladder after long use as ketamine.  Recently, 
a study conducted by Horsley et al. reported that MXE is more potent than ketamine 
[45].  Compared with ketamine, MXE is reported to have a delay in reaching its 
effect (90 min) with a longer duration time [46].  This might lead to overdose due to 
redosing if the user is expecting a faster ketamine onset [47].  A dose of MXE varies 
depending on the method of administration, between 20 to 100 mg for snorting, 10 to 
80 mg for injection, and 40 to 100 mg orally [41].  Hospitalisations and deaths linked 








Fig. 22.  Ketamine samples contained mephedrone and mannitol as cutting agents 
with their 1H NMR assignments, and the MS spectrum confirmation of (a) ketamine, 













Fig. 23.  1H NMR (D2O) spectrum of (a) MDMA cut with ketamine in a ratio of 8.3:1 










Fig. 24.  (a) Ketamine sample cut with a combination of creatine and MXE, 
(b) authentic creatine spiked with maleic acid (6.20 ppm), and (c) MXE structure 
 
Other possible impurities that can be present in the ketamine samples are 
synthetic precursors or solvents.  These are introduced during ketamine production.  
Synthetic routes to ketamine are well documented in the literature [31, 32, 33].  
Ketamine was synthesized via the following route:  o-chloro benzonitrile (1) is used 
as starting material and reacted with a Grignard reagent (cyclopentylmagnesium 
bromide) to form o-chlorophenyl cyclopentyl ketone (2).  This is then brominated to 
give (1-bromocyclopentyl)(2-chlorophenyl) methanone (3).  The product is treated 
with liquid methylamine to form cyclopentanol product 4 and ketamine is achieved 
after heating to cause a ring-expansion (Fig. 25).  Typical precursors involved in the 
production of illegal ketamine are cyclohexanone, methylamine, and chlorobenzene 
[34].  A method for the analogous MXE used 3-methoxy benzonitrile as the starting 
material followed by the same procedure as shown in Fig. 25 [38].  The use of a 










Fig. 25.  Synthesis of ketamine 
 
Trace impurities, either adulterants or solvents, are detected in the 1H NMR of 
ketamine samples.  These can be useful intelligence information as a characteristic 
markers to link between ketamine samples.  Ketamine with the same impurity and 
with a same level might link to the same supplier.  The most frequent solvent that 
was identified in the ketamine samples in this study was ethyl acetate, Fig. 26.  Ethyl 
acetate is commonly used in extractions and its easy accessibility means it may be 
used during illicit manufacture of ketamine. 
Traces of MDMA, paracetamol, mephedrone, and sucrose were identified 
(Figs. 27, 28, 29, and 30 respectively).  31 out of 64 street ketamine samples were 
found to have traces of MDMA.  However, the MDMA was only present in very 
small amount, typically 1-2% of ketamine.  Three different samples of the seized 
ketamine samples, two from Bristol, and one from Glastonbury amnesty bins were 
reanalysed three times each to confirm the MDMA contamination.  One explanation 
for the presence of the MDMA is that it might be introduced during the ketamine 
handling as there are unlikely to be beneficial psychological affects to the abusers 
from these trace amounts.  MDMA is more likely to be a contamination (impurity) 
rather than a cutting agent.  However, it does raise the question about ketamine purity 











Fig. 27.  Stacked spectra showing the MDMA contaminant level, ≥ 1 %, in an illicit 












Fig. 29.  1H NMR (D2O) (a) expansion showing traces of mephedrone in an illicit 








Fig. 30.  Traces of sucrose in an illicit ketamine sample 
 
6.3.4 Optical activity profiling of street and pharmaceutical ketamine samples 
 
The ketamine samples were subjected to measurement of optical rotation in 
methanol (1 mg/mL).  Equal amounts of both enantiomers are present in each of the 
seized, amnesty and pharmaceutical ketamine hydrochloride samples, [α]D20 = 0 (c = 1 
mg/mL, MeOH).  This suggested that the street ketamine samples are more likely to 
be synthesised illegally rather than diverted from legal oversees sources. 
 
6.3.5 Isotope profiling of ketamine samples 
 
6.3.5.1 EA-IRMS analysis 
 
The EA-isotope ratio mass spectrometry (EA-IRMS) was employed as 
another method of profiling the ketamine samples and in particular their possible 
source.  This technique is a bulk measurement technique and it is typically used to 
measure the average isotopic composition of organic compounds and to measure 
accurately variations in the abundance of isotopic ratios of light elements such as:  





abundances of these elements were fixed when the Earth was formed, small 
variations can occur due to chemical, physical, and biological effects.  These 
variations or fractions in the natural abundance of stable isotope are called !, and 
these values are reported in parts per thousand or in parts per million (ppm) [51]. 
These analyses were applied to 14 samples of ketamine from different sources 
and used to determine the region of the world where the samples were produced 
(Table 2, vide supra 25 pp).  The δ13C ‰ and δ15N ‰ values of the medical 
ketamine, VetalarTMV, KetalarTM, and an authentic ketamine HCl (manufactured in 
India) were compared with those samples seized from the street.  Using EA-IRMS 
allows the analysis of ketamine samples without sample preparation avoiding any 
extraction step which can potentially add isotopic fractionation from the solvent.  














Fig. 31.  δ13C ‰ and δ15N ‰ values for seized KT samples (*), Glastonbury amnesty 
bin (●), Bristol night club (!), VetalarTMV (◊), KetalarTM (♦), and Ketamine HCl 
(▲), values are reported as the mean of duplicates 
 
Based on the δ13C‰ and δ15N‰ (parts per thousand) values (Fig. 31), 8 of the 
samples could be grouped into three sets:  I (seized samples), II (Bristol night club), 
and III (Glastonbury).  The δ15N ‰ isotopic ratios of the 11 samples varied between 
4.175 and 13.975‰.  These results showed that the seized ketamine samples (Group 
I) had almost identical values of δ13C‰ and δ15N‰ and therefore might be from a 
































single source.  Similarly, all Bristol night club samples could be grouped together.  
The VetalarTMV and KetalarTM samples had different δ13C‰, but very close δ15N‰ 
values and did not match any of the illicit samples.  None of the illicit samples had an 
isotopic ratio fingerprint comparable to the authentic ketamine (Indian).  Three 
samples from the Glastonbury amnesty bin appeared to have distinctive profiles, 
GB2-1, GB14-11, and GB4-1. 
 
6.3.5.2 Cluster analysis of δ13C ‰, δ15N ‰ and their %C and %N composition 
 
The clustering test was applied on the mean values for the. δ13C ‰ and δ15N 
‰ beside their %C and %N.  Gathering these four variables can provide more 
discrimination between the ketamine samples compared with using only the δ13C ‰ 
and δ15N ‰ values.  The dendrogram (Fig. 32) revealed that the samples can each be 




Fig. 32.  Dendrogram on the δ13C‰ and δ15N‰ isotope values and their element 
percentages of street, medical (VetalarTMV and KetalarTM), seized and amnesty bins 





In the first group, all the authentic and the medical ketamine are branched 
separately with only one sample (GB2-1) from the Glastonbury amnesty bin.  GB2-1 
has mean values very close to the authentic ketamine compared with VetalarTMV (◊) 
and KetalarTM.  Therefore, GB2-1 might be manufactured in India and smuggled into 
the UK or the same starting materials might been used to make these two. 
In the second group, the two seized samples K2 and K3 are branched 
separately.  By comparing with the scatter plot (Fig. 31), these two have very similar 
δ13C ‰ and δ15N ‰ and also close C and N % composition values.  This suggests 
that K2 and K3 might come from the same source or same dealer. 
For the reasons described above, EA-IRMS was used to predict ketamine 
samples sources and to detect any linkage between the samples.  However, even 
though the sources of VetalarTMV, KetalarTM, and Indian ketamine are known, their 
precursor sources cannot be guaranteed.  For example, if ketamine was manufactured 
in India with Chinese precursors, the ketamine will analyse as made in China. 
 
6.3.6 X-ray single-crystal analysis 
 
The stereochemical configurations (Fig. 5) of seized ketamine sample were 
analysed by a single-crystal X-ray diffraction (Fig. 33).  The result shows the racemic 










This study addresses the possibility that street ketamine may have been 
diverted from legal veterinary or human therapeutic sources in the UK.  Medical 
ketamine in the UK is available in different formulations and under eight commercial 
trade names, all these contain excipients or preservatives, benzethonium chloride 
(BZC), ethylenediaminetetraacetic acid disodium salt dihydrate (EDTA), or p-
chlorocresol.  1H NMR has been used to answer this question by profiling the 
impurity in the street samples of ketamine without any pre-step sample preparation.  
The spectroscopic data were compared with the legitimate ketamine samples, 
searching for any evidence of the presence of the listed preservatives.  A 1H NMR 
method has been developed and validated to detect the preservatives at 
concentrations as low as 30 µg/mL.  Other impurities in ketamine samples, e.g. 
solvents, adulterants, were also investigated.  The results indicate that none of the 
ketamine samples contain the preservatives used in the pharmaceutical products and 
therefore they are unlikely to have been diverted even though ketamine is not 
internationally controlled.  Rather, these results support the growing evidence that 
street ketamine is more likely to be synthesised in clandestine laboratories abroad 
rather than diverted from legal sources. 
Legal ketamine is available in the UK as a racemic mixture.  The optical 
configurations of the illicit ketamine samples were investigated.  That the mixtures 
were all racemic by polarimetry was also confirmed by an X-ray structure of an illicit 
(racemic) ketamine.  There is potential that imported versions could be only S-
ketamine, e.g. as used in Australia and the USA, which is about four times as potent 
as R-ketamine, and so with a concomitantly higher risk of overdose.  Isotopic ratio 
analysis was also employed to investigate any possible link between legal ketamine, 
named VetalarTMV and KetalarTM and the street samples.  None of the illicit samples 
had isotopic ratio δ13C‰ and δ15N‰ fingerprints equivalent (or even similar) to the 
VetalarTMV and KetalarTM samples, suggesting they had not been diverted from 
veterinary or hospital supplies.  Furthermore, δ13C‰ can discriminate between 
VetalarTMV and KetalarTM compared to using only δ15N‰.  With one exception 
(GB2-1), statistical analysis by dendrogram clustering successfully discriminated 
between the legal and illicit ketamine samples.  This study shows the feasibility of 
using NMR in the impurity profiling of ketamine samples searching for possible 
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This research project has a focus on the impurity profiling of illicit drugs.  In 
particular, on the NPS which constitute an emerging problem in the UK and 
elsewhere around the world.  Chemical characterization of such NPS is challenging 
due to the high similarity of chemical structures between the samples and, added to 
that, the possible presence of other substances, e.g. adulterants.  Among the main 
aims of this study is the development of a rapid, accurate, and practical analytical 
technique to analyse illicit drugs in street samples in order to be able to aid law 
enforcement.  Different analytical techniques and methodologies were therefore 
tested throughout this study.  In particular, the results show how the capabilities of 
NMR spectroscopy can be used in forensic drug analysis.  One important aspect of 
this technique is the ability to provide accurate and quantitative chemical 
characterization of the drugs and their impurities even between highly similar drugs 
such as NPS and/or drugs in mixtures.  From a practical point of view, using NMR 
spectroscopy as an additional analytical technique, complementary to other simpler 
methods, could be costly.  High resolution NMR spectrometers usually have large 
and expensive superconducting magnets, e.g. a 500 MHz instrument may cost 
£500,000 before the £3,000 annual costs for essential coolants (liquid helium and 
nitrogen) and maintenance.  However, good resolution can be achieved using less 
expensive, lower field-strength spectrometers, as found in research laboratories. 
The first part of this investigation covered the analysis of amnesty bin 
contents as an important source of current drugs being abused.  Two amnesty bins 
were analysed from a Bristol night club and from the Glastonbury music festival 
(2013).  Findings from this kind of analysis provide useful information related to 
drugs’ formulation, doses, adulterations, drugs’ purity, and routes of administration.  
Illicit drugs emerged such as cathinones, e.g. flephedrone, mephedrone, 4-MEC, 
which were found to be impure, cut with benzocaine, creatine, sucrose, and MSG.  
This confirmed the viewpoint that drug purity is more likely to drop after 
biologically/pharmaceutically active compounds, e.g. “legal highs”, have been 
banned so affecting their availability.  Other not common but toxic drugs were 
identified in both amnesty bins, e.g. 2CB, 2CE, DMT.  Both ketamine and 
mephedrone are still widely available and this might be because they are still not 




amnesty bins, ketamine was the third most common drug in both.  From this arises a 
concern about harm associated with the long-term abuse of ketamine with 
irreversible organ damage especially among the youngest abusers.  Findings from 
this analysis can provide information among any newly abused drugs or/and 
medication, e.g. Modalert.  These results were achieved by NMR spectroscopy, 
where a simple 1H NMR experiment requires only minimal sample preparation and 
no need for reference materials, providing a quick (< 4 s, NS = 16), accurate, 
quantitative and non-destructive analytical technique. 
On the national level, these data might contribute in mapping drugs from 
different regions in the UK.  Internationally, a better picture can be provided about 
illicit drug trends by collaborating, sharing findings from amnesty bin analysis with 
other current information sources, e.g. waste water analysis, the internet based 
system, the Forensic Early Warning System (FEWS). 
Recently, many other non-destructive methods have been introduced such as 
rapid screening methods to aid law enforcement, e.g. hand-held Raman, benchtop 
ATR-FTIR, and even benchtop NMR.  An evaluation was carried out on a benchtop 
NMR system to test the ability of this instrument to detect drugs and their impurities 
in seized street samples.  By experiment it was demonstrated that the benchtop NMR 
is unsuitable for the analysis of illicit drug and their impurities because of the poor 
spectrum resolution and the need for large amounts of sample (≈100 mg). 
The close structural similarity between certain cathinone derivatives, e.g. 
mephedrone and flephedrone, can make the specific identification of these illicit 
drugs and their regioisomers challenging.  This could lead to mislabelling with 
possible health and even legal consequences.  Flephedrone, a cathinone derivative, 
was incorrectly assigned in its regioisomers in the literature.  The combination of 1H, 
13C, 15N, and 19F NMR spectroscopy was used to identify and decipher between 
flephedrone regioisomers and other cathinones such as mephedrone, showing the 
applicability of NMR for this kind of accurate analysis.  Furthermore, 2D NMR 
spectroscopic techniques, 15N HMBC and HOESY were applied in the analysis of 
flephedrone and mephedrone, allowing unambiguous assignment of the aromatic 
regions. 
Flephedrone is being cut to increase street profits and this is the first evidence 
of cutting flephedrone with the topical anaesthetic benzocaine.  Flephedrone and 




of benzocaine adulterant quantified in the four (nightclub) flephedrone samples by 
GC; the adulterant levels determined by 1H NMR integration values were in broad 
agreement.  These data show that this now illegal cathinone-derived stimulant (a 
high) is now being cut by 5-12% with benzocaine, so drug users cannot be certain of 
the purity of the drug they are taking.  Benzocaine as an adulterant can cause serious 
health problems, potentially more harmful than flephedrone.  Therefore, there are 
risks from the pharmaceutically active cutting agents themselves.  This is an urgent 
warning about benzocaine that needs to be heeded. 
Drugs intelligence agencies in the analysis of illicit drugs are seeking two 
main important aspects.  The first provides an accurate identity of the illicit drugs.  
The second investigates any relationships between the seized samples that can 
provide information on drugs networking and trafficking.  Impurity profiling was 
used in this aspect to determine any similarity between mephedrone samples in 
chapter 5.  1D and 2D NMR provides unique and powerful analytical techniques for 
the impurity profiling of street mephedrone samples. 
Molecules that can evade NMR spectroscopic detection are really few in 
number in comparison with other chromatographic and spectroscopic methods.  
Impurity profiling of mephedrone illustrated mephedrone samples were cut with safe, 
available and cheap materials, e.g. creatine, MSG, sucrose.  The most common 
administration method of mephedrone is insufflation, with high and multiple doses, 
and harm associated with adulterants, e.g. benzocaine, MSG, and creatine, must be 
taken into account.  Other recreational drugs, e.g. MDMA, are also used as 
adulterants for mephedrone in small amounts.  However, pharmaceutical agents, e.g. 
benzocaine, a topical anaesthetic, is also a choice for an adulterant, perhaps selected 
to mimic the numbing effect of cocaine on the tongue/lips so that it might sold as 
cocaine.  Moreover, benzocaine is shown to be used to cut other cathinones, e.g. 
flephedrone and this might link the mephedrone to another drug distributor. 
Both mephedrone and their adulterants were quantified using quantitative 
NMR (qNMR).  In order to quantify mephedrone another method, e.g. 
chromatography is really required.  Hence, method development to be able to detect 
mephedrone and its adulterants, and the necessary authentic reference materials are 
required.  Regarding the impurities (adulterants), 2D DOSY NMR was used to 
investigate the ability of this technique to separate the spectroscopic data in order to 




separation with limitations linked to where the signals are overlapping.  In reality, 
most of the mephedrone samples were cut with one or two adulterants.  
Consequently, this increases the chance to separate the impurities in the mephedrone 
samples by using DOSY. 
To investigate the possible link between the street mephedrone samples, the 
1H NMR data were further examined by statistical analysis.  The Principal 
Component Analysis (PCA), scree plot, was effective to classify between 
mephedrone samples with good agreement with the 1H NMR impurity profiling 
analysis.  The similarities and the differences between the samples for any possible 
link between them were linked by applying the dendrogram.  This kind of analysis of 
mephedrone street samples with impurity profiling, quantification and statistical 
analysis can provide valuable information about availability and purity showing any 
possible link between the samples and maybe to the source of supply to aid law 
enforcement officers. 
In the last chapter, one example where impurity profiling of an illicit drug can 
play an important role is addressed.  From analysis of the amnesty bins’ data, 
ketamine was the third drug of choice with 9.4% and 15.4% of the night club and of 
Glastonbury amnesty bins samples respectively.  Ketamine is somewhat difficult to 
synthesise and some references suggest it might diverted from hospitals, veterinary 
sources, or pharmaceutical companies.  However, there is no literature evidence to 
prove the diversion of ketamine from legal sources.  A comprehensive analysis was 
applied to ketamine samples investigating their impurities and possibly determining 
their origin. 
Medical ketamine in the UK is available in different formulations and under 
seven commercial trade names, all have excipients. These excipients or preservative 
are BZC, EDTA, and CHLOR.  1H NMR has been used to answer this question by 
profiling the impurity in the street samples of ketamine without any pre-step sample 
preparation.  The data were compared with the medical ketamine searching for any 
evidence of the presence of any of the preservatives.  A 1H NMR method has been 
developed and validated to be able to detect the preservative as low as 30 µg/mL.  
Therefore, with high accuracy, other impurities such as solvents, synthetic precursors 
and adulterants were investigated.  Evidence is presented of sucrose as an adulterant 
in ketamine samples. 




confirmed by an X-ray single crystal structure of the racemic ketamine.  Legal 
Ketamine B.P. available in the UK is a racemic mixture of S- and R-isomers.  There 
is the possibility that imported versions could be only S-ketamine, e.g. as used in 
Australia and the USA.  This isomer is about four times as potent as R-ketamine, and 
therefore there is a concomitantly higher risk of overdose. 
Isotopic ratio analysis was also employed to investigate the possible link 
between the legal ketamine, named VetalarTMV and KetalarTM, and the street 
samples.  None of the illicit samples had isotopic ratio δ13C‰ and δ15N‰ 
fingerprints equivalent (or even similar) to the VetalarTMV and KetalarTM samples, 
suggesting they had not been diverted from veterinary or hospital supplies.  
Furthermore, δ13C‰ can discriminate between VetalarTMV and KetalarTM compared 
to using only δ15N‰.  Statistical analysis by using dendrogram clustering could 
successfully discriminate between the legal and the other ketamine samples. 
Our results indicate that none of the ketamine samples contain a preservative 
that is available in the pharmaceutical products and thus demonstrating that the 
possible diversion of ketamine from legal sources in the UK has not occurred.  
Ketamine is not internationally controlled, and this might suggest that ketamine 
might diverted from another country in to the UK.  However, the results support the 
growing evidence that street ketamine is more likely to be synthesised rather than 
diverted from legal sources.  This study shows the feasibility of NMR in the impurity 
profiling of ketamine samples searching for possible preservatives within the street 
ketamine samples.  However, there has not been any previous NMR study reporting 
investigation of the possible diversion of ketamine from legal sources to the illicit 
drugs market. 
Therefore, by achieving the six objectives set, the two major aims have been 
realised.  The pharmaceutical analysis and impurity profiling of illicit drugs can 
contribute to a harm reduction approach.  This is a complex problem that requires the 
sharing of knowledge from across widely interdisciplinary studies. 
This analytical chemistry research project has deciphered different aspects 
across the wide range of impurities currently found in illicit drugs, with a focus on 
NPS and determining their purity/impurity (adulteration) by bringing together the use 
of many modern spectroscopic and chromatographic methods.  A routine, rapid, and 
quantitative analytical protocol to identify illicit drugs and their impurities (cutting 




Appendix 1. X-ray data of Ketamine 
 
Table 1.  Crystal data and structure refinement for ketamine. 
 
 Identification code ketamine 
 Empirical formula C13 H17 Cl2 N O 
 Formula weight 274.18 
 Temperature 150(2) K 
 Wavelength 0.71073 Å 
 Crystal system Monoclinic 
 Space group P21/c 
 Unit cell dimensions a = 7.0760(1)Å alpha = 90o 
       b = 12.7980(2)Å beta = 103.465(1)o 
       c = 15.2310(3)Å gamma = 90o 
 Volume 1341.38(4) Å3 
 Z 4 
 Density (calculated) 1.358 Mg/m3 
 Absorption coefficient 0.468 mm-1 
 F(000) 576 
 Crystal size 0.25 x 0.15 x 0.10 mm 
 Theta range for data collection 3.54 to 27.50o 
 Index ranges -9<=h<=9; -16<=k<=16; -8<=l<=19 
 Reflections collected 5939 
 Independent reflections 5939 [R(int) = 0.0000] 
 Reflections observed (>2sigma) 5416 
 Data Completeness 0.997 
 Absorption correction Semi-empirical from equivalents 
 Max. and min. transmission 0.912 and 0.823 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 5939 / 2 / 165 
 Goodness-of-fit on F2 1.054 
 Final R indices [I>2sigma(I)] R1 = 0.0368   wR2 = 0.1046 
 R indices (all data) R1 = 0.0433  wR2 = 0.1086 
 Largest diff. peak and hole 0.292 and -0.323 eÅ-3 
 
Notes: 
Equal amounts of both enantiomers are present in this crystal structure. 
H1A and H1B are located and refined at a distance of 0.98 Å from N1. 
Twinning (25%) about the 0,0,1 reciprocal axis vector was accounted for in this 
refinement. 
The lattice is dominated by hydrogen bonded-dimers – each molecule-pair straddling 






Table 2.  Atomic coordinates (x 104) and equivalent isotropic displacement 
parameters (Å2 x 103) for 1.U (eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
 
Atom x y z U(eq) 
Cl(1) -1023(1) 1513(1) 5434(1) 28(1) 
Cl(2) 1574(1) 5719(1) 3816(1) 23(1) 
O(1) -727(2) 3117(1) 3802(1) 27(1) 
N(1) 1714(2) 3898(1) 5182(1) 18(1) 
C(1) 2797(2) 2102(1) 5681(1) 18(1) 
C(2) 1429(2) 1496(1) 5984(1) 19(1) 
C(3) 1944(3) 852(1) 6736(1) 24(1) 
C(4) 3858(3) 782(1) 7197(1) 27(1) 
C(5) 5258(2) 1383(1) 6934(1) 26(1) 
C(6) 4724(2) 2035(1) 6187(1) 21(1) 
C(7) 2306(2) 2846(1) 4874(1) 17(1) 
C(8) 4013(2) 3007(1) 4407(1) 21(1) 
C(9) 4474(2) 2005(1) 3950(1) 26(1) 
C(10) 2724(3) 1626(1) 3239(1) 30(1) 
C(11) 913(3) 1516(1) 3630(1) 27(1) 
C(12) 606(2) 2518(1) 4085(1) 20(1) 
C(13) 3157(2) 4431(1) 5916(1) 22(1) 
 
Table 3.  Bond lengths [Å] and angles [o] for ketamine. 
 
Cl(1)-C(2) 1.7421(16) O(1)-C(12) 1.214(2) 
N(1)-C(13) 1.493(2)  N(1)-C(7) 1.5165(19) 
C(1)-C(2) 1.400(2) C(1)-C(6) 1.404(2) 
C(1)-C(7) 1.530(2) C(2)-C(3) 1.390(2) 
C(3)-C(4) 1.375(3) C(4)-C(5) 1.385(3) 
C(5)-C(6) 1.391(2)  C(7)-C(12) 1.547(2) 
C(7)-C(8) 1.551(2) C(8)-C(9) 1.530(2) 
C(9)-C(10) 1.523(3)  C(10)-C(11) 1.540(3) 
C(11)-C(12) 1.498(2)   
      
C(13)-N(1)-C(7) 116.56(12) C(2)-C(1)-C(6) 116.35(13) 
C(2)-C(1)-C(7) 124.36(13) C(6)-C(1)-C(7) 119.24(13) 
C(3)-C(2)-C(1) 122.08(15) C(3)-C(2)-Cl(1) 116.40(13) 
C(1)-C(2)-Cl(1) 121.52(12) C(4)-C(3)-C(2) 119.86(15) 
C(3)-C(4)-C(5) 120.11(15) C(4)-C(5)-C(6) 119.60(15) 
C(5)-C(6)-C(1) 121.96(15) N(1)-C(7)-C(1) 109.36(11) 
N(1)-C(7)-C(12) 105.08(12) C(1)-C(7)-C(12) 116.40(12) 
N(1)-C(7)-C(8) 108.98(12) C(1)-C(7)-C(8) 113.30(12) 
C(12)-C(7)-C(8) 103.17(12) C(9)-C(8)-C(7) 111.65(13) 
C(10)-C(9)-C(8) 111.51(14) C(9)-C(10)-C(11) 111.47(13) 
C(12)-C(11)-C(10) 108.93(14) O(1)-C(12)-C(11) 124.07(14) 
O(1)-C(12)-C(7) 120.25(14) C(11)-C(12)-C(7) 114.96(13) 
 




Table 4.  Anisotropic displacement parameters (Å2 x 103) for 1. The anisotropic 
displacement factor exponent takes the form:  -2 gpi2 [h2 a*2 U11 + ... + 2 h k a* b* 
U. 
 
Atom  U11  U22  U33  U23  U13  U12 
Cl(1) 18(1) 29(1) 36(1) 5(1) 4(1) -4(1) 
Cl(2) 22(1) 22(1) 24(1) 3(1) 8(1) 1(1) 
O(1) 25(1) 25(1) 28(1) 2(1) -4(1) 1(1) 
N(1) 18(1) 16(1) 19(1) 0(1) 4(1) 0(1) 
C(1) 19(1) 17(1) 18(1) -2(1) 5(1) 1(1) 
C(2) 19(1) 18(1) 20(1) 0(1) 3(1) -1(1) 
C(3) 32(1) 18(1) 23(1) 2(1) 10(1) -1(1) 
C(4) 38(1) 21(1) 18(1) 4(1) 2(1) 7(1) 
C(5) 24(1) 30(1) 22(1) 1(1) 0(1) 7(1) 
C(6) 19(1) 24(1) 21(1) -1(1) 4(1) 0(1) 
C(7) 18(1) 16(1) 16(1) -1(1) 4(1) 0(1) 
C(8) 21(1) 24(1) 19(1) 2(1) 8(1) 0(1) 
C(9) 29(1) 27(1) 24(1) 0(1) 10(1) 5(1) 
C(10) 43(1) 25(1) 21(1) -4(1) 8(1) 4(1) 
C(11) 32(1) 21(1) 23(1) -3(1) -2(1) -2(1) 
C(12) 21(1) 20(1) 18(1) 3(1) 0(1) -3(1) 
C(13) 21(1) 22(1) 22(1) -4(1) 2(1) -2(1) 
 
 
Table 5.  Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2 x 
103) for ketamine. 
 
 Atom  x  y  z  U(eq) 
H(3) 977 460 6931 29 
H(4) 4219 322 7698 32 
H(5) 6574 1349 7262 32 
H(6) 5693 2447 6013 26 
H(8A) 3672 3568 3950 25 
H(8B) 5181 3232 4862 25 
H(9A) 5571 2136 3663 31 
H(9B) 4878 1454 4412 31 
H(10A) 3029 941 3003 36 
H(10B) 2447 2127 2730 36 
H(11A) -240 1359 3139 32 
H(11B) 1097 934 4070 32 
H(13A) 3453 3983 6453 33 
H(13B) 2616 5095 6065 33 
H(13C) 4351 4566 5713 33 
H(1A) 506(16) 3856(15) 5386(12) 24(5) 







Table 6.  Dihedral angles [o] for ketamine. 
 
  Atom1  -  Atom2  -  Atom3  -  Atom4  Dihedral 
C(6) - C(1) - C(2) - C(3) -0.8(2) 
C(7) - C(1) - C(2) - C(3) -178.28(14) 
C(6) - C(1) - C(2) - Cl(1) 179.10(11) 
C(7) - C(1) - C(2) - Cl(1) 1.6(2) 
C(1) - C(2) - C(3) - C(4) -1.2(2) 
Cl(1) - C(2) - C(3) - C(4) 178.92(13) 
C(2) - C(3) - C(4) - C(5) 2.4(2) 
C(3) - C(4) - C(5) - C(6) -1.7(3) 
C(4) - C(5) - C(6) - C(1) -0.4(2) 
C(2) - C(1) - C(6) - C(5) 1.6(2) 
C(7) - C(1) - C(6) - C(5) 179.20(14) 
C(13) - N(1) - C(7) - C(1) 57.48(16) 
C(13) - N(1) - C(7) - C(12) -176.87(12) 
C(13) - N(1) - C(7) - C(8) -66.86(16) 
C(2) - C(1) - C(7) - N(1) 85.63(17) 
C(6) - C(1) - C(7) - N(1) -91.82(16) 
C(2) - C(1) - C(7) - C(12) -33.2(2) 
C(6) - C(1) - C(7) - C(12) 149.34(14) 
C(2) - C(1) - C(7) - C(8) -152.60(15) 
C(6) - C(1) - C(7) - C(8) 29.96(18) 
N(1) - C(7) - C(8) - C(9) -171.10(12) 
C(1) - C(7) - C(8) - C(9) 66.91(16) 
C(12) - C(7) - C(8) - C(9) -59.81(15) 
C(7) - C(8) - C(9) - C(10) 59.25(18) 
C(8) - C(9) - C(10) - C(11) -53.22(19) 
C(9) - C(10) - C(11) - C(12) 52.16(18) 
C(10) - C(11) - C(12) - O(1) 110.20(18) 
C(10) - C(11) - C(12) - C(7) -60.03(17) 
N(1) - C(7) - C(12) - O(1) 6.01(19) 
C(1) - C(7) - C(12) - O(1) 127.15(15) 
C(8) - C(7) - C(12) - O(1) -108.13(17) 
N(1) - C(7) - C(12) - C(11) 176.65(13) 
C(1) - C(7) - C(12) - C(11) -62.21(18) 
C(8) - C(7) - C(12) - C(11) 62.51(16) 
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a  b  s  t  r  a  c  t
Flephedrone  (4-fluoromethcathinone,  4-FMC)  was  analysed  using 1H, 13C, 15N HMBC,  and 19F  observe
spectroscopy,  gas  chromatography-flame  ionisation  detection  (GC-FID),  and  electrospray  ionisation-
mass  spectrometry  (ESI-MS).  Analysis  of  four  4-FMC  samples  (from  a Bristol  nightclub  in  2013)  showed
that  they  all  contained  benzocaine  as  the  cutting  agent  present  in different  amounts  from  5 to  12%.  Using
these  methods,  we successfully  differentiated  between  flephedrone  regioisomers  and  mephedrone  in  an
analytical  method  validated  for flephedrone  as a substituted  cathinone.  The  data  show  that  these  now
illegal  cathinone-derived  stimulants  (highs)  are  now  being  cut;  users  cannot  be  certain  of  the purity  of
the drug  they  are taking.  Furthermore,  there  are risks from the pharmaceutically  active  cutting  agents
themselves.
© 2014  The  Authors.  Published  by  Elsevier  B.V.  This is  an open  access  article  under the  CC  BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
The close similarity between cathinone derivatives (Fig. 1)
makes the specific identification of these drugs and their regioi-
somers challenging and could lead to mislabelling or accidental
misidentification or deliberate deception as in the nature of the cut-
ting of illicit (street) drugs. Flephedrone (4-fluoromethcathinone,
4-FMC) (Fig. 1c) was first synthesised in 1952, but surprisingly there
is a paucity of published data for this compound. Compared with
cathinone (Fig. 1a) and mephedrone (4-methylmethcathinone, 4-
MMC) (Fig. 1b), the C F bond on the aromatic ring of 4-FMC (Fig. 1c)
has a specific polarity effect. This may  influence receptor binding
and therefore influence the biological activity [1,2]. The biological
effects of cathinone ring-substituted derivatives are claimed to be
similar to cocaine, amphetamine, or MDMA  (ecstasy) [3]. In the UK,
a question about a decrease in the purity of cathinones has arisen
after they were banned as Class B drugs under the Misuse of Drugs
Act in April 2010 [4].
As a routine analytical technique, e.g. used by the police,
GC–MS [5–7] or GC-FID [6], infrared (FT-IR) [7], and Raman
spectroscopy are widely used for the detection of controlled
substances [8]. Nevertheless, standard reference materials for
detecting what may  be present in unknown samples are required.
∗ Corresponding author. Tel.: +44 01225 386795; fax: +44 01225 386114.
E-mail address: prsisb@bath.ac.uk (I.S. Blagbrough).
Using GC–MS alone would potentially not distinguish between
the 2-, 3-, and 4-regioisomers of FMC, all the isomers having
been reported in elegant synthetic work with full characterisa-
tion by Archer [7]. Electron impact-mass spectrometry (EI-MS)
also leads to uncertainty in distinguishing between flephedrone
isomers [7]. More recently, screening methods for the detec-
tion of new (illicit) psychoactive drugs in urine were reported
that use liquid chromatography coupled with tandem mass spec-
trometry (LC–MS/MS) [9], HPLC [6], and ultra performance liquid
chromatography–quadrupole time-of-flight-mass spectrometry
(UPLC–QTOF-MS) [5].
NMR  spectroscopy is an established analytical tool for the iden-
tification of controlled substances without the need for sample
derivatisation or the need to remove any impurity. Also, dis-
tinguishing between regioisomers, between salt and free base,
determining percentage purity and impurity ratios are successfully
and rapidly achieved using NMR  spectroscopy. Police or forensic
intelligence information may  be gained from this kind of analysis
to aid law enforcement. The aim of this work is to develop a robust,
rapid, and quantitative analytical approach to detect flephedrone
as well as the impurities (cutting agents) present in street sam-
ples using 1H, 13C, 15N, and 19F NMR  spectroscopy together with
GC.
http://dx.doi.org/10.1016/j.jpba.2014.12.033
0731-7085/© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).











Fig. 1. (a) Cathinone, (b) mephedrone, and (c) flephedrone.
2. Experimental
2.1. Chemicals and materials
Four creamy coloured crystal samples, as part of an amnesty
bin provided in a (Bristol, UK) nightclub, in 2013, were identified
as flephedrone. A reference standard of flephedrone hydrochloride
salt (4-FMC HCl) was purchased from LGC Standards, UK. An ana-
lytical standard of mephedrone hydrochloride salt (4-MMC  HCl)
was purchased from Aldrich, UK. Deuterium oxide (99.8 atom % D,
Aldrich, UK), per-deuteriated methanol (99.8 atom % D, Cambridge
Isotope Laboratories, USA), and all other solvents were of HPLC
grade, ≥99.9% purity (Aldrich, UK). Benzocaine B.P. was purchased
from J. M.  Loveridge plc (Southampton, UK).
2.2. Experimental procedures and instrumentation
Each sample of flephedrone (4-FMC) was weighed, dissolved,
and analysed at 20–25 ◦C without any purification. NMR  spectra
were recorded on Bruker 400 or 500 MHz  spectrometers, referen-
ced to external Me4Si and/or via residual protons in the deuteriated
solvents. Samples (∼30 mg  each) were vortexed for 2 min  in D2O
(0.6 mL). Identification of flephedrone samples and their impuri-
ties followed NMR  analysis including: 1H, 13C, 15N (HMBC), HSQC,
HMBC, and COSY. A GC method was optimised to analyse authentic
4-FMC nightclub samples dissolved in methanol (50 mg/mL), and
benzocaine B.P. injected directly into the GC-FID without any prior
chemical derivatisation. GC separation was performed on a CP-
9003 (Chrompack, Middelburg, The Netherlands) using a capillary
column ZB-WAX (polyethylene glycol, 10 m × 0.25 mm × 0.25 !m,
Phenomenex, UK). An injection volume (1–2 !L) was carried by
helium carrier gas at a flow rate of 23–27 mL/s. The oven tem-
perature was programmed with 250 ◦C injector and detector
temperature, 110 ◦C (2 min) oven initial and 230 ◦C (4 min) final
temperatures with 40 ◦C/min rate of heating, total run time was
9 min. Positive ion [M+H]+ mode LC/MS was performed, on sam-
ples dissolved in methanol, using a Bruker Daltonics micrOTOF
mass spectrometer equipped with an electrospray ionisation (ESI)
source.
3. Results and discussion
3.1. 1H, 13C, 15N, and 19F NMR  spectroscopy
4-FMC NMR  spectra show diagnostic 19F and 1H coupling (Fig. 2)
in the aromatic region; 1H, 13C, and 19F NMR  spectral data are
reported in Table 1. NMR  spectra are discussed and compared
to those of the closely related cathinone derivative mephedrone
4-MMC (Table 1, Fig. 2). The structures were confirmed by com-
paring the NMR  data with those of an authentic sample of 4-FMC
and the literature values [7], establishing the regioisomer as para-
substituted. Unfortunately, two lines in the literature 13C NMR
spectroscopic assignment Table have been transposed [7], and the
correct aromatic region assignment is given in Table 1 for " 116
(d, 2JCF 22 Hz) and 132 (d, 3JCF 10 Hz) ppm, where the coupling
constants are diagnostic for ortho to F (C3, C5) and meta to F (C2,
C6) respectively.
While the 1H NMR  spectrum of 4-FMC is similar to that of 4-
MMC  (Fig. 2), the absence of a 4-methyl aromatic substituent peak,
and the coupling from the 19F atom are diagnostic. The 13C-19F split-
ting patterns around the entire aromatic ring (e.g. 167 ppm, d, 1JCF
255 Hz; 129 ppm, d, 4JCF 3 Hz) in the 13C spectra (Table 1) are also
significant. 15N NMR  HMBC was  run to detect the number, kind,
and position of the nitrogen atoms proving the presence of a sec-
ondary amine coupled to the two N- and #-methyl groups (Fig. 3).
19F NMR  spectroscopy proves the presence and position of a fluo-
rine atom in such samples. Comparing with the literature data [7],
the 19F NMR  chemical shift values for the each of the four 4-FMC
samples show para-substitution: 19F NMR  showed −102.1 ppm (tt,
3JHF 8.4 Hz, 4JHF 5.2 Hz) (Fig. 3) with the d 1JCF 255 Hz easily visible
only in the 13C NMR  spectrum, not in the 19F NMR  spectrum due to
the low (1.1%) 13C natural abundance.
3.2. ESI-MS and impurity profiling
The ESI-MS gave [M+H]+ at 182.0976 and 182.1006 for the
samples and the authentic hydrochloride salt of flephedrone
respectively, C10H13FNO requires 182.0981 thus confirming
the identity of a regioisomer of flephedrone. ESI-MS spec-
tra also gave [M+H]+ 166.0874. Benzocaine C9H12NO2 [M+H]+
requires 166.0868; [M+Na]+ C9H11NO2Na found 188.0689, requires
188.0687.
Analysis of the 4-FMC samples by NMR  and ESI-MS showed that
they were impure. The 1H and 13C NMR  data of the impurity are:
1H NMR  (D2O): ı 1.36 (t, 3JHH 7 Hz), 4.33 (q, 3JHH 7 Hz), 6.83 (H3
and H5, t, 3JHH 7.6 Hz), 7.86 (H2 and H6, d, 3JHH 7.6 Hz) [10]; 13C
NMR  (D2O): ı 15 (C7), 61 (C6), 114 (C3, C5), 119 (C1), 132 (C2, C6),
155 (C4), 169 (C5) ppm [11]. A GC-FID method was then developed
to resolve flephedrone and benzocaine in mixed samples, achieved
with retention times of Rt = 2.8 min  and 4.9 min respectively (Fig. 4).
The benzocaine levels in these 4-FMC samples were quantified by
GC (5, 6, 7, and 12%), impurity levels which are in agreement with
those determined from the (more approximate) 1H NMR  integra-
tion data, 4, 6, 7, and 10%. Benzocaine has previously also been
quantified by HPLC [12].
4-FMC is a designed cathinone derivative either designed to
side-step the banning of the legal high 4-MMC  and/or with one
eye on the potential pharmacological enhancement from incorpo-
rating a fluorine substituent in a biologically active small molecule
as “there is also evidence that single, carbon-bound fluorine sub-
stituents, particularly when on an aromatic ring, can exhibit specific
polarity influences, including H-bonding, that can strongly influ-
ence binding” [1]. The human toxicology of flephedrone is not well
established [13]. Lipophilicity is significant as it often controls the
absorption, transport, or receptor binding of a compound and so
can enhance its bioavailability. The effect on the lipophilicity of
fluorine substituents on an aromatic ring was calculated by Dolbier
showing that CF3 (!x = 0.88) is greater than CH3 (!x = 0.56) follow-
ing from the respective n-octanol/water partition coefficients [1].
So, perhaps counter-intuitively, the presence of the most powerful
electronegative atom, a fluorine substituent, gives rise to enhanced
lipophilicity.
Benzocaine is a well-known topical anaesthetic. However,
the FDA has reported that using a gel or spray containing
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Fig. 2. 1H NMR  of mephedrone (left) and flephedrone (right) (D2O) with aromatic region expansion showing 19F couplings and the ∼7% benzocaine signals here are clearly
visible.
Table 1
1H (400 MHz), 13C (100 MHz), and 19F (470 MHz) spectral data of flephedrone (D2O).
Position Flephedrone Mephedrone
1H 13C 19F 1H 13C
1 – 129 (d, 4JCF 3 Hz) – 129.7
2,6  8.07 (dd, 3JHH 8.4 Hz, 4JHF 5.2 Hz) 132 (d, 3JCF 10 Hz) 7.96 (d, 3JHH 8 Hz) 129.1
3,5  7.31 (t, 3JHH = 3JHF 8.4 Hz) 116 (d, 2JCF 22 Hz) 7.48 (d, 3JHH 8 Hz) 129.9
4  – 167 (d, 1JCF 255 Hz) –102.1, tt, 3J 8.4, 4J 5.2 Hz – 147
7  – 196 – 197
8  5.09 (q, 3JHH 7 Hz) 60 5.11 (q, 3JHH 7 Hz) 60
9  1.60 (d, 3JHH 7 Hz) 15 1.64 (d, 3JHH 7 Hz) 15
N-CH3 2.81, s 31 2.84, s 31
4-Me  – – 2.48, s 21
benzocaine could cause a serious blood disorder, methemoglobine-
mia  [14,15]. Similar concerns are raised elsewhere, e.g. Taleb and
co-workers review the evidence where even following topical
application of benzocaine, oxidised haemoglobin might increase
causing methemoglobinemia [16]. Even more recently, a few weeks
ago, a case of acquired methemoglobinemia due to the frequent
use of the legal high “Pink Panthers” was reported in parallel with
the increasing prevalence of legal highs particularly those contain-
ing added benzocaine [17]. Benzocaine is currently being used in
the illicit drug market as a common adulterant (cutting agent) to
increase profit [18], indeed it is now commonly found in cocaine
hydrochloride [18–20], which might link the supply of such adul-
terated flephedrone to that of other commonly cut illicit drugs.
Drug dealers may  use benzocaine as it is easily accessible and
similar in physical appearance to flephedrone. In sufficient quan-
tity, benzocaine might be added to flephedrone in order to mimic
the initial numbing (anaesthetic) effect of cocaine [21] and possibly
even to sell the mixture not as flephedrone but as cocaine.
Our rapid analysis and quantification of 4-FMC and benzocaine
compare well with the literature methods [7,12]. Research is also
on-going to replace aspects of wet-chemistry based quantitative
analysis on minimal trace amounts of illegal drugs with rapid
in situ (e.g. potentially on-site analysis in a nightclub) screening
using handheld (therefore portable) spectrophotometers [22,23].
The use of Raman spectroscopy to detect counterfeit medicines
[22] may  be extended to the analysis of street drugs [23], whilst
Fig. 3. 15N-HMBC (500 MHz) spectrum of flephedrone (D2O) (left) showing two 15N–1H couplings (with peak assignments) and 19F NMR  spectrum (1H coupled) of flephedrone
(D2O) (right) (in the presence of ∼7% benzocaine).
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Fig. 4. GC-FID of flephedrone samples impure with benzocaine (showing ring num-
bering systems).
discrimination between simple drug mixtures has been achieved
using a deep ultraviolet-visible (DUV–vis) reflected optical fibre
sensor [24]. Both techniques can detect and possibly quantify
known drugs for which standard spectra are available, but are not
suitable for the analysis of new drugs.
4. Conclusions
The combination of 1H, 13C, 15N, and 19F NMR  spectroscopy was
used to identify and decipher between flephedrone regioisomers
and other cathinones such as mephedrone. We  have separated
flephedrone and benzocaine with base-line resolution by GC-FID
and quantified the amount of benzocaine adulterant in the four
(nightclub) flephedrone samples by GC, the 1H NMR  integration
was in broad agreement. These data show that this now illegal
cathinone-derived stimulant (a high) is now being cut by 5–12%
with benzocaine, so drug users cannot be certain of the purity of
the drug they are taking. Benzocaine as an adulterant can cause seri-
ous health problems, potentially more harmful than flephedrone.
Therefore, there are risks from the pharmaceutically active cutting
agents themselves.
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 Abstract - An amnesty bin was offered by the police at a 
nightclub in Bristol.  It was found to contain different 
numbers of various illegal drug samples.  These were 
provided as:  powders or crystals in folded paper or 
plastic bags, tablets, capsules, or as “rocks” or “bombs” 
(a twisted cigarette paper).  Legal highs, medicinal and 
herbal (cannabis) drugs were detected therein.  1H and 
13C NMR spectroscopy was used as the main analytical 
technique supported by electrospray ionisation-mass 
spectrometry (ESI-MS).  2D NMR (15N, H2BC, HMBC, 
DEPT) analysis was run in some cases to provide 
additional analytical data.  The samples contained drugs 
from different classes, class A (cocaine, crack cocaine, 
ecstasy), class B (mephedrone, flephedrone, cannabis), 




 In the UK, drugs users represent 8.9% of the population 
[1], and the widespread use of drugs is estimated to cost 
society £15.4 bn annually [2]. 
 
MATERIALS AND METHODS 
 
 The Police made available ~200 tablet and powder 
samples from an amnesty bin provided in a Bristol (UK) 
nightclub (2013) (in addition to ~20 herbal samples that 
were not analysed further).  Each tablet and powder sample 
was weighed, labelled, analysed, and identified without any 
initial purification.  Samples (20-50 mg) were dissolved in 
deuteriated solvent (0.6 mL) for Nuclear Magnetic 
Resonance (NMR) spectroscopy, as well as analysed by 
Fourier-transform infrared spectroscopy (FT-IR) and ESI-
MS analysis.  All measurements were run at 20-25 °C on:  a 
Bruker 400 MHz NMR Spectrometer, a Perkin Elmer-
Spectrum 65-FT-IR Spectrometer, and a Bruker Daltonics 
micrOTOF. 
 
RESULTS AND DISCUSSION 
 
A total of seven different classes of drugs were found in 
the amnesty bin.  A crystalline form of ecstasy (MDMA) 
was clearly the dominant drug 68% (129 samples) (see Fig. 
1) alongside 2% (4) MDMA freebase.  The second most 
common drug was ketamine (freebase) 10% (19) followed 
by:  mephedrone (salt) 7% (13); benzocaine 6% (11); 
cocaine (salt) 3% (6); flephedrone (salt) 2% (4); one sample 
of cocaine freebase (crack) and one of Benzo Fury provided 
for “chemical research”.  Of the mephedrone samples, 9 out 
of 13 were cut with monosodium glutamate (MSG) either as 
an easily accessible compound or due to it being similar in 
appearance.  All the flephedrone samples were diluted (cut) 
with benzocaine, a topical anaesthetic. 
 
Fig. 1.  Substances in an amnesty bin from a Bristol nightclub (2013). 
 
A few samples were found to contain such an adulterant 
or cutting agent alone, e.g. benzocaine, creatine, or sugar.  
Benzocaine can mimic the numbing effect of cocaine and 




 Amnesty bin analysis can provide potential information 
about currently abused drugs and possibly about such drug 
availability.  One aim of this study is therefore to elicit any 
trends in such drug abuse, and then to corroborate them with 
regional data to provide better intelligence for police drug 
control.  Drug formulation may determine the route of 
administration e.g. a freebase is likely to be smoked, whilst 
the salt form is mostly administered as an injection or drunk 
if mixed with alcohol.  Despite emerging concerns over new 
psychoactive substances (NPS), class A drugs are still 
available.  These analytical results show the application of 
NMR spectroscopy in drug detection with no need for 
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Forensic analysis of a Glastonbury amnesty bin:   
Evaluation of compact spectrometer techniques compared to NMR 
 
Majdah Alotaibi, Ian S. Blagbrough, and Stephen M. Husbands 
Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, UK 
 
Forensic analysis of amnesty bins provides reliable and quantitative data on identity and 
purity of drug substances.  Identification of cutting agents and their ratios can help link directly to 
a manufacturer or trafficking network.  ATR-FTIR equipped with the TICTAC drug identification 
database was evaluated in this study and compared to NMR to provide a rapid, precise test for 
identifying substances and their impurities in an amnesty bin.  The Glastonbury music festival 
(2013) amnesty bin samples were obtained from the Drug Expert Action Team (DEAT), Avon and 
Somerset Constabulary, UK.  ATR-FTIR spectroscopic analysis was performed on a Bruker FT-
IR spectrometer (ALPHA Bruker Optics, Billerica, MA, USA).  1H NMR data were collected on 
a Bruker 500 MHz NMR spectrometer and NMReady-60 PRO (Nanalysis Corp., Canada). 
ATR-IR was successfully used to identify a wide variety of illicit drug samples, e.g. 
ketamine (22), mephedrone (33), flephedrone (4), cocaine (13), heroin (10), MDMA (76), 
methylone (1), and popper (14).  Both ATR-IR and NMR discriminated between mephedrone and 
flephedrone, but benzocaine as a cutting agent was not recognized by ATR-IR.  The possible 
diversion of street ketamine samples from legal sources was investigated by detecting the low 
levels of preservatives, down to 5 µg/mL, present in pharmaceutical formulations using 1H NMR 
when ATR-IR could not detect such concentrations of these preservatives.  Although ATR-IR 
provides a quick non-destructive method to identify illicit drugs in seized samples, NMR provides 
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To determine the geographical origin of street ketamine samples 
by using 13C and 15N stable isotope ratio analysis 
 
Majdah Alotaibi, Ian S. Blagbrough, and Stephen M. Husbands 
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Abstract - The anaesthetic ketamine is abused for its dissociative effects resulting in it being a controlled 
substance.  There is a need to determine the sources of the abused ketamine, in particular whether it is being 
diverted from legitimate veterinary and clinical supplies or manufactured abroad and imported illegally.  
Element analysis by isotopic ratio was employed to help answer this question.  Therefore, the isotopic ratio 
values of 11 street samples were compared with the available ketamine pharmaceutical products, VetalarTMV 
and Ketalar®, as well as an authentic ketamine HCl sample purchased from Sigma Aldrich. 
 
MATERIALS AND APPARATUS 
 
 Eleven different ketamine samples obtained from different sources were subjected to isotopic ratio 
analysis, EA-IRMS analysis.  VetalarTMV and Ketalar® were purchased as ketamine hydrochloride 
injections, ketamine HCl was purchased from Sigma-Aldrich.  All % elemental data are traceable to The 
National Institute of Standards and Technology (NIST) primary references, with 15N calibrated to reference 
IAEA-N1 ammonium sulfate and 13C calibrated to reference IAEA-CH-3 cellulose. 
 
RESULTS AND DISCUSSION 
 
 We applied the EA-IRMS technique to obtain evidence for any of the seized and amnesty bin 
ketamine samples we are investigating having been diverted from hospital or veterinary supplies.  The δ13C 
‰ and δ15N ‰ values of these samples were therefore compared with the data from ketamine obtained from 
known geographical sources, specifically VetalarTMV (Germany), Ketalar® (Ireland), and authentic ketamine 
HCl (India).  δ13C and δ15N of samples of interest were determined by EA-IRMS, avoiding any extraction 
step to nullify potential isotopic fractionation from the solvent. 
 
Based on the δ13C‰ and δ15N‰ (parts per thousand) values, 8 of the 11 samples can be grouped into 
three sets:  I (seized samples), II (Bristol night club amnesty bin), and III (Glastonbury 2013 amnesty bin).  
The δ15N ‰ isotopic ratios of the 11 samples varied between 4.175 and 13.975‰.  These results show that 
the seized ketamine samples had almost identical values of δ13C‰ and δ15N‰ and therefore might be from a 
single source.  Similarly, all the Bristol night club samples could be grouped together.  The VetalarTMV and 
Ketalar® samples had different δ15N‰, but very close δ13C‰ values which did not match any of the illicit 
samples.  None of the illicit samples had an isotopic ratio fingerprint comparable to the purchased ketamine 




 This study shows the feasibility of using δ13C‰ and δ15N‰ values to link or discriminate between 
various ketamine samples.  None of the illicit samples had isotopic ratio fingerprints equivalent (or even 
similar) to the VetalarTMV and Ketalar® samples, suggesting they had not been diverted from veterinary or 
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Abstract – The identification of fluorine-containing drugs 
and their metabolites can potentially be achieved using 
NMR spectroscopic analysis.  Pharmaceutical analysis of 
flephedrone (4-fluoromethcathinone, 4-FMC) included 
1H, 13C, 19F, 15N HMBC and 15N HSQC spectroscopy and 
electrospray ionisation-mass spectrometry (ESI-MS).  
Analysis of four 4-FMC samples (from a nightclub in 
2013) showed that they all contained benzocaine as a 




Flephedrone (4-fluoromethcathinone, 4-FMC) (Fig. 1) 
was first synthesized in 1952, but surprisingly there is a 
paucity of published data for this compound.  Compared 
with cathinone, the C-F bond on an aromatic ring shows a 
specific polarity effect that might influence receptor binding 




Fig. 1.  Cathinone (a), mephedrone (b), and flephedrone (c). 
 
MATERIALS AND METHODS 
 
Four flephedrone samples were identified in an amnesty 
bin from a nightclub in Bristol (UK) in 2013.  The samples 
were analysed, without any initial purification, at 20-25 °C.  
All reagents were purchased from Sigma-Aldrich, UK.  
Spectroscopic measurements were recorded on a Bruker 500 
MHz NMR Spectrometer, a Perkin Elmer-Spectrum 65-FT-
IR Spectrometer, and a Bruker Daltonics micrOTOF. 
 
RESULTS AND DISCUSSION 
 
A spectroscopic dataset (NMR, FT-IR, MS) was 
acquired for the hydrochloride salt samples.  The structures 
were confirmed by comparing the spectroscopic data with 
the literature values [1].  1H NMR (D2O) δ 8.09-8.05 (2H, 
m, ArH), 7.33-7.29 (2H, m, ArH), 5.09 (1H, q, J 7 Hz, α-
CH), 2.81 (3H, s, N-CH3), 1.60 (3H, d, J 7 Hz, α-CH3); 13C 
NMR (D2O) δ 196 (C=O), 167 (C-F, d, J 254 Hz), 132 
(CHarom, d, J 10 Hz), 129 (Cq, d, J 3 Hz), 116 (CHarom, d, J 
22 Hz), 59 (CH), 31 (N-CH3), 15 (α-CH3) ppm; [M+H]+ 
C10H13FNO requires 182.0981, found 182.0988.  Spectral 
data are compared with mephedrone (4-methylcathinone), a 
closely related cathinone derivative, and the 4-FMC was 
also shown to be impure (i.e. 7, 9, 10, and 13%) with 
benzocaine [2] using 1H and 13C NMR data. 
 
 
19F NMR spectroscopy 
 
The 1H NMR spectrum of 4-FMC shows high similarity 
to cathinone and mephedrone (Fig. 1) and this can lead to 
mis-labelling.  19F NMR spectroscopy proves the presence 
and position of a fluorine atom in such samples.  Comparing 
with the literature data [1], the 19F NMR chemical shift 
values for the 4-FMC samples show para-substitution:  19F 
NMR -102.1 ppm (tt, 3JHF 10 Hz, 4JHF 5 Hz) (Fig. 2). 
 
 




 19F NMR is a useful characteristic signal to decipher 
between flephedrone and other cathinones by providing a 
unique peak at -102 ppm for para-cathinone substituted with 
fluorine.  Benzocaine is a common cutting agent that has 
been used in cutting cocaine and other drugs, which might 
link such adulterated flephedrone to other commonly cut 
drugs [2].  Finally, any harm associated with benzocaine as 
an adulterant can cause a serious health problem, more 
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Abstract - The anaesthetic ketamine is abused for its 
dissociative effects resulting in it being a controlled 
substance.  There is a need to determine the sources of 
the abused ketamine, in particular whether it is being 
diverted from legitimate veterinary and clinical supplies 
or manufactured abroad and imported illegally.  Isotopic 
ratio analysis was employed to help answer this question.  
The isotopic ratio values were compared with 
commercially available pharmaceutical products of 
ketamine, VetalarTMV and Ketalar®, as well as an 




 Reports from UK police services suggest increasing 
ketamine (KT) abuse in many UK regions [1].  The majority 
of illicit KT is pure, not adulterated, suggesting possible 
diversion from hospital or veterinary sources rather than 
synthesis [2].  Isotopic ratio analysis has been utilised to 
establish the geographical origin of various substances, 
including drugs of abuse and their precursors. 
 
MATERIALS AND APPARATUS 
 
 Eleven different ketamine (KT) samples from different 
sources (Table 1) were subjected to EA-IRMS analysis.  
VetalarTMV and Ketalar® were purchased as ketamine 
hydrochloride injections.  Authentic ketamine HCl was 
purchased from Sigma Aldrich.  All % element data are 
traceable to The National Institute of Standards and 
Technology (NIST) primary references, 15N calibrated to  
IAEA-N1 ammonium sulfate and 13C calibrated to reference 
IAEA-CH-3 cellulose.  1H NMR data were collected on a 
Bruker (500 MHz NMR) spectrometer.  Mass spectrometry 
was recorded on a Bruker Daltonics “micrOTOF” 
electrospray ionization mass spectrometer (ESI-MS). 
 
Table 1.  Identification of KT samples by origin 
 
Sample Country of origin Supplier 
VetalarTMV Germany Zoetis UK Limited 
Ketalar® Ireland Pfizer Ltd, Kent, UK 





festival amnesty bin, 
(2013) 
Avon and Somerset 
Constabulary, UK 
AH9, AS5, AV1 A night club in Bristol, 
UK (2013) 
Avon and Somerset 
Constabulary, UK  
K2, K3 Seized samples, Avon 
and Somerset 
Constabulary 
Drug Expert Action Team 
(DEAT), UK 
 
RESULTS AND DISCUSSION 
 
We applied the EA-IRMS technique to provide 
evidence for any of the seized and amnesty bin KT samples 
having been diverted from hospital or veterinary supplies.  
δ13C ‰ and δ15N ‰ values of these samples were compared 
with those from known sources, specifically VetalarTMV, 
Ketalar®, and authentic ketamine HCl. 
 
 δ13C and δ15N of samples of interest were determined by 
EA-IRMS, avoiding any extraction step to nullify potential 
isotopic fractionation from the solvent.  Approximately 10 
mg of the ketamine samples were accurately weighed and 
submitted to the EA-IRMS in a tin capsule. 
Based on the δ13C‰ and δ15N‰ (parts per thousand) 
values (Fig. 1), 8 of the samples could be grouped into three 
sets:  I (seized samples), II (Bristol night club), and III 
(Glastonbury).  The δ15N ‰ isotopic ratios of the 11 
samples varied between 4.175 and 13.975‰.  These results 
showed that the seized ketamine samples (Group I) had 
almost identical values of δ13C‰ and δ15N‰ and therefore 
might be from a single source.  Similarly, all Bristol night 
club samples could be grouped together.  The VetalarTMV 
and Ketalar® samples had different δ15N‰ but very close 
δ13C‰ values and did not match any of the illicit samples.  
None of the illicit samples had an isotopic ratio fingerprint 
comparable to the authentic ketamine (Indian).  Three 

















Fig. 1. δ13C ‰ and δ15N ‰ values for the seized KT samples (*), 
Glastonbury amnesty bin (●), Bristol night club (○), VetalarTMV (◊), 




 This study shows the feasibility of using δ13C‰ and 
δ15N‰ values to link or discriminate between various 
ketamine samples.  None of the illicit samples had isotopic 
ratio fingerprints equivalent (or even similar) to the 
VetalarTMV and Ketalar® samples, suggesting they had not 
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Abstract – Anaesthetic ketamine B.P. is now also known 
as a drug of abuse.  Pharmaceutical products 
VetalarTMV and Ketalar® were analysed by 
spectroscopic profiling (1H and 13C NMR, [α]D20, ESI-MS 
and UPLC/MS/MS) together with many seized and 
amnesty bin samples of ketamine.  It is likely that the 
drug being abused is synthetic rather than diverted B.P. 




 Misuse of ketamine appeared in the 1960s [1], but this 
was not particularly common in Europe until ketamine was 
used as an adulterant in ecstasy tablets in the 1990s [2].  The 
majority of ketamine is pure and not adulterated, but is this 
diverted from pharmaceutical companies, hospital or 
veterinary clinics rather than of synthetic origin, even on a 
large scale [3]?  Based on a most recent update (02.04.15), 
the Veterinary Medicine Directorate (VMD) product 
information database, authorised in the UK, ketamine 
products are available with any of these excipients:   
benzethonium chloride, disodium edetate or chlorocresol in 
solution for injection.  However, hospital versions are 
available with/or without benzethonium chloride as a 
preservative.  The presence of specific organic impurities, 
including excipients in medicines, can be a valuable aid to 
identify and to discriminate between possible sources. 
 
MATERIALS AND METHODS 
 
 Three different seized ketamine (KT) samples (KT-1, 2, 
and 3) were obtained from the Drug Expert Action Team 
(DEAT), Avon and Somerset Constabulary, UK, 39 samples 
were from the Glastonbury music festival (2014) and from a 
night club in Bristol, UK (2013).  Ketamine Hydrochloride 
Injections, VetalarTMV and Ketalar® (100 mg/mL) with 
benzethonium chloride as preservative, 0.01% and 1% w/v 
respectively, were from Pfizer Ltd (Kent, UK).  Reagents 
and solvents were purchased from Sigma-Aldrich, UK. 
 Chromatographic separation was performed on an Ultra 
High Performance LC (UPLC/MS/MS) system (Thermo 
Scientific, Milford, MA, USA); a UPLC method developed 
to detect both ketamine and benzethonium chloride.  NMR 
data were collected on a Bruker (500 MHz) spectrometer.  
Optical rotation data were determined on an ADP-220 
polarimeter (Bellingham and Stanley, Tunbridge Wells, 
UK). 
 
RESULTS AND DISCUSSION 
 
A water suppression technique PURGE (Presaturation 
Utilizing Relaxation Gradients and Echoes) [4] was used to 
detect ketamine and any excipients in the injectable 
solutions of VetalarTMV and Ketalar®.  13C satellites peaks 
were used as the internal standard to calculate sample purity. 
 
Many NMR scans were required to achieve good 
signal/noise for benzethonium chloride at 0.01% w/v.  
Ketamine 13C NMR (D2O):  δ 21.5, 28.1, 29.4, 38.5, 40.2, 
72.5, 128.4, 128.5, 131.6, 131.8, 131.9, 135.1, 205.5 ppm. 
[α]D20 = 0 (c = 1 mg/mL, MeOH).  ESI-MS (positive ion 
mode) calculated for [M+H]+ C13H1735ClNO requires 
238.0993, found 238.0982.  Positive ion ESI-MS also 
showed a molecular ion at m/z 412.3403 which matched the 
m/z value of authentic benzethonium chloride. 
 
 
Fig. 1. 1H NMR of VetalarTMV in D2O (lower) and ketamine spiked with 




 Equal amounts of both enantiomers are present in each 
of the seized and amnesty bin ketamine hydrochloride 
samples.  Based on our results, there is no evidence yet that 
ketamine is diverted from hospital or veterinary sources, 
even though the ketamine used in the UK is a racemic 
mixture of enantiomers.  There is potential that imported 
versions could be (only) S-ketamine, e.g. as used in 
Australia, which is about twice as potent as R-ketamine, and 
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 Abstract - Seventeen samples, provided by the study 
participants, were not of pharmaceutical grade and 
while they were believed to contain MDMA (ecstasy) this 
needed to be confirmed authoritatively as part of a 
clinical study into the unique sociotropic effects of 
MDMA.  In order to identify the components of the 
samples, in particular, to determine if other psychoactive 
substances were present, the crystalline samples were 




 There has been a revival of interest in the use of 
psychedelic and stimulant drugs as therapeutic agents with 
studies suggesting that some compounds (for example 
psilocybin) can induce positive, long-lasting personality 
changes akin to those mediated by prolonged and intensive 
psychotherapy.  3,4-Methylenedioxy-N-methylamphetamine 
(MDMA, ecstasy) has a unique and complex pharmacology, 
acting on the monoamine, oxytocin and vasopressin systems 
[1].  Use of MDMA has been linked to feelings of enhanced 
interpersonal relatedness, or a sense of connection to others, 
activities that have contributed to it being evaluated in a 
number of small-scale clinical trials as an adjunct to 
psychotherapy.  A recent study examined whether ecstasy 
(and therefore, presumably, MDMA) use caused 
subjectively positive or therapeutically relevant effects in 
recreational users [2].  While the findings were supportive 
of a role for ecstasy/MDMA and its proposed use as an 
adjunct to psychotherapy, no chemical analysis was 
performed on the ecstasy samples. Thus, MDMA 
dose/purity, or even whether the samples contained any 
MDMA, was unknown.  This current study therefore aims to 
determine the composition of each ecstasy sample used in a 
similar, recently completed, clinical study. 
 
REAGENTS AND STANDARDS 
 
Methoxyphenamine hydrochloride and formic acid (98-
100%) were purchased from Sigma Aldrich.  A pure (≈ 
99%) sample of MDMA was used as reference material.  
Deuteriated (d4) methanol with 0.05% TMS as internal 
standard was used for NMR analysis and quantification.  All 




All 1H NMR data were collected on a Bruker (500 MHz 
NMR) spectrometer; mass spectrometric data were recorded 
on a Bruker Daltonics “micrOTOF” electrospray ionization 
mass spectrometer (ESI-MS).  Chromatographic separation 
was performed on an Ultra High Performance LC 
(UPLC/MS/MS) system (Thermo Scientific, Milford, MA, 
USA). 
 
RESULTS AND DISCUSSION 
 
UPLC/MS/MS and NMR investigation showed that 16 
out of 17 samples contained MDMA.  Approximately half 
of these samples were highly pure with MDMA content 
>99% (Table 1).  Of those that had been cut with other 
substances, purity ranged from <50% to 83% MDMA.  Four 
samples contained sugar (sucrose and/or glucose) alone or in 
the presence of another substance (in one case, this was a 
psychoactive substance, mephedrone), one sample was cut 
with cocaine (1:1) and the remaining sample (as provided 
and taken by the participant) had no MDMA present. 
 
Table. 1. 1H NMR (500 MHz) of illicit drug samples (CD3OD 0.05%TMS). 
Participant)no. Psychoactive)Substances Impurity) )MDMA)Purity)(%)
1 MDMA − >'99
2,'3' MDMA − >'99
4 'MDMA − >'99
5 MDMA − >'99
6,7,11 MDMA − >'99
8,9 MDMA' − >'99
10 MDMA' − >'99
12 MDMA 'glucose 83%
13,'14 MDMA − >'99
17,'18 MDMA − >'99
19 unknown' unknown
20 MDMA − >'99
21 MDMA glucose 77%
22 MDMA,'mephedrone'(12%) sucrose 77%
23,'24 MDMA sucrose'+'unknown <50%
25 MDMA unknown'insoluble soluble'materials'>99%'
27 MDMA,'cocaine'(50%) − 50%  




 These results will be invaluable in helping to interpret 
the findings of the associated clinical study.  They confirm 
the importance of verifying the chemical composition of 
drug samples used by recreational users as MDMA content 
of the ecstasy samples employed in the current study varied 
from 0 to ~100%.  The presence of other psychoactive 
substances such as cocaine and mephedrone further 
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Abstract – MDMA tablets (75) were received from the 
police from a Bristol night club (2013) and Glastonbury 
amnesty bins (2013).  All the tablets were identified from 
the TICTAC library using Attenuated Total Reflectance 
Fourier Transform Infrared (ATR-FTIR) followed by 1H 
NMR spectroscopy and confirmed by Electrospray 
Ionisation Mass Spectrometry (ESI-MS).  All 75 tablets 
were correctly identified using benchtop ATR-FTIR as 
containing MDMA, but the impurities were not always 
accurately identified.  An advantage of NMR over FT-IR 
is that almost all the soluble contents of the MDMA 




 MDMA is very popular as party drugs in Europe.  These 
drugs commonly available as tablets [1] structure (Fig. 1).  
According to the European Monitoring Centre for Drugs and 
Drug Addiction (EMCDDA), the composition of the 
MDMA tablets is changing all the time in Europe [2]. 
 
MATERIALS AND METHODS 
 
 The Glastonbury music festival (2013) and the Bristol 
night club (2013) amnesty bins samples were obtained from 
the Drug Expert Action Team (DEAT), Avon and Somerset 
Constabulary, UK.  Recrystallized MDMA was prepared 
from pure street samples, analysed by NMR and used as a 
reference material.  Reagents and solvents were purchased 
from Sigma-Aldrich, U.K.  ATR-FTIR spectroscopic 
analysis was performed on a Bruker FT-IR spectrometer 
(ALPHA Bruker Optics, Billerica, MA, U.S.A.) equipped 
with the TICTAC drugs identification database.  1H NMR 
data were collected on a Bruker 500 MHz NMR 
spectrometer.  ESI-MS were obtained on a Bruker MS. 
 
RESULTS AND DISCUSSION 
 
 75 MDMA tablets from DEAT composed of 19 different 
logos, sizes, and colours (Fig. 1).  An FT-IR spectrum from 
a pure sample of MDMA matched well with a spectrum in 
the TICTAC library (Fig. 2).  In the analysis of these tablets, 
this protocol was followed:  tablets were labelled, weighed, 
photographed, and then ground. Part (30 mg) of the ground 
powder was mixed in d4-MeOD (0.6 mL) to extract MDMA 
with brief centrifugation to free from insoluble material, e.g. 
tablet filler or cornflour.  MDMA was confirmed by ESI-
MS.  Another part of the ground powder was used to obtain 
ATR-FTIR data which were automatically matched with the 
TICTAC database.  There was good correlation between 
pure MDMA tablets and the database.  However, in tablets 
containing less than 50% MDMA, the mixture is identified 
incorrectly by this ATR-FTIR library-based approach, e.g. a 
tablet which contained MDMA, caffeine, and amphetamine 





Fig. 1.  MDMA tablets detected in the Glastonbury festival 







Fig. 2.  FT-IR spectrum of a pure MDMA tablet (lower) 
with the matching MDMA (ecstasy) spectrum (upper) from 




 1H NMR is a powerful technique to identify MDMA 
and soluble impurities in seized tablets.  The Alpha 
benchtop FT-IR provides a quick characterization of drugs, 
e.g. MDMA, in seized materials, with the benefit of simple 
sample handling, but mixture analysis is challenging and not 
accurate by FT-IR.  Impurity profiling of the contents of the 
seized MDMA tablets using only the ATR-FTIR technique 
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